<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>chemex21_012616.htm
<DESCRIPTION>CHEMICAL EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>EXHIBIT 2.1&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"><I>EXECUTION COPY</I><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B></B>&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-underline-style: double"><B><U>______________________________________________________________________________</U></B></FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>BY AND BETWEEN</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>CHEMICAL FINANCIAL CORPORATION</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>AND</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0 0 0.25in; text-align: center"><B>TALMER BANCORP, INC.</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Dated as of January 25, 2016</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-underline-style: double"><B><U>___________________________________________________________________________</U></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Table of Contents</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B><U></U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 83%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 7%; text-decoration: underline; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Page</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE I THE MERGER</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effective Time</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effects of the Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conversion of Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock Options and Other Stock-Based Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Articles of Incorporation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bylaws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax Consequences</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bank Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.10</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors and Officers</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.11</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.12</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional Actions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.13</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Right to Revise Structure</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE II DELIVERY OF MERGER CONSIDERATION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chemical to Make Shares Available</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exchange of Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE III REPRESENTATIONS AND WARRANTIES OF TALMER</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Authorization, No Conflicts, Etc.</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Organization and Good Standing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiaries</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Capital Stock</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial Statements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Absence of Certain Changes or Events</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulatory Filings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No Indemnification Claims</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conduct of Business</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transaction Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreements With Bank Regulators</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.14</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Properties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.15</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intellectual Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.16</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Required Licenses, Permits, Etc.</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence -->ii</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.17</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Material Contracts and Change of Control</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.18</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Labor and Employment Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.19</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employee Benefits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.20</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Environmental Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.21</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Duties as Fiduciary</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.22</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investment Bankers and Brokers</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.23</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fairness Opinion</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.24</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Talmer-Related Persons</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.25</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in Business Relationships</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.26</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insurance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.27</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Books and Records</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.28</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan Guarantees</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.29</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Data Security and Customer Privacy</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.30</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance for Loan and Lease Losses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.31</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loans and Investments</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.32</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan Origination and Servicing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.33</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities Laws Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.34</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Joint Ventures; Strategic Alliances</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.35</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Policies and Procedures</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.36</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder Rights Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.37</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Absence of Undisclosed Liabilities</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.38</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No Other Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF CHEMICAL</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Authorization, No Conflicts, Etc.</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Organization and Good Standing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiaries</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Capital Stock</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial Statements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Absence of Certain Changes or Events</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulatory Filings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No Indemnification Claims</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.10</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conduct of Business</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.11</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transaction Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.12</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreements With Bank Regulators</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.13</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax Matters</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.14</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Properties</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intellectual Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.16</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Required Licenses, Permits, Etc.</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.17</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Material Contracts and Change of Control</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.18</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Labor and Employment Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.19</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employee Benefits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.20</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Environmental Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.21</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Duties as Fiduciary</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.22</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investment Bankers and Brokers</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.23</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fairness Opinion</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.24</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chemical-Related Persons</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.25</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in Business Relationships</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.26</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insurance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.27</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Books and Records</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.28</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan Guarantees</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.29</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Data Security and Customer Privacy</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.30</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance for Loan and Lease Losses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.31</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loans and Investments</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.32</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan Origination and Servicing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.33</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities Laws Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.34</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Joint Ventures; Strategic Alliances</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.35</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Policies and Procedures</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.36</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder Rights Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.37</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Absence of Undisclosed Liabilities</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.38</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No Other Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE V COVENANTS RELATING TO CONDUCT OF BUSINESS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conduct of Business Before the Effective Time</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Talmer Forbearances</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chemical Forbearances</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE VI ADDITIONAL AGREEMENTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulatory Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Access to Information; Confidentiality</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">59</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preparation of the Joint Proxy Statement and Registration Statement; Shareholders&rsquo; Meetings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<BR>
60</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NASDAQ Listing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">62</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employee Matters</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">62</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnification; Directors&rsquo; and Officers&rsquo; Insurance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">64</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->iv<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional Agreements</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">65</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Advice of Changes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">65</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No Solicitation by Talmer</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">65</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.10</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No Solicitation by Chemical</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">68</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.11</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Corporate Governance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">71</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.12</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restructuring Efforts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.13</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exemption from Liability Under Section 16(b)</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.14</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trust Preferred Securities; Senior Debt Facility</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.15</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Data Conversion</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.16</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commercially Reasonable Efforts; Cooperation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">73</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.17</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securityholder Litigation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">73</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.18</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expenses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">73</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.19</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fairness Opinions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">73</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.20</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividends</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE VII CONDITIONS PRECEDENT</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conditions to Each Party&rsquo;s Obligation To Effect the Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conditions to Obligations of Talmer</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conditions to Obligations of Chemical</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE VIII TERMINATION AND AMENDMENT</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effect of Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">79</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Extension; Waiver</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE IX&nbsp;&nbsp;DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">82</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE X GENERAL PROVISIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Closing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.2</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonsurvival of Representations, Warranties and Agreements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.3</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notices</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.4</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interpretation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">95</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.5</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Entire Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">95</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.6</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Governing Law</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">96</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.7</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exclusive Jurisdiction</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">96</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.8</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Waiver of Jury Trial</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">96</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.9</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Publicity</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">96</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.10 </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assignment; Third-Party Beneficiaries</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">96</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.11 </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Enforcement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">v<!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.12</FONT></TD>
    <TD STYLE="text-align: justify; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Severability</FONT></TD>
    <TD STYLE="text-align: right; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">97</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.13</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Counterparts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.14</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Construction</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.15</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Calculation of Dates and Deadlines</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>EXHIBITS</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">EXHIBIT A-1</FONT></TD>
    <TD STYLE="width: 7%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD>
    <TD STYLE="width: 70%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">FORM OF TALMER SUPPORT AGREEMENT</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">EXHIBIT A-2</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">FORM OF CHEMICAL SUPPORT AGREEMENT</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">vi<!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This AGREEMENT AND
PLAN OF MERGER (this &ldquo;<B><I>Agreement</I></B>&rdquo;), dated as of January 25, 2016, is entered into by and between Chemical
Financial Corporation, a Michigan corporation (&ldquo;<B><I>Chemical</I></B>&rdquo;), and Talmer Bancorp, Inc., a Michigan corporation
(&ldquo;<B><I>Talmer</I></B>&rdquo;). Each of Chemical and Talmer is referred to herein as a &ldquo;<B><I>Party</I></B>&rdquo;
and, together, as the &ldquo;<B><I>Parties</I></B>.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>W I T N E S S E T H:</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B>
the Boards of Directors of Chemical and Talmer (the &ldquo;<B><I>Chemical Board</I></B>&rdquo; and the &ldquo;<B><I>Talmer Board</I></B>,&rdquo;
respectively) have determined that it is in the best interests of their respective companies and their shareholders to consummate
the strategic business combination transaction provided for in this Agreement in which Talmer will, on the terms and subject to
the conditions set forth in this Agreement, merge with and into Chemical (the &ldquo;<B><I>Merger</I></B>&rdquo;), so that Chemical
is the surviving corporation in the Merger (sometimes referred to in such capacity as the &ldquo;<B><I>Surviving Corporation</I></B>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B>
the Chemical Board and the Talmer Board have each adopted this Agreement, duly authorized the Merger and the other transactions
contemplated hereby, and resolved to recommend that the shareholders of each of Chemical and Talmer approve this Agreement and
the transactions contemplated hereby, including the Merger;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>concurrently
with the execution of this Agreement, each member of the Chemical Board and each member of the Talmer Board is entering into a
voting and support agreement substantially in the forms attached hereto as <U>Exhibit A-1</U> and <U>Exhibit A-2</U>, respectively
(each, a &ldquo;<B><I>Support Agreement</I></B>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B>
it is intended that, following the Merger, Talmer Bank and Trust, a Michigan banking corporation and wholly-owned subsidiary of
Talmer (&ldquo;<B><I>Talmer Bank</I></B>&rdquo;), will be merged with and into Chemical Bank, a Michigan banking corporation and
wholly-owned subsidiary of Chemical (&ldquo;<B><I>Chemical Bank</I></B>&rdquo;), so that Chemical Bank is the surviving bank (sometimes
referred to in such capacity as the &ldquo;<B><I>Surviving Bank</I></B>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B>
for federal income Tax purposes, it is intended that the Merger shall qualify as a reorganization under the provisions of Section
368(a) of the Internal Revenue Code of 1986, as amended and including the Treasury Regulations promulgated thereunder (the &ldquo;<B><I>Code</I></B>&rdquo;);
and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B>
the Parties desire to make certain representations, warranties and agreements in connection with the Merger and to prescribe certain
conditions precedent to the Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B>
in consideration of the mutual covenants, representations, warranties, and agreements contained in this Agreement, and other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby,
the Parties agree as follows:</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">1<!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
I</FONT><BR>
THE <FONT STYLE="color: windowtext">MERGER</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>The
<FONT STYLE="color: windowtext">Merger</FONT></U>. Subject to the terms and conditions of this <FONT STYLE="color: windowtext">Agreement</FONT>,
in accordance with the Michigan Business Corporation Act (the &ldquo;<FONT STYLE="color: windowtext"><B><I>MBCA</I></B></FONT>&rdquo;),
at the <FONT STYLE="color: windowtext">Effective Time</FONT>, <FONT STYLE="color: windowtext">Talmer </FONT>shall merge with and
into <FONT STYLE="color: windowtext">Chemical</FONT>. <FONT STYLE="color: windowtext">Chemical </FONT>shall be the surviving entity
in the <FONT STYLE="color: windowtext">Merger </FONT>and shall continue its corporate existence under the laws of the State of
Michigan. As of the <FONT STYLE="color: windowtext">Effective Time</FONT>, the separate corporate existence of <FONT STYLE="color: windowtext">Talmer
</FONT>shall cease.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective
Time</U></FONT>. <FONT STYLE="font-family: Times New Roman, Times, Serif">The <FONT STYLE="color: windowtext">Merger </FONT>shall
become effective on the date and at the time for effectiveness set forth in the <FONT STYLE="color: windowtext">Certificate of
Merger </FONT>(the &ldquo;<FONT STYLE="color: windowtext"><B><I>Effective Time</I></B></FONT>&rdquo;) accepted for filing by the
Michigan Department of Licensing and Regulatory Affairs (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Certificate of Merger</I></B></FONT>&rdquo;).
The <FONT STYLE="color: windowtext">Parties </FONT>agree, if requested by <FONT STYLE="color: windowtext">Chemical</FONT>, that
the <FONT STYLE="color: windowtext">Effective Time </FONT>shall occur on either the last day or the first day of a month, but shall
not occur during a month in which a calendar quarter ends.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effects
of the <FONT STYLE="color: windowtext">Merger</FONT></U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">At and after
the <FONT STYLE="color: windowtext">Effective Time</FONT>, the <FONT STYLE="color: windowtext">Merger </FONT>shall have the effects
set forth in this <FONT STYLE="color: windowtext">Agreement </FONT>and in the relevant provisions of the <FONT STYLE="color: windowtext">MBCA</FONT>.
Without limiting the generality of the foregoing, and subject thereto, at the <FONT STYLE="color: windowtext">Effective Time</FONT>,
all the property, rights, privileges, powers, and franchises of <FONT STYLE="color: windowtext">Talmer </FONT>shall vest in the
<FONT STYLE="color: windowtext">Surviving Corporation</FONT>, and all debts, liabilities, and duties of <FONT STYLE="color: windowtext">Talmer
</FONT>shall become the debts, liabilities, and duties of the <FONT STYLE="color: windowtext">Surviving Corporation</FONT>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conversion
of Shares</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">At the <FONT STYLE="color: windowtext">Effective Time</FONT>,
by virtue of the <FONT STYLE="color: windowtext">Merger </FONT>and without any further <FONT STYLE="color: windowtext">action </FONT>on
the part of <FONT STYLE="color: windowtext">Chemical</FONT>, <FONT STYLE="color: windowtext">Talmer</FONT>, or the holder of any
of the following securities:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
share of Common Stock, $1.00 par value per share, of <FONT STYLE="color: windowtext">Chemical </FONT>(the &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Common Stock</I></B></FONT>&rdquo;) issued and outstanding immediately prior to the <FONT STYLE="color: windowtext">Effective Time
</FONT>shall remain issued and outstanding and shall not be affected by the <FONT STYLE="color: windowtext">Merger</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
shares of <FONT STYLE="color: windowtext">Class A Common Stock</FONT>, $1.00 par value per share, of Talmer (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Common Stock</I></B></FONT>&rdquo;) issued and outstanding immediately prior to the <FONT STYLE="color: windowtext">Effective Time
</FONT>that are owned, directly or indirectly, by <FONT STYLE="color: windowtext">Talmer </FONT>or <FONT STYLE="color: windowtext">Chemical
</FONT>(other than <FONT STYLE="color: windowtext">Trust Account Shares </FONT>and other than shares of <FONT STYLE="color: windowtext">Talmer
Common Stock </FONT>held as a result of debts previously contracted) shall no longer be outstanding, shall automatically be cancelled,
and shall cease to exist, and no <FONT STYLE="color: windowtext">Chemical Common Stock </FONT>or other consideration shall be delivered
in exchange therefor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject
to <U>Section <FONT STYLE="color: windowtext">1.4(e)</FONT></U>, each share of <FONT STYLE="color: windowtext">Talmer Common Stock</FONT>,
except for shares of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>owned by <FONT STYLE="color: windowtext">Chemical</FONT>,
<FONT STYLE="color: windowtext">Talmer</FONT>, or any of their respective wholly-owned <FONT STYLE="color: windowtext">Subsidiaries
</FONT>(other than <FONT STYLE="color: windowtext">Trust Account Shares </FONT>and shares of <FONT STYLE="color: windowtext">Talmer
Common Stock </FONT>held as a result of debts previously contracted), shall be converted into the right to receive (i) 0.4725
shares (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Exchange Ratio</I></B></FONT>&rdquo;) of validly issued, fully paid,
and nonassessable shares of <FONT STYLE="color: windowtext">Chemical Common Stock (</FONT>the &ldquo;<FONT STYLE="color: windowtext"><B><I>Stock
Consideration</I></B></FONT>&rdquo;); and (ii) $1.61<FONT STYLE="color: windowtext"> </FONT>in cash, without interest (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Cash
Consideration</I></B></FONT>&rdquo; and, together with the <FONT STYLE="color: windowtext">Stock Consideration</FONT>, the &ldquo;<FONT STYLE="color: windowtext"><B><I>Merger
Consideration</I></B></FONT>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">2</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
of the shares of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>converted into the right to receive the <FONT STYLE="color: windowtext">Merger
Consideration </FONT>pursuant to this <U>Article <FONT STYLE="color: windowtext">I</FONT></U><FONT STYLE="color: windowtext"> </FONT>shall
no longer be outstanding, shall automatically be cancelled, and shall cease to exist as of the <FONT STYLE="color: windowtext">Effective
Time</FONT>, and each book entry notation of record ownership and each certificate previously representing any such shares of <FONT STYLE="color: windowtext">Talmer
Common Stock </FONT>shall thereafter represent only the right to receive the <FONT STYLE="color: windowtext">Merger Consideration
</FONT>into which the shares of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>represented by such book entry notation
of record ownership or such certificate have been converted pursuant to this <U>Section <FONT STYLE="color: windowtext">1.4</FONT></U>,
as well as any dividends to which holders of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>become entitled in accordance
with <U>Section <FONT STYLE="color: windowtext">2.2</FONT></U><FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I</FONT>f,
between the date of this <FONT STYLE="color: windowtext">Agreement </FONT>and the <FONT STYLE="color: windowtext">Effective Time</FONT>,
there is declared (with an <FONT STYLE="color: windowtext">effective time </FONT>prior to the <FONT STYLE="color: windowtext">Effective
Time</FONT>) or effected a reorganization, reclassification, recapitalization, stock split (<FONT STYLE="color: windowtext">including
</FONT>a reverse stock split), split-up, stock dividend or stock distribution (<FONT STYLE="color: windowtext">including </FONT>any
dividend or distribution of securities convertible into <FONT STYLE="color: windowtext">Chemical Common Stock </FONT>or <FONT STYLE="color: windowtext">Talmer
Common Stock</FONT>), combination, exchange, or readjustment of shares with respect to, or rights issued in respect of, <FONT STYLE="color: windowtext">Chemical
Common Stock </FONT>or <FONT STYLE="color: windowtext">Talmer Common Stock</FONT>, the <FONT STYLE="color: windowtext">Exchange
Ratio </FONT>shall be proportionately adjusted accordingly to provide to the holders of <FONT STYLE="color: windowtext">Talmer
Common Stock </FONT>the same economic effect as contemplated by this <FONT STYLE="color: windowtext">Agreement </FONT>prior to
such event. Notwithstanding any other provisions of this <U>Section <FONT STYLE="color: windowtext">1.4(e)</FONT></U>, no adjustment
shall be made in the event of the issuance of additional shares of <FONT STYLE="color: windowtext">Chemical Common Stock </FONT>or
<FONT STYLE="color: windowtext">Talmer Common Stock </FONT>pursuant to any dividend reinvestment plan or direct investment plan
of <FONT STYLE="color: windowtext">Chemical </FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, as applicable, pursuant to
the exercise of stock options awarded under any director, employee or <FONT STYLE="color: windowtext">affiliate </FONT>stock option
plans of <FONT STYLE="color: windowtext">Chemical </FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, as applicable, or their
<FONT STYLE="color: windowtext">Subsidiaries</FONT>, or upon the grant or sale of shares or rights to receive shares to or for
the account of any director, employee, or <FONT STYLE="color: windowtext">Affiliate </FONT>of <FONT STYLE="color: windowtext">Chemical
</FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, as applicable, or any of their <FONT STYLE="color: windowtext">Subsidiaries
</FONT>pursuant to any stock option or other compensation or benefit plans of <FONT STYLE="color: windowtext">Chemical </FONT>or
<FONT STYLE="color: windowtext">Talmer</FONT>, as applicable, or in connection with the issuance of shares as consideration in
a transaction where <FONT STYLE="color: windowtext">Chemical </FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, as applicable,
is the <FONT STYLE="color: windowtext">surviving corporation </FONT>or in connection with any offering of shares where <FONT STYLE="color: windowtext">Chemical
</FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, as applicable, receives consideration in exchange for the shares so offered.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Stock
Options and Other Stock-Based Awards</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Unless
otherwise expressly provided in this <FONT STYLE="color: windowtext">Agreement</FONT>, the provisions of this <U>Section <FONT STYLE="color: windowtext">1.5</FONT></U><FONT STYLE="color: windowtext">
</FONT>pertain to all plans sponsored by <FONT STYLE="color: windowtext">Talmer </FONT>under which options, restricted stock and
other stock-based awards are granted, and the award agreements thereunder (collectively, the &ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Stock Plans</I></B></FONT>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As of the Effective Time, each outstanding option to purchase a share or shares of Talmer Common Stock (each,
a &ldquo;<B><I>Talmer Stock Option</I></B>&rdquo;), excluding any Talmer Stock Options cancelled immediately prior to the Effective
Time in accordance with <U>Section 1.5(c)</U>) (the &ldquo;<B><I>Cancelled Talmer Stock Options</I></B>&rdquo;), shall be assumed
by Chemical substantially in accordance with the terms of the Talmer Stock Plans and the option grants or other award agreements
by which they are evidenced in accordance with the terms of the applicable Talmer Stock Plans, such that after the Merger and without
any action on the part of the holders of such Talmer Stock Options, the Talmer Stock Options shall be converted into and become
stock options with respect to Chemical Common Stock (each, a &ldquo;<B><I>Surviving Corporation Stock </I></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">3</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B><I>Option</I></B>&rdquo;). From
and after the Effective Time, (i) each Talmer Stock Option may be exercised solely for shares of Chemical Common Stock; (ii) the
number of shares of Chemical Common Stock subject to such Talmer Stock Option shall be equal to the product of (A) the total number
of shares of Talmer Common Stock subject to such Talmer Stock Option <I>multiplied by</I> (B) the Equity Award Exchange Ratio,
rounded up or down, if necessary, to the nearest whole share of Chemical Common Stock; and (iii) the per-share exercise price under
each such Talmer Stock Option shall be adjusted to equal the quotient of (x) the exercise price per share of such Talmer Stock
Option at which such Talmer Stock Option was exercisable immediately prior to the Effective Time <I>divided by</I> (y) the Equity
Award Exchange Ratio, rounded up or down to the nearest whole cent, if necessary. For purposes of this Agreement, the &ldquo;<B><I>Equity
Award Exchange Ratio</I></B>&rdquo; shall mean the sum of (1) the Exchange Ratio <I>plus</I> (2) the quotient of (I) the Cash Consideration
<I>divided by</I> (II) the Chemical Closing Price.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer may offer to cancel, effective immediately prior to the Effective Time, up to twenty-five percent (25%)
of the Talmer Stock Options outstanding as of the date of this Agreement. In exchange for the cancellation of any such Cancelled
Talmer Stock Options, each holder thereof shall be entitled to receive, for each Cancelled Talmer Stock Option, cash in an amount
equal to the Option Cash-Out Consideration, less any required withholding taxes. For purposes of this Agreement, the &ldquo;<FONT STYLE="font: 12pt Times New Roman, Times, Serif"><B><I>Option
Cash-Out Consideration</I></B>&rdquo; shall mean, for each Cancelled Talmer Stock Option, cash in an amount equal to the difference
between (i) the sum of (A) the product of (x) the Exchange Ratio <I>multiplied by </I>(y) the Chemical Closing Price, <I>plus</I>
(B) the Cash Consideration, <I>minus</I> (ii) the per-share exercise price under each such Cancelled Talmer Stock Option. Prior
to any offer by Talmer to cancel Talmer Stock Options in accordance with this <U>Section 1.5(c)</U>, the Parties shall mutually
agree regarding which holders of Talmer Stock Options may be given the opportunity to cancel Talmer Stock Options in exchange for
the Option Cash-Out Consideration in accordance with this <U>Section 1.5(c)</U> and the manner in which Talmer would make any such
offer to any such holders of Talmer Stock Options</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
restricted stock award granted under a <FONT STYLE="color: windowtext">Talmer Stock Plan </FONT>(a &ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Stock Award</I></B></FONT>&rdquo;) which is unvested or contingent and outstanding immediately prior to the <FONT STYLE="color: windowtext">Effective
Time </FONT>shall cease, at the <FONT STYLE="color: windowtext">Effective Time</FONT>, to represent any rights with respect to
shares of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>and shall be converted, without any <FONT STYLE="color: windowtext">action
</FONT>on the part of the holder thereof, into a restricted stock award of <FONT STYLE="color: windowtext">Chemical </FONT>(a &ldquo;<FONT STYLE="color: windowtext"><B><I>Surviving
Corporation Stock Award</I></B></FONT>&rdquo;), on the same terms and conditions as were applicable under the applicable <FONT STYLE="color: windowtext">Talmer
Stock Plans </FONT>(but taking into account any changes thereto, <FONT STYLE="color: windowtext">including </FONT>any acceleration
of vesting thereof, provided for in the applicable <FONT STYLE="color: windowtext">Talmer Stock Plans </FONT>or in the related
award document by reason of the <FONT STYLE="color: windowtext">Merger</FONT>). The <FONT STYLE="color: windowtext">number of shares
of Chemical Common Stock subject to each such Surviving Corporation Stock Award </FONT>shall be equal to the product of (i) the
total <FONT STYLE="color: windowtext">number of shares of Talmer Common Stock subject to the Talmer Stock Award </FONT><I>multiplied
by</I> (ii) the <FONT STYLE="color: windowtext">Equity Award Exchange Ratio</FONT>, rounded up or down, if necessary, to the nearest
whole share of <FONT STYLE="color: windowtext">Chemical Common Stock</FONT>. <FONT STYLE="color: windowtext">Talmer </FONT>or <FONT STYLE="color: windowtext">Chemical</FONT>,
as applicable, shall be entitled to deduct and withhold such amounts as may be required to be deducted and withheld under the <FONT STYLE="color: windowtext">Code
</FONT>and any applicable state or local <FONT STYLE="color: windowtext">Tax </FONT>laws with respect to the lapsing of any restrictions
on <FONT STYLE="color: windowtext">Talmer Stock Awards </FONT>pursuant to this <U>Section <FONT STYLE="color: windowtext">1.5(d)</FONT></U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical shall
take all corporate action necessary to reserve a sufficient number of shares of Chemical Common Stock for delivery upon the exercise
or settlement of </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">4</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">each of the Surviving Corporation Stock Options and the Surviving Corporation Stock Awards. As soon as reasonably
practicable after the Effective Time, if and to the extent necessary to cause a sufficient number of shares of Chemical Common
Stock to be registered and issuable upon the exercise or settlement of the Surviving Corporation Stock Options and the Surviving
Corporation Stock Awards, Chemical shall file a post-effective amendment to the Form S-4 or one or more registration statements
on Form S-8 (or any successor or other appropriate form) with respect to the shares of Chemical Common Stock subject to the Surviving
Corporation Stock Options or Surviving Corporation Stock Awards and shall use its commercially reasonable efforts to maintain the
effectiveness of such registration statement or registration statements (and maintain the current status of the prospectus or prospectuses
contained therein) for so long as such Surviving Corporation Stock Options and Surviving Corporation Stock Awards remain outstanding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(f)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At or prior to the <FONT STYLE="color: windowtext">Effective Time</FONT>, <FONT STYLE="color: windowtext">Chemical</FONT>,
the <FONT STYLE="color: windowtext">Chemical Board</FONT>, and the compensation committee of the <FONT STYLE="color: windowtext">Chemical
Board</FONT>, as applicable, and <FONT STYLE="color: windowtext">Talmer</FONT>, the <FONT STYLE="color: windowtext">Talmer Board
</FONT>and the compensation committee of the <FONT STYLE="color: windowtext">Talmer Board</FONT>, as applicable, shall adopt any
resolutions and take any actions (<FONT STYLE="color: windowtext">including </FONT>obtaining any <FONT STYLE="color: windowtext">Talmer
</FONT>or Talmer Bank employee or other participant consents or providing any required or advisable notices to any <FONT STYLE="color: windowtext">Talmer
</FONT>or Talmer Bank employee) necessary to effectuate the provisions of this <U>Section <FONT STYLE="color: windowtext">1.5</FONT></U><FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Articles
of Incorporation</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">At the <FONT STYLE="color: windowtext">Effective
Time</FONT>, the <FONT STYLE="color: windowtext">Articles of Incorporation of Chemical</FONT>, <FONT STYLE="color: windowtext">including
</FONT>any amendments thereto (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical Articles</I></B></FONT>&rdquo;), shall
be the <FONT STYLE="color: windowtext">Articles of Incorporation </FONT>of the <FONT STYLE="color: windowtext">Surviving Corporation
</FONT>until thereafter amended in accordance with applicable <FONT STYLE="color: windowtext">Law</FONT>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Bylaws</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">At the <FONT STYLE="color: windowtext">Effective Time</FONT>, the <FONT STYLE="color: windowtext">Bylaws
of Chemical</FONT>, <FONT STYLE="color: windowtext">including </FONT>any amendments thereto (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Bylaws</I></B></FONT>&rdquo;), shall be the Bylaws of the <FONT STYLE="color: windowtext">Surviving Corporation </FONT>until thereafter
amended in accordance with applicable <FONT STYLE="color: windowtext">Law</FONT>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">1.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
</U></FONT><U>Consequences</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">It is intended that the <FONT STYLE="color: windowtext">Merger
</FONT>shall constitute a &ldquo;<FONT STYLE="color: windowtext">reorganization</FONT>&rdquo; within the meaning of Section 368(a)
of the <FONT STYLE="color: windowtext">Code</FONT>, and that this <FONT STYLE="color: windowtext">Agreement </FONT>shall constitute
a &ldquo;<FONT STYLE="color: windowtext">plan of reorganization</FONT>&rdquo; for purposes of Sections 354 and 361 of the <FONT STYLE="color: windowtext">Code
(collectively, the &ldquo;<B><I>Intended Tax Treatment</I></B>&rdquo;)</FONT>. Each <FONT STYLE="color: windowtext">Party </FONT>shall
not, and shall not <FONT STYLE="color: windowtext">permit </FONT>any of its respective <FONT STYLE="color: windowtext">Subsidiaries
</FONT>to, take any <FONT STYLE="color: windowtext">action</FONT> or fail to take any <FONT STYLE="color: windowtext">action</FONT>
that would reasonably be expected to jeopardize the qualification of the <FONT STYLE="color: windowtext">Merger </FONT>as a reorganization
under Section 368(a) of the <FONT STYLE="color: windowtext">Code</FONT>. Each <FONT STYLE="color: windowtext">Party </FONT>shall
<FONT STYLE="color: windowtext">use commercially reasonable efforts</FONT>, and shall cause their respective <FONT STYLE="color: windowtext">Subsidiaries
</FONT>to <FONT STYLE="color: windowtext">use commercially reasonable efforts</FONT>, to cause the <FONT STYLE="color: windowtext">Merger
</FONT>to qualify as a reorganization within the meaning of Section 368(a) of the <FONT STYLE="color: windowtext">Code</FONT>,
<FONT STYLE="color: windowtext">including </FONT>providing reasonable and customary representations, covenants and certificates
requested by legal counsel. Within forty-five (45) days following the <FONT STYLE="color: windowtext">Effective Time</FONT>, the
Surviving Corporation shall comply with the reporting requirements of Section 1.6045B-1(a)(2) of the Treasury Regulations. Each
<FONT STYLE="color: windowtext">Party </FONT>shall report the Merger as a reorganization within the meaning of Section 368(a) of
the <FONT STYLE="color: windowtext">Code </FONT>on its United States federal income <FONT STYLE="color: windowtext">Tax Return</FONT>,
unless otherwise required pursuant to a &ldquo;<FONT STYLE="color: windowtext">determination</FONT>&rdquo; within the meaning of
Section 1313(a) of the <FONT STYLE="color: windowtext">Code</FONT>. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bank Merger</U>. Following the Merger, Talmer Bank shall merge with and into Chemical Bank (the &ldquo;<B><I>Bank Merger</I></B>&rdquo;).
Chemical Bank shall be the surviving entity in the Bank </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">5</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Merger and shall continue its corporate existence. Following the Bank Merger,
the separate corporate existence of Talmer Bank shall cease. The Bank Merger shall be effected pursuant to a subsidiary plan of
merger in a form to be mutually agreed upon by the Parties (the &ldquo;<B><I>Subsidiary Plan of Merger</I></B>&rdquo;). In order
to obtain the Regulatory Approvals for the Bank Merger, the Parties shall cause the following to be accomplished prior to the filing
of applications for such Regulatory Approvals: (a) Chemical shall cause Chemical Bank to approve the Subsidiary Plan of Merger;
(b) Chemical, as the sole shareholder of Chemical Bank, shall approve the Subsidiary Plan of Merger; (c) Chemical shall cause Chemical
Bank to duly execute and deliver the Subsidiary Plan of Merger to Talmer; (d) Talmer shall cause Talmer Bank to approve the Subsidiary
Plan of Merger; (e) Talmer, as the sole shareholder of Talmer Bank, shall approve the Subsidiary Plan of Merger; and (f) Talmer
shall cause Talmer Bank to duly execute and deliver the Subsidiary Plan of Merger to Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.10&nbsp;
&nbsp; &nbsp; &nbsp; &nbsp;<U>Directors and Officers</U>. At the Effective Time, (a) the directors of the Surviving Corporation
shall be as set forth in <U>Section 6.11(a)</U> until such time as their successors are duly elected and qualified; and (b) the
officers of the Surviving Corporation shall be as set forth in <U>Section 6.11(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Name</U>. At the Effective
Time, the name of the Surviving Corporation shall be &ldquo;Chemical Financial Corporation.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Actions</U>.
At any time after the Effective Time, the Surviving Corporation may determine that deeds, assignments, or assurances or any other
acts are necessary or desirable to vest, perfect, or confirm, of record or otherwise, in the Surviving Corporation its rights,
title, or interest in, to, or under any of the rights, properties, or assets of Chemical and Talmer acquired or to be acquired
by the Surviving Corporation as a result of, or in connection with, the Merger, or to otherwise carry out the purposes of this
Agreement. Chemical and Talmer grant to the Surviving Corporation an irrevocable power of attorney to execute and deliver all such
deeds, assignments, and assurances and to do all acts necessary, proper, or convenient to accomplish this purpose. This irrevocable
power of attorney shall only be operative following the Effective Time and at such time the officers and directors of the Surviving
Corporation shall be fully authorized in the name of Chemical and Talmer to take any and all such actions contemplated by this
Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right to Revise Structure</U>.
At Chemical&rsquo;s election, the Merger may be alternatively structured so that (a) Talmer is merged with and into any direct
or indirect wholly-owned subsidiary of Chemical or (b) any direct or indirect wholly-owned subsidiary of Chemical is merged with
and into Talmer; <I>provided, however</I>, that no such change shall (i) alter or change the amount or kind of the Merger Consideration
or the treatment of the holders of Talmer Common Stock; (ii) prevent the Parties from obtaining the opinions of legal counsel referred
to in <U>Section 7.2(e)</U> and <U>Section 7.3(e)</U> or otherwise cause the Merger to fail to qualify for the Intended Tax Treatment;
or (iii) materially impede or delay consummation of the transactions contemplated by this Agreement. In the event of such an election,
the Parties agree to execute an appropriate amendment to this Agreement (to the extent such amendment only changes the method of
effecting the business combination and does not substantively affect this Agreement or the rights and obligations of the Parties
or their respective shareholders) in order to reflect such election.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">6</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
II</FONT><BR>
DELIVERY OF <FONT STYLE="color: windowtext">MERGER CONSIDERATION</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Chemical
</U></FONT><U>to Make Shares Available</U>. <FONT STYLE="color: black">At or prior to the <FONT STYLE="font: 12pt Times New Roman, Times, Serif">Effective Time, Chemical shall deposit,
or shall cause to be deposited, with Computershare Investor Services, LLC or such other bank or trust company designated by Chemical
and reasonably acceptable to Talmer (the &ldquo;<B><I>Exchange Agent</I></B>&rdquo;), for the benefit of the holders of certificates
representing shares of Talmer Common Stock immediately prior to the Effective Time (&ldquo;<B><I>Talmer Certificates</I></B>,&rdquo;
it being understood that any reference herein to &ldquo;Talmer Certificate&rdquo; shall be deemed to include reference to book-entry
account statements relating to the ownership of shares of Talmer Common Stock, and it being further understood that provisions
herein relating to Talmer Certificates shall be interpreted in a manner that appropriately accounts for book-entry shares, including
that, in lieu of delivery of a Talmer Certificate and a letter of transmittal as specified herein, shares held in book-entry form
may be transferred by means of an &ldquo;agent&rsquo;s message&rdquo; to the Exchange Agent or such other evidence of transfer
as the Exchange Agent may reasonably request), for exchange in accordance with this <U>Article II</U>, (a) evidence of shares in
book-entry form representing shares of Chemical Common Stock (collectively, &ldquo;<B><I>Chemical Certificates</I></B>&rdquo;)
to be issued pursuant to this Agreement and exchanged pursuant to <U>Section 2.2(a)</U> in exchange for outstanding shares of Talmer
Common Stock, and (b) cash in an amount sufficient to pay (i)&nbsp;the Cash Consideration and (ii) cash in lieu of issuing any
fractional shares (such cash and Chemical Certificates described in the foregoing clauses (a) and (b), together with any dividends
or distributions with respect thereto, being hereinafter referred to as the &ldquo;<B><I>Exchange Fund</I></B>&rdquo;)</FONT>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exchange
of Shares</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 11pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
promptly as practicable after the Effective Time, but in no event later than ten (10) days thereafter, Chemical shall cause the
Exchange Agent to mail to each holder of record of one or more Talmer Certificates representing shares of Talmer Common Stock immediately
prior to the Effective Time that have been converted at the Effective Time into the right to receive the Merger Consideration pursuant
to <U>Article I</U>, a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to
the Talmer Certificates shall pass, only upon proper delivery of the Talmer Certificates to the Exchange Agent) and instructions
for use in effecting the surrender of the Talmer Certificates in exchange for certificates representing the number of whole shares
of Chemical Common Stock, any cash in lieu of fractional shares, and the Cash Consideration that the shares of Talmer Common Stock
represented by such Talmer Certificate or Talmer Certificates shall have been converted into the right to receive pursuant to this
Agreement, as well as any dividends or distributions to be paid pursuant to <U>Section 2.2(b)</U>. From and after the Effective
Time, upon proper surrender of a Talmer Certificate or Talmer Certificates for exchange and cancellation to the Exchange Agent,
together with such properly completed letter of transmittal, duly executed, the holder of such Talmer Certificate or Talmer Certificates
shall be entitled to receive in exchange therefor, as applicable, (i) book-entry shares representing that number of whole shares
of Chemical Common Stock to which such holder of Talmer Common Stock shall have become entitled pursuant to the provisions of <U>Article
I</U> and (ii) a check representing the amount of (A) the Cash Consideration which such holder has the right to receive in respect
of the Talmer Certificate or Talmer </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">7</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Certificates surrendered pursuant to the provisions of this <U>Article II</U>, (B) any cash
in lieu of fractional shares which such holder has the right to receive in respect of the Talmer Certificate or Talmer Certificates
surrendered pursuant to the provisions of this <U>Article II</U>, and (C) any dividends or distributions which the holder thereof
has the right to receive pursuant to this <U>Section 2.2</U>, and the Talmer Certificate or Talmer Certificates so surrendered
shall forthwith be cancelled. Until surrendered as contemplated by this <U>Section 2.2</U>, each Talmer Certificate shall be deemed
at any time after the Effective Time to represent only the right to receive, upon surrender, the Merger Consideration, any cash
in lieu of fractional shares payable pursuant to <U>Section 2.2(e)</U>, and any cash in respect of dividends or distributions as
contemplated by this <U>Section 2.2</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No dividends
or other distributions declared with respect to Chemical Common Stock shall be paid to the holder of any unsurrendered Talmer Certificate
until the holder thereof has surrendered such Talmer Certificate in accordance with this <U>Article II</U>. After the surrender
of a Talmer Certificate in accordance with this <U>Article II</U>, the record holder thereof shall be entitled to receive any such
dividends or other distributions, without any interest thereon, with respect to the whole shares of Chemical Common Stock that
the shares of Talmer Common Stock represented by such Talmer Certificate have been converted into (i) with a record date and a
payment date on or after the Effective Time and on or prior to the date of such surrender, and (ii) at the appropriate payment
date, with a record date on or after the Effective Time but prior to the date of such surrender and a payment date subsequent to
the date of such surrender.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any Chemical
Certificate representing shares of Chemical Common Stock is to be issued in a name other than that in which the Talmer Certificate
or Talmer Certificates surrendered in exchange therefor is or are registered, it shall be a condition to the issuance thereof that
the Talmer Certificate or Talmer Certificates so surrendered shall be properly endorsed (or accompanied by an appropriate instrument
of transfer) and otherwise in proper form for transfer, and that the Person requesting such exchange shall pay to the Exchange
Agent in advance any transfer or other similar taxes required by reason of the issuance of a Chemical Certificate representing
shares of Chemical Common Stock in any name other than that of the registered holder of the Talmer Certificate or Talmer Certificates
surrendered, or required for any other reason, or shall establish to the satisfaction of the Exchange Agent that such tax has been
paid or is not payable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After the Effective
Time, there shall be no transfers on the stock transfer books of Talmer of the shares of Talmer Common Stock that were issued and
outstanding immediately prior to the Effective Time. If, after the Effective Time, Talmer Certificates representing such shares
are presented for transfer to the Exchange Agent, they shall be cancelled and exchanged for the Merger Consideration, cash in lieu
of fractional shares, and dividends or distributions that the holder presenting such Talmer Certificates is entitled to, as provided
in this <U>Article II</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary contained herein, no Chemical Certificates or scrip representing fractional shares of Chemical Common
Stock shall be issued upon the surrender for exchange of Talmer Certificates, no dividend or distribution with respect to Chemical
Common Stock shall be payable on or with respect to any fractional share, and such fractional share interests shall not entitle
the owner thereof to vote or to any other rights of a </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">8</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">shareholder of Chemical. In lieu of the issuance of any such fractional share,
Chemical shall pay to each former shareholder of Talmer who otherwise would be entitled to receive such fractional share an amount
in cash (rounded up to the nearest cent), without any interest thereon, equal to the product of (i) the Chemical Closing Price
<I>multiplied by</I> (ii) the fraction of a share (rounded to the nearest thousandth when expressed in decimal form) of Chemical
Common Stock which such holder would otherwise be entitled to receive pursuant to <U>Section 1.4</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any former
holders of Talmer Common Stock who have not exchanged their Talmer Certificates pursuant to this <U>Article II</U> shall look only
to the Exchange Agent for payment of the Merger Consideration, cash in lieu of fractional shares, and any unpaid dividends and
distributions on the Chemical Common Stock deliverable in respect of each former share of Talmer Common Stock such shareholder
holds as determined pursuant to this Agreement, in each case, without any interest thereon. Notwithstanding the foregoing, none
of Chemical, Talmer, the Surviving Corporation, the Exchange Agent or any other Person shall be liable to any former holder of
Talmer Common Stock for any amount delivered in good faith to a public official pursuant to applicable abandoned property, escheat,
or similar laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical shall
be entitled to deduct and withhold, or cause the Exchange Agent to deduct and withhold, from the Merger Consideration, any cash
in lieu of fractional shares of Chemical Common Stock, cash dividends or distributions payable pursuant to this <U>Section 2.2</U>,
or any other cash amounts otherwise payable pursuant to this Agreement to any holder of Talmer Common Stock such amounts as it
is required to deduct and withhold with respect to the making of such payment under the Code or any provision of state, local or
foreign Tax Law. To the extent that amounts are so withheld by Chemical or the Exchange Agent, as the case may be, and paid over
to the appropriate governmental authority, the withheld amounts shall be treated for all purposes of this Agreement as having been
paid to the holder of Talmer Common Stock in respect of which the deduction and withholding was made by Chemical or the Exchange
Agent, as the case may be.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event
any Talmer Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming
such Talmer Certificate to be lost, stolen or destroyed and the posting by such Person of a bond in such amount as the Exchange
Agent would charge other similarly situated holders of Chemical Common Stock as indemnity against any claim that may be made against
it with respect to such Talmer Certificate, the Exchange Agent will issue in exchange for such lost, stolen or destroyed Talmer
Certificate the Merger Consideration, any cash in lieu of fractional shares deliverable in respect thereof, and any dividends or
distributions that the holder presenting such Talmer Certificates is entitled to, each as provided pursuant to this Agreement.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
III</FONT><BR>
REPRESENTATIONS AND WARRANTIES OF <FONT STYLE="color: windowtext">TALMER</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Except as disclosed
in the Talmer SEC Reports filed with or furnished to the SEC prior to the date of this Agreement (excluding any risk factor disclosures
set forth under the heading &ldquo;Risk Factors,&rdquo; any disclosure of risks included in any &ldquo;forward-looking statements&rdquo;
disclaimer or any other forward-looking statement of risk that does not contain a reasonable level of detail about the risks of
which the statement warns) or as disclosed in the disclosure schedules </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">9</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify">delivered by Talmer to Chemical prior to or concurrently
with the execution of this Agreement (the &ldquo;<B><I>Talmer Disclosure Schedules</I></B>&rdquo;), it being understood and agreed
that the disclosure of any item in the Talmer SEC Reports shall be deemed a disclosure only to the extent the relevance of such
disclosure to the sections or subsections of this <U>Article III</U> is reasonably apparent on the face of such disclosure, Talmer
represents and warrants to Chemical that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authorization,
No Conflicts, Etc</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer has the requisite corporate power and authority to execute and deliver this Agreement, and, subject
to receipt of the Talmer Shareholder Approval, to consummate the transactions contemplated by this Agreement. This Agreement has
been duly adopted, and the consummation of the Merger and the other transactions contemplated by this Agreement have been duly
authorized, by the Talmer Board. The Talmer Board has (i) determined that the terms of this Agreement are fair to and in the best
interests of Talmer and the Talmer Shareholders, and (ii) adopted this Agreement and authorized the transactions contemplated by
this Agreement and resolved to make the Talmer Board Recommendation. Except for the Talmer Shareholder Approval, no other corporate
proceedings on the part of Talmer are necessary to authorize this Agreement or to consummate the Merger (other than the submission
to the Talmer Shareholders of an advisory (non-binding) vote on the compensation that may be paid or become payable to Talmer&rsquo;s
named executive officers that is based on or otherwise related to the transactions contemplated by this Agreement). This Agreement
has been duly executed and delivered by, and (assuming due authorization, execution and delivery by Chemical) constitutes valid
and binding obligations of, Talmer and is enforceable against Talmer in accordance with its terms, except to the extent that (A)
such enforcement may be subject to applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or
hereafter in effect, relating to creditors&rsquo; rights generally and (B) equitable remedies of specific performance and injunctive
and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution,
delivery, and performance of this Agreement by Talmer and the consummation of the Merger, do not and will not violate, conflict
with, or result in a breach of: (i) any provision of the articles of incorporation or bylaws (or similar organizational documents)
of Talmer or any Subsidiary of Talmer (each a &ldquo;<B><I>Talmer Subsidiary</I></B>&rdquo; and collectively, the &ldquo;<B><I>Talmer
Subsidiaries</I></B>&rdquo;); or (ii) any Law or Order applicable to Talmer or any Talmer Subsidiary, assuming the timely receipt
of each of the approvals referred to in <U>Section 3.1(d)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution,
delivery, and performance of this Agreement by Talmer and the consummation of the Merger do not and will not violate, conflict
with, result in a breach of, constitute a default under, or require any consent, approval, waiver, extension, amendment, authorization,
notice, or filing under, any cease and desist order, written agreement, memorandum of understanding, board resolutions or other
Regulatory Agreement or commitment with or from a Governmental Entity to which Talmer or any Talmer Subsidiary is a party or subject,
or by which Talmer or any Talmer Subsidiary is bound or affected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No notice to,
filing with, authorization of, exemption by, or consent or approval of, any Governmental Entity is necessary for the consummation
of the transactions contemplated by this Agreement by Talmer other than in connection or compliance with the </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">10</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">provisions of the
MBCA, compliance with federal and state securities laws, and the consents, authorizations, approvals, or exemptions required under
the BHC Act and the Michigan Banking Code. Talmer has no Knowledge of any reason why the Regulatory Approvals referred to in this
<U>Section 3.1(d)</U> cannot be obtained or why the regulatory approval process would be materially impeded.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Good Standing</U>. Talmer is a corporation duly organized, validly existing, and in good standing under the laws of the State
of Michigan. Talmer has all requisite corporate power and authority to own, operate, and lease its properties and assets and to
carry on its business as it is now being conducted in all material respects. Talmer is a bank holding company duly registered as
such with the Federal Reserve Board under the BHC Act. Talmer is not, and is not required to be, qualified or admitted to conduct
business as a foreign corporation in any other state, except where such failure to be so qualified has not had, and would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiaries</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer has
provided to Chemical a true and complete list of each Talmer Subsidiary as of the date of this Agreement. Other than the Talmer
Subsidiaries, Talmer does not have &ldquo;control&rdquo; (as defined in Section 2(a)(2) of the BHC Act, using five percent (5%)
rather than twenty-five percent (25%)), either directly or indirectly, of any Person engaged in an active trade or business or
that holds any significant assets. Talmer or a Talmer Subsidiary owns all of the issued and outstanding capital stock or other
equity interests of each of the Talmer Subsidiaries, free and clear of any claim or Lien of any kind. There is no legally binding
and enforceable subscription, option, warrant, right to acquire, or any other similar agreement pertaining to the capital stock
or other equity interests of any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the
Talmer Subsidiaries (i) is duly organized and validly existing under the laws of its jurisdiction of organization; (ii) is duly
qualified to do business and in good standing in all jurisdictions (whether federal, state, or local) where its ownership or leasing
of property or the conduct of its business requires it to be so qualified; and (iii) has all requisite corporate power and authority
to own or lease its properties and assets and to carry on its business as now conducted, except in each of (ii) and (iii) as has
not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The deposits
of Talmer Bank are insured by the FDIC to the fullest extent permitted by Law, and all premiums and assessments to be paid in connection
therewith have been paid when due. No proceeding for the revocation or termination of such deposit insurance is pending or, to
the Knowledge of Talmer, threatened. Talmer and each Talmer Subsidiary has paid as and when due all material fees, charges, assessments,
and the like as required by Law to each and every Governmental Entity having jurisdiction over Talmer or each Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">11</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capital
Stock</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The authorized capital stock of Talmer consists of 198,000,000 shares of Talmer Common Stock, of which, as
of the close of business on January 21, 2016 (the &ldquo;<B><I>Capitalization Date</I></B>&rdquo;), 66,129,873 shares were issued
and outstanding, 2,000,000 shares of Class B Non-Voting Common Stock, $1.00 par value per share (the &ldquo;<B><I>Talmer Class
B Common Stock</I></B>&rdquo;), of which, as of the Capitalization Date, no shares were issued and outstanding, and 20,000,000
shares of Preferred Stock, $1.00 par value per share (the &ldquo;<B><I>Talmer Preferred Stock</I></B>&rdquo;), of which, as of
the Capitalization Date, no shares were issued and outstanding. Except for the Talmer Share-Based Awards, as of the date of this
Agreement, there is no security or class of securities outstanding that represents, is convertible into, or is exercisable for
capital stock of Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
3.4(b)</U> of the Talmer Disclosure Schedules sets forth, as of the date of this Agreement, the number of shares of Talmer Common
Stock that are authorized and reserved for issuance under each Talmer Stock Plan, and the number of shares of Talmer Common Stock
that are subject to outstanding Talmer Stock Options and Talmer Stock Awards (collectively, &ldquo;<B><I>Talmer Share-Based Awards</I></B>&rdquo;)
issued under a Talmer Stock Plan. All Talmer Share-Based Awards have been awarded under a Talmer Stock Plan, and, as of the date
of this Agreement, there are no other compensatory awards outstanding pursuant to which Talmer Common Stock has been issued or
is issuable, or that relate to or are determined by reference to the value of Talmer Common Stock. All outstanding shares of Talmer
Common Stock, and all Talmer Common Stock reserved for issuance under the Talmer Stock Plans when issued in accordance with the
respective terms of the Talmer Stock Plans, are or will be duly authorized, validly issued, fully paid and non-assessable and not
issued in violation of any preemptive rights, purchase option, call or right of first refusal rights.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After the date
of this Agreement, the number of issued and outstanding shares of Talmer Common Stock, Talmer Class B Common Stock, and Talmer
Preferred Stock is not subject to change before the Effective Time, other than the issuance of shares of Talmer Common Stock upon
the exercise of any Talmer Stock Options granted pursuant to a Talmer Stock Plan prior to the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than
the issued and outstanding shares of Talmer Common Stock described in <U>Section 3.4(a)</U>, neither Talmer nor any Talmer Subsidiary
has outstanding any security or issue of securities the holder or holders of which have the right to vote on the approval of the
Merger or this Agreement, or that entitle the holder or holders to consent to, or withhold consent on, the Merger or this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Talmer Shareholder
will be entitled to appraisal rights pursuant to the MBCA as a result of the consummation of the Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial
Statements</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated
financial statements of Talmer as of and for each of the three (3) years ended December 31, 2014, 2013, and 2012, as reported on
by Talmer&rsquo;s independent accountants, and the unaudited consolidated financial statements of Talmer as of </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">12</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">and for each quarter
in 2015 ended before the date of this Agreement, including all schedules and notes relating to such statements, as previously delivered
to Chemical (collectively, &ldquo;<B><I>Talmer Financial Statements</I></B>&rdquo;), fairly present, and the unaudited consolidated
financial statements of Talmer as of and for each quarter ending after the date of this Agreement until the Effective Time, including
all schedules and notes relating to such statements, will fairly present the financial condition and the results of operations,
changes in shareholders&rsquo; equity, and cash flows of Talmer as of the respective dates of and for the periods referred to in
such financial statements, all in accordance with GAAP, consistently applied, subject, in the case of unaudited interim financial
statements, to normal, recurring year-end adjustments (the effect of which has not had, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on Talmer) and the absence of notes (that, if presented, would
not differ materially from those included in Talmer Financial Statements). No financial statements of any entity or enterprise
other than the Talmer Subsidiaries are required by GAAP to be included in the consolidated financial statements of Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following
reports (including all related schedules, notes, and exhibits) were prepared and filed in conformity with applicable regulatory
requirements and were correct and complete in all material respects when filed:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Consolidated Reports of Condition and Income (Form FFIEC 041) of each Talmer Subsidiary required to file such reports (including
any amendments) as of and for each of the fiscal years ended December 31, 2014, 2013, and 2012, and as of and for each of the first,
second and third quarter of 2015 as filed with the FDIC; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Consolidated Financial Statements for Bank Holding Companies (Form FR Y-9C) and Parent Company Only Financial Statements for Large
Bank Holding Companies (Form FR Y-9LP) (including any amendments) for Talmer as of and for each of the fiscal years ended December
31, 2014, 2013, and 2012, and as of and for each quarter ended in 2015 before the date of this Agreement as filed with the Federal
Reserve Board. All of such reports required to be filed prior to the Effective Time by Talmer or any Talmer Subsidiary will be
prepared and filed in conformity with applicable regulatory requirements applied consistently throughout their respective periods
(except as otherwise noted in such reports) and will be correct and complete in all material respects when filed. All of the reports
identified in this <U>Section 3.5(b)</U> are collectively referred to as the &ldquo;<B><I>Talmer Call Reports</I></B>.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Certain Changes or Events</U>. Since September 30, 2015, (a) Talmer and the Talmer Subsidiaries have conducted their respective
businesses in the ordinary course consistent with past practice and (b) no event has occurred that has had, or would reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Legal
Proceedings</U>. There is no Action pending or, to the Knowledge of Talmer, threatened against Talmer or any of the Talmer Subsidiaries
that (a) as of the date of this Agreement, challenges or seeks to enjoin, alter, prevent or materially delay the Merger or (b)
has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer. There
is no material unsatisfied judgment, penalty or award against Talmer or any of the Talmer Subsidiaries. Neither Talmer nor any
of the Talmer Subsidiaries, </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">13</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">nor any of their respective properties or assets, is subject to any Order or any investigation by a
Governmental Entity that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Talmer. No officer or director of Talmer or any of the Talmer Subsidiaries is a defendant in any Action commenced by
any shareholder of Talmer or any of the Talmer Subsidiaries with respect to the performance of his or her duties as an officer
or a director of Talmer or any of the Talmer Subsidiaries under any applicable Law, except for any Action arising out of or relating
to the Merger and the transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Filings</U>. In the last three (3) years:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer and
each Talmer Subsidiary has filed in a timely manner all filings with Governmental Entities as required by applicable Law; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All such filings,
as of their respective filing dates, complied in all material respects with all Laws, forms, and guidelines applicable to such
filings.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Indemnification
Claims</U>. To the Knowledge of Talmer, there has been no event, action, or omission by or with respect to any director, officer,
employee, trustee, agent, or other Person who may be entitled to receive indemnification or reimbursement of any claim, loss, or
expense under any Contract or arrangement providing for indemnification or reimbursement of any such Person by Talmer or any Talmer
Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct
of Business</U>. Talmer and each Talmer Subsidiary has conducted its business and used its properties in compliance with all applicable
Laws, including without limitation applicable federal and state laws and regulations concerning banking, securities, truth-in-lending,
truth-in-savings, mortgage origination and servicing, usury, fair credit reporting, consumer protection, occupational safety, fair
lending, civil rights, employee protection, fair employment practices, fair labor standards, real estate settlement and procedures,
insurance, privacy, and Environmental Laws; except for violations that have not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transaction
Documents</U>. None of the information supplied or to be supplied by Talmer for inclusion or incorporation by reference in any
Transaction Document will contain any untrue statement of material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading,
(a) in the case of any Transaction Document (other than the Form S-4 and the Joint Proxy Statement), at the time it is filed or
at any time it is amended or supplemented, (b) in the case of the Form S-4, at the time it is filed with the SEC, at any time it
is amended or supplemented and at the time it becomes effective under the Securities Act, and (c) in the case of the Joint Proxy
Statement, at the date it is first mailed to the Chemical Shareholders and the Talmer Shareholders and at the time of the Chemical
Shareholder Meeting and the Talmer Shareholder Meeting. The Joint Proxy Statement (other than those portions relating solely to
the Chemical Shareholder Meeting) will, at the time the Joint Proxy Statement is filed with the SEC, at any time it is amended
or supplemented, at the date it is first mailed to the Chemical Shareholders and the Talmer Shareholders and at the time of the
Chemical Shareholder Meeting </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">14</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">and the Talmer Shareholder Meeting, comply as to form in all material respects with the requirements
of the Exchange Act and the rules and regulations thereunder, except that no representation is made by Talmer with respect to statements
made or incorporated by reference therein based on information supplied by or on behalf of Chemical for inclusion or incorporation
by reference in the Joint Proxy Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreements
With Bank Regulators</U>. Neither Talmer nor any Talmer Subsidiary is a party to any Contract, cease and desist order, written
agreement or memorandum of understanding with, or a party to any commitment letter, board resolution or similar undertaking to,
or is subject to any Order by, or is a recipient of any extraordinary supervisory letter from, any Governmental Entity that restricts
materially the conduct of Talmer&rsquo;s or a Talmer Subsidiary&rsquo;s business, or in any manner relates to the capital adequacy,
credit or reserve policies or management of Talmer or any Talmer Subsidiary (a &ldquo;<B><I>Regulatory Agreement</I></B>&rdquo;),
nor has Talmer nor any Talmer Subsidiary been advised by any Governmental Entity that a Governmental Entity is contemplating issuing
or requesting (or is considering the appropriateness of issuing or requesting) an Order or a Regulatory Agreement. Neither Talmer
nor any Talmer Subsidiary is required by Section 32 of the Federal Deposit Insurance Act or FDIC Regulation Part 359 or the Federal
Reserve Board to give prior notice to a federal banking agency of the proposed addition of an individual to its board of directors
or the employment of an individual as a senior executive officer or to limit golden parachute payments or indemnification.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All material
Tax Returns required by applicable Law to have been filed by Talmer and each Talmer Subsidiary since January 1, 2010 have been
filed when due (taking into account any extensions), and each such Tax Return is complete and accurate and correctly reflects the
liability for Taxes in all material respects. Since January 1, 2010, Talmer and each Talmer Subsidiary has withheld and paid all
material Taxes required to have been withheld and paid in connection with amounts paid or owing to any third party. Since January
1, 2010, all material Taxes that are due and payable by Talmer and each Talmer Subsidiary have been paid.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
audit or other proceeding pending against or with respect to Talmer or any Talmer Subsidiary with respect to any material amount
of Tax. There are no material Liens on any of the assets of Talmer or any of the Talmer Subsidiaries that arose in connection with
any failure (or alleged failure) to pay any Tax, other than Liens for Taxes not yet due and payable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer
nor any Talmer Subsidiary has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect
to any Taxes, which waiver or extension is still open.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as required
by Law, neither Talmer nor any Talmer Subsidiary is a party to any Tax allocation or sharing agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer
nor any Talmer Subsidiary has been included in any &ldquo;consolidated,&rdquo; &ldquo;unitary&rdquo; or &ldquo;combined&rdquo;
Tax Return for any taxable period for which the statute </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">15</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">of limitations has not expired (other than a group of which Talmer and
one or more Talmer Subsidiaries are the only members). Neither Talmer nor any Talmer Subsidiary is a general partner in any partnership
that is material to its business operations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within the
past three (3) years, neither Talmer nor any Talmer Subsidiary has been a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled
corporation&rdquo; in a distribution intended to qualify for tax-free treatment under Section 355 of the Code.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer
nor any Talmer Subsidiary has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes
a &ldquo;listed transaction&rdquo; for purposes of Section 6011 of the Code (or a similar provision of state Law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer
nor any Talmer Subsidiary has taken any action or has Knowledge of any fact that would reasonably be expected to prevent the Merger
from qualifying for the Intended Tax Treatment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There has been
no disallowance of a deduction under Section 162(m) or 280G of the Code for any amount paid or payable by Talmer or any Talmer
Subsidiary as employee compensation, whether under any Contract, plan, program or arrangement, understanding or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Properties</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except with
such exceptions that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Talmer, Talmer and each Talmer Subsidiary has good and valid title to, or valid leasehold interests in, all of their
respective personal and real properties and assets as used in their respective businesses as presently conducted, and all such
personal and real properties and assets, other than personal and real properties and assets in which Talmer or any of the Talmer
Subsidiaries has leasehold interests, are free and clear of all Liens, except for Permitted Liens. Talmer and each Talmer Subsidiary
has complied in all material respects with the terms of all leases to which it is a party. All material leases to which Talmer
or any Talmer Subsidiary is a party and under which it is in possession of any personal or real property are valid and binding
contracts and are in full force and effect, and neither Talmer nor any Talmer Subsidiary has received any written notice alleging
violation, breach, or default of such lease. Talmer and each Talmer Subsidiary is in possession of the properties or assets purported
to be leased under all its material leases (except where Talmer or a Talmer Subsidiary is the lessor). The tangible personal and
real property and assets of Talmer and all Talmer Subsidiaries are in good operating condition and repair, reasonable wear and
tear excepted, and, subject to maintenance and repair in the ordinary course of business consistent with past practice, are adequate
for the uses to which they are being put.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect
to real property owned by Talmer or any Talmer Subsidiary, none of Talmer nor any Talmer Subsidiary (i) has received written notice
of any pending, and to the Knowledge of Talmer there is no threatened, condemnation proceeding against any of such real property
or (ii) has received written notice from any Governmental Entity that such real property is not in compliance with any applicable
Law, except as have not had, and would not </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">16</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect
to real property leased, subleased or licensed by Talmer or any Talmer Subsidiary, none of Talmer nor any Talmer Subsidiary (i)
has received any written notice alleging a violation, breach or default under any lease of such real property, except for matters
being contested in good faith for which adequate accruals or reserves have been established on the books and records of Talmer
or (ii) (A) has received written notice of any pending, and to the Knowledge of Talmer there is no threatened, condemnation proceeding
with respect to any of such real property or (B) has received written notice from any Governmental Entity that such real property
is not in compliance with any applicable Law, except as have not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No lease or
license pursuant to which Talmer or any Talmer Subsidiary, as lessor, lessee, licensor or licensee, has possession of, or leases
or licenses to others, any real or personal property, excluding any personal property lease with payments of less than $500,000
per year, contains any provision, including any prohibition against assignment by Talmer or any Talmer Subsidiary, by operation
of Law or otherwise, that would require any third party consent or approval for, or that would materially interfere with, the possession,
use or rights with respect to the property by the Surviving Corporation or its Subsidiaries for the same purposes and upon the
same rental and other terms following consummation of the Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property</U>. Talmer and the Talmer Subsidiaries exclusively own, or have a valid license or other valid right to use, all material
Intellectual Property as used in their business as presently conducted; it being understood that the foregoing shall not be construed
to expand or diminish the scope of the non-infringement representations and warranties that follow in this <U>Section 3.15</U>.
No Actions, suits or other proceedings are pending or, to the Knowledge of Talmer, threatened that Talmer or any of the Talmer
Subsidiaries is infringing, misappropriating or otherwise violating the rights of any Person with regard to any Intellectual Property.
To the Knowledge of Talmer, no Person is materially infringing, misappropriating or otherwise violating the rights of Talmer or
any of the Talmer Subsidiaries with respect to any material Intellectual Property owned or purported to be owned by Talmer or any
of the Talmer Subsidiaries (collectively the &ldquo;<B><I>Talmer-Owned Intellectual Property</I></B>&rdquo;). Except as have not
had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer, to the
Knowledge of Talmer: (a) no circumstances exist which could reasonably be expected to give rise to any (i) Action that challenges
the rights of Talmer or any of the Talmer Subsidiaries with respect to the validity or enforceability of the Talmer-Owned Intellectual
Property or (ii) claim of infringement, misappropriation, or violation of the Intellectual Property rights of any Person, and (b)
the consummation of the transactions contemplated by this Agreement will not give rise to any claim by any Person to a right to
own, purchase, transfer, use, alter, impair, extinguish or restrict any Talmer-Owned Intellectual Property or Intellectual Property
licensed to Talmer or any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Required
Licenses, Permits, Etc</U>. Talmer and each Talmer Subsidiary hold all material Permits and other rights from all appropriate
Governmental Entities necessary for the conduct of its business as presently conducted. All such material Permits and rights are
in full </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">17</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">force and effect. Each Talmer Subsidiary, as applicable, is an approved seller-servicer for each mortgage investor with
whom it conducts business, and holds all material Permits, authorizations, and approvals necessary to carry on a mortgage banking
business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Material
Contracts and Change of Control</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the purposes
of this Agreement, the term &ldquo;<B><I>Talmer Material Contract</I></B>&rdquo; means any of the following Contracts to which
Talmer or any of the Talmer Subsidiaries is a party or bound as of the date of this Agreement:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that (A) has been or (B) would be required to be, but has not been, filed by Talmer as a material contract pursuant to
Item 601(b)(10) of Regulation S-K on Form 10-K under the Exchange Act as if such Form 10-K were filed as of the date of this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract, other than any Contracts contemplated by this Agreement, that limits (or purports to limit) in any material respect the
ability of Talmer or any of the Talmer Subsidiaries to engage or compete in any business (including geographic restrictions and
exclusive or preferential arrangements);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that creates a material partnership or joint venture to which Talmer or any of the Talmer Subsidiaries is a party;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract between or among Talmer and any Talmer Subsidiary;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract with a correspondent banker;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract relating to the borrowing of money by Talmer or any Talmer Subsidiary or guarantee by Talmer or any Talmer Subsidiary
of such obligation (other than Contracts evidencing deposit liabilities, purchases of federal funds, fully-secured repurchase agreements,
FHLB advances of depository institution Talmer Subsidiaries, trade payables and Contracts relating to borrowings or guarantees
made in the ordinary course of business consistent with past practice) in excess of $2,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that relates to the acquisition or disposition of any material business (whether by merger, sale of stock, sale of assets
or otherwise) or material asset, other than this Agreement, pursuant to which Talmer or any of the Talmer Subsidiaries has any
material continuing obligations, contingent or otherwise;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that grants any right of first refusal or right of first offer or similar right or that limits or purports to limit the
ability of Talmer or any of the Talmer Subsidiaries to own, operate, sell, transfer, pledge or otherwise dispose of any material
amount of assets or businesses;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
voting agreement or registration rights agreement with respect to the capital stock of Talmer or any of the Talmer Subsidiaries;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">18</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract granting Talmer or any Talmer Subsidiary the right to use, restricting Talmer&rsquo;s or any Talmer Subsidiary&rsquo;s
right to use, or granting any other Person the right to use Intellectual Property that is material to the conduct of Talmer&rsquo;s
or any Talmer Subsidiary&rsquo;s business (including any license, franchise agreement, co-existence agreement, concurrent-use agreement,
settlement agreement or other similar type Contract);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that limits the payment of dividends by Talmer or any Talmer Subsidiary;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract involving a standstill or similar obligation of Talmer or any of the Talmer Subsidiaries relating to the purchase of securities
of Talmer or any other Person;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
transactions made in accordance with Regulation O and agreements entered into in the ordinary course of business consistent with
past practice for compensation or indemnity, any Contract between Talmer or any Talmer Subsidiary, on the one hand, and, on the
other hand (A) any officer or director of Talmer or a Talmer Subsidiary, or (B) to the Knowledge of Talmer, any (1) record or beneficial
owner of five percent (5%) or more of the voting securities of Talmer, (2) Affiliate or family member of any such officer, director,
or record or beneficial owner, or (3) other Affiliate of Talmer, except those Contracts of a type available to employees of Talmer
generally;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract for any one capital expenditure or a series of capital expenditures, the aggregate amount of which is in excess of $1,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract or commitment to make a loan not yet fully disbursed or funded to any Person, wherein the undisbursed or unfunded amount
exceeds $10,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract or commitment for a loan participation agreement with any other Person in excess of $10,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
employment Contract with an employee of Talmer or any Talmer Subsidiary or any other compensatory Contract or plan in which any
executive officer of Talmer or any Talmer Subsidiary participates (other than any compensatory Contract or plan which pursuant
to its terms is available to employees, officers or directors generally and which in operation provides for the same method of
allocation of benefits between management and non-management participants); and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that is material to the financial condition, results of operations or business of Talmer or any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the
date of this Agreement, Talmer has provided or made available to Chemical a true and complete copy of each Talmer Material Contract
in effect as of the date of this Agreement. Except for matters that have not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on Talmer, (i) all Talmer Material Contracts are in full force and
effect as of the date of this Agreement, (ii) </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">19</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">neither Talmer nor any of the Talmer Subsidiaries is in violation or breach of or
default under (or with notice or lapse of time, or both, would be in violation or breach of or default under) the terms of any
Talmer Material Contract, (iii) to the Knowledge of Talmer, no other party to any Talmer Material Contract is in breach of or in
default under any Talmer Material Contract, and (iv) neither Talmer nor any Talmer Subsidiary has received written notice of breach
or termination (or proposed breach or termination) of any Talmer Material Contract.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
Talmer Material Contract under which (i) a consent or approval is required, (ii) a prohibited assignment by operation of Law could
occur, (iii) a waiver or loss of any right could occur, or (iv) an acceleration of any obligation could occur, in each case as
a result of the execution and delivery of this Agreement or the consummation of the transactions contemplated herein, where any
such occurrence would reasonably be expected to (A) materially interfere with the ordinary course of business conducted by Talmer,
any Talmer Subsidiary or the Surviving Corporation or (B) have a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) All data
processing Contracts of Talmer or any of the Talmer Subsidiaries are cancelable by Talmer or a Talmer Subsidiary on or immediately
after the Effective Time without cost, penalty or further obligation, except for costs, penalties or further obligations that,
in the aggregate with respect to any Contract, do not exceed $1,000,000; and (ii) neither Talmer nor any Talmer Subsidiary is party
to any Contract that would require any payment to another party upon termination in excess of $1,000,000.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor
and Employment Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (i) Talmer
and all of the Talmer Subsidiaries are in compliance with all applicable Laws relating to labor and employment practices, including
those relating to wages, employee benefits, hours and overtime, workplace safety and health, immigration, individual and collective
termination, non-discrimination and data privacy, workers&rsquo; compensation, the identification of particular employees or job
classifications as &ldquo;exempt&rdquo; or &ldquo;non-exempt&rdquo; for purposes of such obligations, and any and all other matters
involving compensation or benefits afforded to or not afforded to employees, contractors or consultants except for such noncompliance
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer;
(ii) as of the date of this Agreement, there is no unfair labor practice charge or complaint pending before the NLRB or, to the
Knowledge of Talmer, threatened against Talmer or any of the Talmer Subsidiaries; (iii) as of the date of this Agreement and during
the past three (3) years, there has been no labor strike, slowdown, work stoppage or lockout pending or, to the Knowledge of Talmer,
threatened against or affecting Talmer or any of the Talmer Subsidiaries; (iv) there is no representation claim or petition pending
before the NLRB or any similar foreign agency relating to the employees of Talmer or any Talmer Subsidiary; (v) as of the date
of this Agreement, Talmer has not received written notice of charges with respect to or relating to Talmer or any Talmer Subsidiary
pending before the Equal Employment Opportunity Commission or other Governmental Entity responsible for the prevention of unlawful
employment practices, nor is there any claim pending before any court or administrative agency regarding any unlawful employment
practices relating to Talmer or any Talmer Subsidiary; and (vi) neither Talmer nor any Talmer Subsidiary has received any written
notice from any Governmental Entity responsible for the enforcement of labor or </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">20</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">employment laws of an intention to conduct an investigation
of Talmer or any Talmer Subsidiary and, to the Knowledge of Talmer, no such investigation is in progress.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer
nor any Talmer Subsidiary is party to, bound by, or negotiating any Collective Bargaining Agreement or any other Contract with
any labor organization, union, works council, employee representative or association.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All salaried employees, hourly employees, and temporary employees of Talmer and its Subsidiaries are employed
on an at-will basis by Talmer and/or its Subsidiaries and may be terminated at any time with or without cause and without any severance
or other liabilities to Talmer or any Talmer Subsidiary, or have signed an agreement or acknowledged in writing that their employment
is at will. There has been no written representation by Talmer or any Talmer Subsidiary made to any employee that commits Talmer,
any Talmer Subsidiary, or the Surviving Corporation to retain them as employees for any period of time subsequent to the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since January
1, 2013, neither Talmer nor any Talmer Subsidiary has effectuated a &ldquo;plant closing&rdquo; or a &ldquo;mass lay off&rdquo;
(in each case, as defined in the WARN Act), in either case affecting any site of employment or facility of Talmer or any Talmer
Subsidiary, except in compliance with the WARN Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
audit, investigation, charge or proceeding with respect to a material violation of any occupational health and safety standards
that is pending or unremedied, or, to the Knowledge of Talmer, threatened against Talmer or any Talmer Subsidiary. Talmer and all
of the Talmer Subsidiaries are in compliance with all applicable occupational health and safety Laws, except for such failures
to comply as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect
on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer
nor any Talmer Subsidiary is a party or subject to any Contract which restricts Talmer or any Talmer Subsidiary from relocating,
closing or terminating any of its operations or facilities or any portion of its operations or facilities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consummation
of the transactions contemplated by this Agreement will not create Liabilities for any act by Talmer or any Talmer Subsidiary on
or prior to the Closing under any Collective Bargaining Agreement, Contract or Talmer Benefit Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer has
implemented commercially reasonable procedures to ensure that all employees who are performing services for Talmer or any Talmer
Subsidiary in the United States are legally permitted to work in the United States and will be legally permitted to work in the
United States for the Surviving Corporation or any of its Subsidiaries following the consummation of the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The policies,
programs, and practices of Talmer and all Talmer Subsidiaries relating to equal opportunity and affirmative action, wages, employee
classifications (including independent contractor versus employee and exempt versus non-exempt), hours of work, employee disabilities,
employment termination, employment discrimination, employee safety, labor relations, and other terms and conditions of employment
are in compliance in all </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">21</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">material respects with applicable Law governing or relating to employment and employer practices and facilities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee
Benefits</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer has
delivered or made available to Chemical true and complete copies of all material Talmer Benefit Plans. Each Talmer Benefit Plan
is in compliance with all applicable requirements of ERISA, the Code and all other applicable Laws and has been administered in
accordance with its terms and such Laws, except for such noncompliance that has not had, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Talmer
Benefit Plan that is intended to be qualified within the meaning of Section 401 of the Code is so qualified and has at all times
since its adoption been so qualified, and, to the Knowledge of Talmer, no condition exists and no event has occurred that could
reasonably be expected to result in the loss or revocation of such qualification in any material respect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All contributions,
payments or premiums required to be made with respect to any Talmer Benefit Plan by Talmer on or before the date of this Agreement
have been timely made, and all benefits accrued under any unfunded Talmer Benefit Plan have been paid, accrued or otherwise adequately
reserved in accordance with GAAP, and each of Talmer and the Talmer Subsidiaries have performed all material obligations required
to be performed under all Talmer Benefit Plans with respect to which Talmer or any ERISA Affiliate of Talmer has an obligation
to contribute.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Talmer nor any ERISA Affiliate of Talmer (or, to Talmer&rsquo;s Knowledge, their respective predecessors)
participates in nor since December 31, 1973, has ever participated in any Multiemployer Plan, and neither Talmer nor any ERISA
Affiliate of Talmer (or, to Talmer&rsquo;s Knowledge, their respective predecessors) maintains or contributes to, or is party to,
and, at no time maintained, contributed to, or was a party to, any plan, program, agreement or policy that (i) is a &ldquo;defined
benefit plan&rdquo; within the meaning of Section 414(j) of the Code or Section 3(35) of ERISA, (ii) is a &ldquo;multiple employer
plan&rdquo; as defined in ERISA or the Code (whether or not subject thereto), (iii) is described in Section 401(a)(1) of ERISA
(whether or not subject thereto), (iv) is a multiple employer welfare arrangement within the meaning of Section 3(40)(A) of ERISA,
(v) is a voluntary employees beneficiary association within the meaning of Code Section 501(c)(9), or (vi) is primarily for the
benefit of employees who reside outside of the United States. No Liability under Title IV of ERISA has been or is expected to be
incurred by Talmer or any Talmer Subsidiary with respect to any applicable Talmer Benefit Plan. Except as may arise in connection
with the transactions contemplated by this Agreement, there has been no &ldquo;reportable event,&rdquo; within the meaning of ERISA
Section 4043, for which the 30-day reporting requirement has not been waived in relation to any applicable Talmer Benefit Plan.
In relation to each applicable Talmer Benefit Plan, (A) all contributions required to be made under one or both of Section 412
and 430 of the Code have been timely made, (B) there has been no application for any waiver of the minimum funding premium standards
imposed by Section 412 of the Code, and such minimum funding standards have been met to date, and (C) there is no &ldquo;amount
of unfunded benefit liabilities&rdquo; as defined in Section 4001(a)(18) of ERISA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">22</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as required
by Part 6 of Subtitle B of Title I of ERISA or Section 4980B of the Code or any state Laws requiring continuation of benefits coverage
following termination of employment, neither Talmer nor any Talmer Subsidiary provides health or welfare benefits for any retired
or former employee following such employee&rsquo;s retirement or other termination of service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution,
delivery of, and performance by Talmer of its obligations under the transactions contemplated by this Agreement (either alone or
upon the occurrence of any additional or subsequent event) will not (i) result in any payment (whether of severance pay or otherwise),
acceleration, forgiveness of indebtedness, vesting, distribution, increase in benefits or obligation to fund benefits with respect
to any current, former or retired employees, officers, consultants, independent contractors, agents or directors of Talmer or any
of the Talmer Subsidiaries; (ii) result in the triggering or imposition of any restrictions or limitations on the right of Talmer
or any of the Talmer Subsidiaries to amend or terminate any Talmer Benefit Plan; or (iii) result in any &ldquo;excess parachute
payments&rdquo; within the meaning of Section 280G(b)(1) of the Code that would result in a deduction disallowance under Code Section
280G(a) on the part of Talmer or any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer and
the Talmer Subsidiaries may, subject to the limitations imposed by applicable Law and the terms of the applicable Talmer Benefit
Plan, without the consent of any employee, beneficiary, or other Person, prospectively terminate, modify, or amend any such Talmer
Benefit Plan effective as of any date on or after the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect
to each Talmer Benefit Plan that is a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined under Section 409A(d)(1)
of the Code), (i) such plan has been operated and administered in compliance with Section 409A of the Code or (ii) any payments
under such plan have been earned and vested on or prior to December 31, 2004, and such plans have not been materially modified
other than modifications to comply with Code Section 409A and the regulations promulgated thereunder. Neither Talmer nor any of
the Talmer Subsidiaries have entered into any agreement or arrangement to, and do not otherwise have any obligation to, indemnify
or hold harmless any Person for any Liability that results from the failure to comply with the requirements of Section 409A of
the Code and the regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
pending or, to the Knowledge of Talmer, threatened Action with respect to any Talmer Benefit Plans, other than ordinary and usual
claims for benefits by participants and beneficiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since January
1, 2015, neither Talmer nor any of the Talmer Subsidiaries have agreed or otherwise committed to, whether in writing or otherwise,
adopt any new plan, program, agreement or policy that would constitute a Talmer Benefit Plan or result in participation in a Multiemployer
Plan or increase or improve the compensation, benefits, or terms and conditions of employment or service of any director, officer,
employee, or consultant, except (i) in the ordinary course of business consistent with past practice with respect to individual
employees who are not officers (and not with respect to a substantial class of employees) or (ii) as required by applicable Law
or any applicable Talmer Benefit Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">23</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the
Talmer Benefit Plans which is an &ldquo;employee welfare benefit plan&rdquo; within the meaning of Section 3(1) of ERISA is in
compliance with the Patient Protection and Affordable Care Act and its companion bill, the Health Care and Education Reconciliation
Act of 2010, to the extent applicable, except for such noncompliance that has not had, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on Talmer. Additionally, Talmer and Talmer Subsidiaries operate
such Talmer Benefit Plans to avoid assessable payments under Code Sections 4980H(a) and (b).<FONT STYLE="color: #1F497D">&nbsp;
</FONT>Neither Talmer nor any of the Talmer Subsidiaries have any liability in the nature of a retroactive rate adjustment, loss
sharing arrangement or other material Liability arising wholly or partially out of events occurring on or before the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No stock options,
stock appreciation rights or other grants of stock-based awards by Talmer or any Talmer Subsidiaries were backdated, spring-loaded,
or granted at less than fair market value.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental
Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for
any matters that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Talmer: (i) Talmer and each of the Talmer Subsidiaries is and has been in compliance with and has no Liability under
applicable Environmental Laws; (ii) Talmer and each of the Talmer Subsidiaries possesses, has possessed and is and has been in
compliance with all required Environmental Permits; (iii) there are no Environmental Claims pending or, to the Knowledge of Talmer,
threatened against Talmer or any of the Talmer Subsidiaries, and, to the Knowledge of Talmer, there are no facts or circumstances
which could reasonably be expected to form the basis for any Environmental Claim against Talmer or any of the Talmer Subsidiaries;
(iv) no Releases of Hazardous Materials have occurred and no Person has been exposed to any Hazardous Materials at, from, in, to,
on, or under any Talmer Site and no Hazardous Materials are present in, on, about or migrating to or from any Talmer Site in quantities
or concentrations or under circumstances that could give rise to an Environmental Claim against Talmer or any of the Talmer Subsidiaries;
(v) neither Talmer nor any of the Talmer Subsidiaries has entered into or is subject to, any judgment, decree, order or other similar
requirement of or agreement with any Governmental Entity under any Environmental Laws; (vi) neither Talmer nor any of the Talmer
Subsidiaries has assumed responsibility for or agreed to indemnify or hold harmless any Person for any Liability, arising under
or relating to Environmental Laws; and (vii) neither Talmer nor any of the Talmer Subsidiaries, any predecessors of Talmer or any
of the Talmer Subsidiaries, nor any entity previously owned by Talmer or any of the Talmer Subsidiaries, has transported or arranged
for the treatment, storage, handling, disposal, or transportation of any Hazardous Material to any off-Site location which has
or could result in an Environmental Claim against Talmer or any of the Talmer Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge
of Talmer, each underground storage tank presently or previously located on any Talmer Site has been operated, maintained and removed
or closed in place, as applicable, in compliance with all applicable Environmental Laws, and has not been the source of any Release
of a Hazardous Material to the environment that has not been fully remediated as required by applicable Environmental Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">24</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Duties
as Fiduciary</U>. To the Knowledge of Talmer, Talmer and each Talmer Subsidiary has performed all of its respective duties in any
capacity as trustee, executor, administrator, registrar, guardian, custodian, escrow agent, receiver, or other fiduciary in a fashion
that complies in all material respects with all applicable Laws, Contracts, wills, instruments and common law standards. Neither
Talmer nor any Talmer Subsidiary has received any notice of any Action, claim, allegation or complaint from any Person that Talmer
or any Talmer Subsidiary failed to perform these duties in a manner that complies in all material respects with all applicable
Laws, Contracts, wills, instruments and common law standards, except for notices involving matters that have been resolved and
any cost of such resolution is reflected in the Talmer Financial Statements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Bankers and Brokers</U>. Talmer has employed Keefe, Bruyette &amp; Woods, Inc. (the &ldquo;<B><I>Talmer Investment Banker</I></B>&rdquo;)
in connection with the Merger. Talmer, the Talmer Subsidiaries, and their respective Representatives have not employed, engaged,
or consulted with any broker, finder, or investment banker other than the Talmer Investment Banker in connection with this Agreement
or the Merger. Other than the fees and expenses payable by Talmer to the Talmer Investment Banker in connection with the Merger,
as described in <U>Section 3.22</U> of the Talmer Disclosure Schedules, there is no investment banking fee, financial advisory
fee, brokerage fee, finder&rsquo;s fee, commission, or compensation of a similar type payable by Talmer or any Talmer Subsidiary
to any Person with respect to the Agreement or the consummation of the Merger. Talmer has provided to Chemical true and complete
copies of each agreement, arrangement, and understanding between Talmer and the Talmer Investment Banker prior to the date of this
Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fairness
Opinion</U>. The Talmer Board has received the opinion (which, if initially rendered orally, has been or will be confirmed
by a written opinion, dated the same date) of the Talmer Investment Banker, to the effect that, as of the date of such opinion
and based on and subject to the assumptions, qualifications and limitations contained therein, the Merger Consideration is fair
to the holders of Talmer Common Stock from a financial point of view. Such opinion has not been rescinded as of the date of this
Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Talmer-Related
Persons</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Talmer-Related
Person has any loan, credit or other Contract outstanding with Talmer or any Talmer Subsidiary that does not conform to applicable
rules and regulations of the FDIC, the Federal Reserve Board, or any other Governmental Entity with jurisdiction over Talmer or
any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than
in a capacity as a shareholder, director, or executive officer of Talmer or any Talmer Subsidiary, no Talmer-Related Person owns
or controls any assets or properties that are used in the business of Talmer or any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than
ordinary and customary banking relationships, no Talmer-Related Person has any contractual relationship with Talmer or any Talmer
Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">25</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Talmer-Related
Person has any outstanding loan or loan commitment from, or on whose behalf an irrevocable letter of credit has been issued by,
Talmer or any Talmer Subsidiary in a principal amount of $2,000,000 or more.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change
in Business Relationships</U>. As of the date of this Agreement, no director or executive officer of Talmer has Knowledge, whether
on account of the Merger or otherwise, that any customer, agent, representative, supplier of Talmer or any Talmer Subsidiary, or
other Person with whom Talmer or any Talmer Subsidiary has a contractual relationship, intends to discontinue, diminish, or change
its relationship with Talmer or any Talmer Subsidiary, the effect of which would reasonably be expected to have a Material Adverse
Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
Talmer and the Talmer Subsidiaries maintain in full force and effect insurance on their respective assets, properties, premises,
operations, and personnel in such amounts and against such risks and losses as are customary and adequate for comparable entities
engaged in the same business and industry. There is no unsatisfied claim of $400,000 or more under such insurance as to which the
insurance carrier has denied liability. Since January 1, 2014, no insurance company has canceled or refused to renew a policy of
insurance covering Talmer&rsquo;s or any Talmer Subsidiary&rsquo;s assets, properties, premises, operations, directors or personnel.
Talmer and the Talmer Subsidiaries have given adequate and timely notice to each insurance carrier, and have complied with all
policy provisions, with respect to any material known claim for which a defense or indemnification or both may be available to
Talmer or the Talmer Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Books
and Records</U>. The books of account, minute books, stock record books, and other records of Talmer are complete and correct in
all material respects, represent bona fide transactions, and have been maintained in accordance with sound business practices,
including the maintenance of an adequate internal control system. The corporate minute books of Talmer and the Talmer Subsidiaries
contain accurate and complete records of all meetings of, and corporate action taken by, their shareholders, boards, and committees
in all material respects. Since January 1, 2013, the minutes of each meeting (or corporate action without a meeting) of any such
shareholders, boards, or committees have been duly prepared and are contained in such minute books. All such minute books and related
exhibits or attachments for all meetings since January 1, 2013, have been made available for Chemical&rsquo;s review prior to the
date of this Agreement without material omission or redaction (other than with respect to the minutes relating to (a) the Merger
or recent and similarly proposed transactions or (b) matters which Talmer is prohibited from disclosing pursuant to applicable
Law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loan
Guarantees</U>. Except as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect on Talmer, all guarantees of indebtedness owed to Talmer or any Talmer Subsidiary, including without limitation
those of the Federal Housing Administration, the Small Business Administration, and any other Governmental Entity, are valid and
enforceable, except as limited by bankruptcy, insolvency, moratorium, reorganization, or similar laws affecting the rights of creditors
generally and the availability of equitable remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Data
Security and Customer Privacy</U>. Talmer and each Talmer Subsidiary is in compliance in all material respects with (a) all applicable
Laws and applicable requirements of </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">26</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Governmental Entities regarding the security of each of their customers&rsquo; data and the
systems operated by Talmer and each Talmer Subsidiary, and (b) their respective privacy policies, including as relates to the use
of individually identifiable personal information relating to identifiable or identified natural persons.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Allowance
for Loan and Lease Losses</U>. The allowance for loan and lease losses as reflected in Talmer&rsquo;s consolidated financial statements
and the Talmer Call Reports as of December 31, 2014 and as of each quarter ended after December 31, 2014 was, in the reasonable
opinion of Talmer&rsquo;s management, (a) adequate to meet all reasonably anticipated loan and lease losses, net of recoveries
related to loans previously charged off as of those dates, (b) consistent with GAAP and reasonable and sound banking practices,
and (c) in conformance with recommendations and comments in reports of examination in all material respects.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loans
and Investments</U>. All investments and, except as would not reasonably be expected to have a Material Adverse Effect on Talmer,
all loans of Talmer and each Talmer Subsidiary are: (a) evidenced by notes, agreements or other evidences of indebtedness that
are true, genuine and what they purport to be; (b) legal and enforceable in accordance with their terms, except as may be limited
by any bankruptcy, insolvency, moratorium, or other laws affecting the rights of creditors generally or by the exercise of judicial
discretion; (c) authorized under all applicable Laws; and (d) to the extent secured, secured by valid Liens which have been perfected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loan
Origination and Servicing</U>. In originating, underwriting, servicing, selling, transferring, and discharging loans, mortgages,
land contracts, and other contractual obligations, either for its own account or for the account of others, Talmer and each Talmer
Subsidiary has complied with all applicable terms and conditions of such obligations and with all applicable Laws, Contracts, rules,
and procedures, except for incidents of noncompliance that have not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities
Laws Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since the date
of becoming a reporting company with the SEC, Talmer has filed or furnished all forms, documents and reports required to be filed
or furnished with the SEC under the Securities Act or the Exchange Act (collectively with any amendments thereto, but excluding
the Joint Proxy Statement and the Form S-4, the &ldquo;<B><I>Talmer SEC Reports</I></B>&rdquo;). Each of the Talmer SEC Reports,
in each case as of its filing or furnishing date, or, if amended, as finally amended prior to the date of this Agreement (with
respect to those Talmer SEC Reports filed or furnished prior to the date of this Agreement), has complied as to form in all material
respects with the applicable requirements of the Securities Act and the Exchange Act, and none of the Talmer SEC Reports, when
filed or furnished or, if amended, as finally amended prior to the date of this Agreement, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. None of the Talmer Subsidiaries are or ever have
been required to file periodic reports with the SEC. As of the date of this Agreement, there are no material outstanding or unresolved
comments received from the SEC with respect to any of the Talmer SEC Reports.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">27</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer has
established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act)
as required by Rule 13a-15(a) under the Exchange Act, and Talmer has established and maintains internal controls over financial
reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) as required by Rule 13a-15(a) under the Exchange Act.
Talmer has disclosed, based on its most recent evaluation prior to the date of this Agreement, to Talmer&rsquo;s auditors and the
audit committee of the Talmer Board (i) any significant deficiencies and material weaknesses in the design or operation of its
internal controls over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) which are reasonably likely to adversely
affect Talmer&rsquo;s ability to record, process, summarize and report financial information and (ii) any fraud that involves management
or other employees who have a significant role in Talmer&rsquo;s internal controls over financial reporting. Since January 1, 2012,
neither Talmer nor any of the Talmer Subsidiaries has Knowledge of any written complaint, allegation, assertion or claim regarding
the accounting or auditing practices, procedures, methodologies or methods of Talmer or any Talmer Subsidiary or their respective
internal accounting controls, including any written complaint, allegation, assertion or claim that Talmer or any Talmer Subsidiary
has engaged in questionable accounting or auditing practices, which, if true, would constitute a significant deficiency or a material
weakness. Since the date of becoming a reporting company with the SEC, subject to any applicable grace periods, Talmer has been
and is in compliance with (A) the applicable provisions of the Sarbanes Oxley Act of 2002 and (B) the applicable listing and corporate
governance rules and regulations of NASDAQ, except in each case as has not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Joint
Ventures; Strategic Alliances</U>. Neither Talmer nor any Talmer Subsidiary is, directly or indirectly, a party to or bound by
any material joint venture, partnership, limited partnership, limited liability company, or strategic alliance agreement or arrangement
with or through any unaffiliated Person providing for their joint or cooperative development, marketing, referrals, or sales of
banking, securities, insurance, or other financial products or services, or their joint investment in and management of any active
business enterprise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Policies
and Procedures</U>. Talmer and each Talmer Subsidiary have complied in all material respects with the policies and procedures as
formally adopted and disclosed to Chemical as applicable to the periods when those policies and procedures were in effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shareholder Rights Plan</U>.
Talmer does not have in effect any shareholder rights plan, &ldquo;poison pill,&rdquo; or similar plan or arrangement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Undisclosed
Liabilities</U>. There exist no Liabilities of Talmer or any Talmer Subsidiary of the type required to be disclosed in the liabilities
column of a balance sheet prepared in accordance with GAAP, other than (a) Liabilities that are adequately reflected, reserved
for or disclosed in the Talmer Financial Statements, (b) Liabilities under executory contracts to which Talmer or a Talmer Subsidiary
is a party or otherwise incurred in the ordinary course of business of Talmer or a Talmer Subsidiary, or (c) Liabilities that have
not had, and would not reasonably be expected to have, individually or in the aggregate, a  Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">28</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Other
Representations and Warranties</U>. Except for the express representations and warranties made by Talmer and the Talmer Subsidiaries
in this Article III, neither Talmer nor any other Person makes or has made any representation or warranty with respect to Talmer
or the Talmer Subsidiaries or their respective business, operations, assets, Liabilities, condition (financial or otherwise) or
prospects, notwithstanding the delivery or disclosure to Chemical or any of its Affiliates or Representatives of any documentation,
projections, forecasts, estimates, budgets, prospect information or other information with respect to any one or more of the foregoing.
Talmer has not relied on any representations or warranties relating to Chemical or any Chemical Subsidiary in determining to enter
into this Agreement, except for those expressly made by Chemical in <U>Article IV</U>.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
IV</FONT><BR>
REPRESENTATIONS AND WARRANTIES OF <FONT STYLE="color: windowtext">CHEMICAL</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Except as disclosed
in the Chemical SEC Reports filed with or furnished to the SEC prior to the date of this Agreement (excluding any risk factor disclosures
set forth under the heading &ldquo;Risk Factors,&rdquo; any disclosure of risks included in any &ldquo;forward-looking statements&rdquo;
disclaimer or any other forward-looking statement of risk that does not contain a reasonable level of detail about the risks of
which the statement warns) or as disclosed in the disclosure schedules delivered by Chemical to Talmer prior to or concurrently
with the execution of this Agreement (the &ldquo;<B><I>Chemical Disclosure Schedules</I></B>&rdquo;), it being understood and agreed
that the disclosure of any item in the Chemical SEC Reports shall be deemed a disclosure only to the extent the relevance of such
disclosure to the sections or subsections of this <U>Article IV</U> is reasonably apparent on the face of such disclosure, Chemical
represents and warrants to Talmer that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization,
No Conflicts, Etc</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical has the requisite corporate power and authority to execute and deliver this Agreement, and, subject
to receipt of the Chemical Shareholder Approval, to consummate the transactions contemplated by this Agreement. This Agreement
has been duly adopted, and the consummation of the Merger and the other transactions contemplated by this Agreement have been duly
authorized, by the Chemical Board. The Chemical Board has (i) determined that the terms of this Agreement are fair to and in the
best interests of Chemical and the Chemical Shareholders, and (ii) adopted this Agreement and authorized the transactions contemplated
by this Agreement and resolved to make the Chemical Board Recommendation to the Chemical Shareholders. Except for the Chemical
Shareholder Approval, no other corporate proceedings on the part of Chemical are necessary to authorize this Agreement or to consummate
the Merger (other than the submission to the Chemical Shareholders of an advisory (non-binding) vote on the compensation that may
be paid or become payable to Chemical&rsquo;s named executive officers that is based on or otherwise related to the transactions
contemplated by this Agreement). This Agreement has been duly executed and delivered by, and (assuming due authorization, execution
and delivery by Talmer) constitutes valid and binding obligations of, Chemical and is enforceable against Chemical in accordance
with its terms, except to the extent that (A) such enforcement may be subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other similar laws, now or hereafter in effect, relating to creditors&rsquo; rights generally and (B) equitable remedies
of specific performance and injunctive and other forms of </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">29</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">equitable relief may be subject to equitable defenses and to the discretion
of the court before which any proceeding therefor may be brought.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution,
delivery, and performance of this Agreement by Chemical, the issuance of shares of Chemical Common Stock constituting the Merger
Consideration, and the consummation of the Merger, do not and will not violate, conflict with, or result in a breach of: (i) any
provision of the articles of incorporation or bylaws (or similar organizational documents) of Chemical or any Subsidiary of Chemical
(each a &ldquo;<B><I>Chemical Subsidiary</I></B>&rdquo; and collectively, the &ldquo;<B><I>Chemical Subsidiaries</I></B>&rdquo;);
or (ii) any Law or Order applicable to Chemical or any Chemical Subsidiary, assuming the timely receipt of each of the approvals
referred to in <U>Section 4.1(d)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution,
delivery, and performance of this Agreement by Chemical, the issuance of shares of Chemical Common Stock constituting the Merger
Consideration, and the consummation of the Merger do not and will not violate, conflict with, result in a breach of, constitute
a default under, or require any consent, approval, waiver, extension, amendment, authorization, notice, or filing under, any cease
and desist order, written agreement, memorandum of understanding, board resolutions or other Regulatory Agreement or commitment
with or from a Governmental Entity to which Chemical or any Chemical Subsidiary is a party or subject, or by which Chemical or
any Chemical Subsidiary is bound or affected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No notice to,
filing with, authorization of, exemption by, or consent or approval of, any Governmental Entity is necessary for the consummation
of the transactions contemplated by this Agreement by Chemical other than in connection or compliance with the provisions of the
MBCA, compliance with federal and state securities laws, and the consents, authorizations, approvals, or exemptions required under
the BHC Act and the Michigan Banking Code. Chemical has no Knowledge of any reason why the Regulatory Approvals referred to in
this <U>Section 4.1(d)</U> cannot be obtained or why the regulatory approval process would be materially impeded.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Good Standing</U>. Chemical is a corporation duly organized, validly existing, and in good standing under the laws of the State
of Michigan. Chemical has all requisite corporate power and authority to own, operate, and lease its properties and assets and
to carry on its business as it is now being conducted in all material respects. Chemical is a financial holding company duly registered
as such with the Federal Reserve Board under the BHC Act. Chemical is not, and is not required to be, qualified or admitted to
conduct business as a foreign corporation in any other state, except where such failure to be so qualified has not had, and would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiaries</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical has
provided to Talmer a true and complete list of each Chemical Subsidiary as of the date of this Agreement. Other than the Chemical
Subsidiaries, Chemical does not have &ldquo;control&rdquo; (as defined in Section 2(a)(2) of the BHC Act, using five percent (5%)
rather than twenty-five percent (25%)), either directly or indirectly, of any Person engaged in an active trade or business or
that holds any significant assets. Chemical or a </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">30</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Chemical Subsidiary owns all of the issued and outstanding capital stock or other
equity interests of each of the Chemical Subsidiaries, free and clear of any claim or Lien of any kind. There is no legally binding
and enforceable subscription, option, warrant, right to acquire, or any other similar agreement pertaining to the capital stock
or other equity interests of any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the
Chemical Subsidiaries (i) is duly organized and validly existing under the laws of its jurisdiction of organization; (ii) is duly
qualified to do business and in good standing in all jurisdictions (whether federal, state, or local) where its ownership or leasing
of property or the conduct of its business requires it to be so qualified; and (iii) has all requisite corporate power and authority
to own or lease its properties and assets and to carry on its business as now conducted, except in each of (ii) and (iii) as has
not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The deposits
of Chemical Bank are insured by the FDIC to the fullest extent permitted by Law, and all premiums and assessments to be paid in
connection therewith have been paid when due. No proceeding for the revocation or termination of such deposit insurance is pending
or, to the Knowledge of Chemical, threatened. Chemical and each Chemical Subsidiary has paid as and when due all material fees,
charges, assessments, and the like as required by Law to each and every Governmental Entity having jurisdiction over Chemical or
each Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capital
Stock</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The authorized
capital stock of Chemical consists of 60,000,000 shares of Chemical Common Stock, of which, as of the Capitalization Date, 38,167,861
shares were issued and outstanding; and 2,000,000 shares of Preferred Stock (the &ldquo;<B><I>Chemical Preferred Stock</I></B>&rdquo;),
of which, as of the Capitalization Date, no<FONT STYLE="background-color: white"> </FONT>shares were issued and outstanding. Except
for the Chemical Share-Based Awards, as of the date of this Agreement, there is no security or class of securities outstanding
that represents, is convertible into, or is exercisable for capital stock of Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
4.4(b)</U> of the Chemical Disclosure Schedules sets forth, as of the date of this Agreement, the number of shares of Chemical
Common Stock that are authorized and reserved for issuance under each plan sponsored by Chemical under which options and other
stock-based awards are granted, and the award agreements thereunder (collectively, the &ldquo;<B><I>Chemical Stock Plans</I></B>&rdquo;),
and the number of shares of Chemical Common Stock that are subject to outstanding Chemical Stock Options and Chemical Stock Awards
(collectively, &ldquo;<B><I>Chemical Share-Based Awards</I></B>&rdquo;) issued under a Chemical Stock Plan. All Chemical Share-Based
Awards have been awarded under a Chemical Stock Plan, and, as of the date of this Agreement, there are no other compensatory awards
outstanding pursuant to which Chemical Common Stock has been issued or is issuable, or that relate to or are determined by reference
to the value of Chemical Common Stock. All outstanding shares of Chemical Common Stock, and all Chemical Common Stock reserved
for issuance under the Chemical Stock Plans when issued in accordance with the respective terms of the Chemical Stock Plans, are
or will be duly authorized, validly issued, fully </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">31</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">paid and non-assessable and not issued in violation of any preemptive rights,
purchase option, call or right of first refusal rights.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After the date
of this Agreement, the number of issued and outstanding shares of Chemical Common Stock and Chemical Preferred Stock is not subject
to change before the Effective Time, other than the issuance of shares of Chemical Common Stock upon the exercise of any Chemical
Stock Options granted pursuant to a Chemical Stock Plan prior to the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than
the issued and outstanding shares of Chemical Common Stock described in <U>Section 4.4(a)</U>, neither Chemical nor any Chemical
Subsidiary has outstanding any security or issue of securities the holder or holders of which have the right to vote on the approval
of the Merger, this Agreement, or the issuance of Chemical Common Stock that constitutes the Merger Consideration, or that entitle
the holder or holders to consent to, or withhold consent on, the Merger, this Agreement or the issuance of Chemical Common Stock
that constitutes the Merger Consideration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Chemical
Shareholder will be entitled to appraisal rights pursuant to the MBCA as a result of the consummation of the Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial
Statements</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated
financial statements of Chemical as of and for each of the three (3) years ended December 31, 2014, 2013, and 2012, as reported
on by Chemical&rsquo;s independent accountants, and the unaudited consolidated financial statements of Chemical as of and for each
quarter in 2015 ended before the date of this Agreement, including all schedules and notes relating to such statements, as previously
delivered to Talmer (collectively, &ldquo;<B><I>Chemical Financial Statements</I></B>&rdquo;), fairly present, and the unaudited
consolidated financial statements of Chemical as of and for each quarter ending after the date of this Agreement until the Effective
Time, including all schedules and notes relating to such statements, will fairly present the financial condition and the results
of operations, changes in shareholders&rsquo; equity, and cash flows of Chemical as of the respective dates of and for the periods
referred to in such financial statements, all in accordance with GAAP, consistently applied, subject, in the case of unaudited
interim financial statements, to normal, recurring year-end adjustments (the effect of which has not had, and would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical) and the absence of notes (that, if
presented, would not differ materially from those included in Chemical Financial Statements). No financial statements of any entity
or enterprise other than the Chemical Subsidiaries are required by GAAP to be included in the consolidated financial statements
of Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following
reports (including all related schedules, notes, and exhibits) were prepared and filed in conformity with applicable regulatory
requirements and were correct and complete in all material respects when filed:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Consolidated
Reports of Condition and Income (Form FFIEC 041) of each Chemical Subsidiary required to file such reports (including any amendments)
as of and for each of the fiscal years ended December 31, 2014, 2013, and </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">32</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify">as of and for each of the first, second and third quarter
of 2015 as filed with the FDIC; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Consolidated Financial Statements for Bank Holding Companies (Form FR Y-9C) and Parent Company Only Financial Statements for Large
Bank Holding Companies (Form FR Y-9LP) (including any amendments) for Chemical as of and for each of the fiscal years ended December
31, 2014, 2013, and 2012, and as of and for each quarter ended in 2015 before the date of this Agreement as filed with the Federal
Reserve Board. All of such reports required to be filed prior to the Effective Time by Chemical or any Chemical Subsidiary will
be prepared and filed in conformity with applicable regulatory requirements applied consistently throughout their respective periods
(except as otherwise noted in such reports) and will be correct and complete in all material respects when filed. All of the reports
identified in this <U>Section 4.5(b</U>) are collectively referred to as the &ldquo;<B><I>Chemical Call Reports</I></B>.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Certain Changes or Events</U>. Since September 30, 2015, (a) Chemical and the Chemical Subsidiaries have conducted their respective
businesses in the ordinary course consistent with past practice and (b) no event has occurred that has had, or would reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Legal
Proceedings</U>. There is no Action pending or, to the Knowledge of Chemical, threatened against Chemical or any of the Chemical
Subsidiaries that (a) as of the date of this Agreement, challenges or seeks to enjoin, alter, prevent or materially delay the Merger
or (b) has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical.
There is no material unsatisfied judgment, penalty or award against Chemical or any of the Chemical Subsidiaries. Neither Chemical
nor any of the Chemical Subsidiaries, nor any of their respective properties or assets, is subject to any Order or any investigation
by a Governmental Entity that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Chemical. No officer or director of Chemical or any of the Chemical Subsidiaries is a defendant in any Action commenced
by any shareholder of Chemical or any of the Chemical Subsidiaries with respect to the performance of his or her duties as an officer
or a director of Chemical or any of the Chemical Subsidiaries under any applicable Law, except for any Action arising out of or
relating to the Merger and the transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory Filings</U>.
In the last three (3) years:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical and
each Chemical Subsidiary has filed in a timely manner all filings with Governmental Entities as required by applicable Law; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All such filings,
as of their respective filing dates, complied in all material respects with all Laws, forms, and guidelines applicable to such
filings.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Indemnification
Claims</U>. To the Knowledge of Chemical, there has been no event, action, or omission by or with respect to any director, officer,
employee, trustee, agent, or other Person who may be entitled to receive indemnification or reimbursement of any claim, </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">33</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">loss, or
expense under any Contract or arrangement providing for indemnification or reimbursement of any such Person by Chemical or any
Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct
of Business</U>. Chemical and each Chemical Subsidiary has conducted its business and used its properties in compliance with all
applicable Laws, including without limitation applicable federal and state laws and regulations concerning banking, securities,
truth-in-lending, truth-in-savings, mortgage origination and servicing, usury, fair credit reporting, consumer protection, occupational
safety, fair lending, civil rights, employee protection, fair employment practices, fair labor standards, real estate settlement
and procedures, insurance, privacy, and Environmental Laws; except for violations that have not had, and would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transaction
Documents</U>. None of the information supplied or to be supplied by Chemical for inclusion or incorporation by reference in any
Transaction Document will contain any untrue statement of material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading,
(a) in the case of any Transaction Document (other than the Form S-4 and the Joint Proxy Statement), at the time it is filed or
at any time it is amended or supplemented, (b) in the case of the Form S-4, at the time it is filed with the SEC, at any time it
is amended or supplemented and at the time it becomes effective under the Securities Act, and (c) in the case of the Joint Proxy
Statement, at the date it is first mailed to the Chemical Shareholders and the Talmer Shareholders and at the time of the Chemical
Shareholder Meeting and the Talmer Shareholder Meeting. The Joint Proxy Statement (other than those portions relating solely to
the Talmer Shareholder Meeting) will, at the time the Joint Proxy Statement is filed with the SEC, at any time it is amended or
supplemented, at the date it is first mailed to the Chemical Shareholders and the Talmer Shareholders and at the time of the Chemical
Shareholder Meeting and the Talmer Shareholder Meeting, comply as to form in all material respects with the requirements of the
Exchange Act and the rules and regulations thereunder, except that no representation is made by Chemical with respect to statements
made or incorporated by reference therein based on information supplied by or on behalf of Talmer for inclusion or incorporation
by reference in the Joint Proxy Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreements With Bank
Regulators</U>. Neither Chemical nor any Chemical Subsidiary is a party to any Regulatory Agreement, nor has Chemical nor any Chemical
Subsidiary been advised by any Governmental Entity that a Governmental Entity is contemplating issuing or requesting (or is considering
the appropriateness of issuing or requesting) an Order or a Regulatory Agreement. Neither Chemical nor any Chemical Subsidiary
is required by Section 32 of the Federal Deposit Insurance Act or FDIC Regulation Part 359 or the Federal Reserve Board to give
prior notice to a federal banking agency of the proposed addition of an individual to its board of directors or the employment
of an individual as a senior executive officer or to limit golden parachute payments or indemnification.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All material
Tax Returns required by applicable Law to have been filed by Chemical and each Chemical Subsidiary since January 1, 2010 have been
filed when due (taking </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">34</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">into account any extensions), and each such Tax Return is complete and accurate and correctly reflects the
liability for Taxes in all material respects. Since January 1, 2010, Chemical and each Chemical Subsidiary has withheld and paid
all material Taxes required to have been withheld and paid in connection with amounts paid or owing to any third party. Since January
1, 2010, all material Taxes that are due and payable by Chemical and each Chemical Subsidiary have been paid.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
audit or other proceeding pending against or with respect to Chemical or any Chemical Subsidiary with respect to any material amount
of Tax. There are no material Liens on any of the assets of Chemical or any of the Chemical Subsidiaries that arose in connection
with any failure (or alleged failure) to pay any Tax, other than Liens for Taxes not yet due and payable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical
nor any Chemical Subsidiary has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect
to any Taxes, which waiver or extension is still open.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as required
by Law, neither Chemical nor any Chemical Subsidiary is a party to any Tax allocation or sharing agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical
nor any Chemical Subsidiary has been included in any &ldquo;consolidated,&rdquo; &ldquo;unitary&rdquo; or &ldquo;combined&rdquo;
Tax Return for any taxable period for which the statute of limitations has not expired (other than a group of which Chemical and
one or more Chemical Subsidiaries are the only members). Neither Chemical nor any Chemical Subsidiary is a general partner in any
partnership that is material to its business operations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within the
past three (3) years, neither Chemical nor any Chemical Subsidiary has been a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled
corporation&rdquo; in a distribution intended to qualify for tax-free treatment under Section 355 of the Code.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical
nor any Chemical Subsidiary has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes
a &ldquo;listed transaction&rdquo; for purposes of Section 6011 of the Code (or a similar provision of state Law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical
nor any Chemical Subsidiary has taken any action or has Knowledge of any fact that would reasonably be expected to prevent the
Merger from qualifying for the Intended Tax Treatment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There has been
no disallowance of a deduction under Section 162(m) or 280G of the Code for any amount paid or payable by Chemical or any Chemical
Subsidiary as employee compensation, whether under any Contract, plan, program or arrangement, understanding or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Properties</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except with
such exceptions that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Chemical, Chemical and each Chemical Subsidiary has good and valid title to, or valid leasehold interests </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">35</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">in, all of
their respective personal and real properties and assets as used in their respective businesses as presently conducted, and all
such personal and real properties and assets, other than personal and real properties and assets in which Chemical or any of the
Chemical Subsidiaries has leasehold interests, are free and clear of all Liens, except for Permitted Liens. Chemical and each Chemical
Subsidiary has complied in all material respects with the terms of all leases to which it is a party. All material leases to which
Chemical or any Chemical Subsidiary is a party and under which it is in possession of any personal or real property are valid and
binding contracts and are in full force and effect, and neither Chemical nor any Chemical Subsidiary has received any written notice
alleging violation, breach, or default of such lease. Chemical and each Chemical Subsidiary is in possession of the properties
or assets purported to be leased under all its material leases (except where Chemical or a Chemical Subsidiary is the lessor).
The tangible personal and real property and assets of Chemical and all Chemical Subsidiaries are in good operating condition and
repair, reasonable wear and tear excepted, and, subject to maintenance and repair in the ordinary course of business consistent
with past practice, are adequate for the uses to which they are being put.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect
to real property owned by Chemical or any Chemical Subsidiary, none of Chemical nor any Chemical Subsidiary (i) has received written
notice of any pending, and to the Knowledge of Chemical there is no threatened, condemnation proceeding against any of such real
property or (ii) has received written notice from any Governmental Entity that such real property is not in compliance with any
applicable Law, except as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect
to real property leased, subleased or licensed by Chemical or any Chemical Subsidiary, none of Chemical nor any Chemical Subsidiary
(i) has received any written notice alleging a violation, breach or default under any lease of such real property, except for matters
being contested in good faith for which adequate accruals or reserves have been established on the books and records of Chemical
or (ii) (A) has received written notice of any pending, and to the Knowledge of Chemical there is no threatened, condemnation proceeding
with respect to any of such real property or (B) has received written notice from any Governmental Entity that such real property
is not in compliance with any applicable Law, except as have not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No lease or
license pursuant to which Chemical or any Chemical Subsidiary, as lessor, lessee, licensor or licensee, has possession of, or leases
or licenses to others, any real or personal property, excluding any personal property lease with payments of less than $500,000
per year, contains any provision, including any prohibition against assignment by Chemical or any Chemical Subsidiary, by operation
of Law or otherwise, that would require any third party consent or approval for, or that would materially interfere with, the possession,
use or rights with respect to the property by the Surviving Corporation or its Subsidiaries for the same purposes and upon the
same rental and other terms following consummation of the Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property</U>. Chemical and the Chemical Subsidiaries exclusively own, or have a valid license or other valid right to use, all
material Intellectual Property as used in </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">36</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">their business as presently conducted; it being understood that the foregoing shall not
be construed to expand or diminish the scope of the non-infringement representations and warranties that follow in this <U>Section
4.15</U>. No Actions, suits or other proceedings are pending or, to the Knowledge of Chemical, threatened that Chemical or any
of the Chemical Subsidiaries is infringing, misappropriating or otherwise violating the rights of any Person with regard to any
Intellectual Property. To the Knowledge of Chemical, no Person is materially infringing, misappropriating or otherwise violating
the rights of Chemical or any of the Chemical Subsidiaries with respect to any material Intellectual Property owned or purported
to be owned by Chemical or any of the Chemical Subsidiaries (collectively the &ldquo;<B><I>Chemical-Owned Intellectual Property</I></B>&rdquo;).
Except as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect
on Chemical, to the Knowledge of Chemical: (a) no circumstances exist which could reasonably be expected to give rise to any (i)
Action that challenges the rights of Chemical or any of the Chemical Subsidiaries with respect to the validity or enforceability
of the Chemical-Owned Intellectual Property or (ii) claim of infringement, misappropriation, or violation of the Intellectual Property
rights of any Person, and (b) the consummation of the transactions contemplated by this Agreement will not give rise to any claim
by any Person to a right to own, purchase, transfer, use, alter, impair, extinguish or restrict any Chemical-Owned Intellectual
Property or Intellectual Property licensed to Chemical or any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Required
Licenses, Permits, Etc</U>. Chemical and each Chemical Subsidiary hold all material Permits and other rights from all appropriate
Governmental Entities necessary for the conduct of its business as presently conducted. All such material Permits and rights are
in full force and effect. Each Chemical Subsidiary, as applicable, is an approved seller-servicer for each mortgage investor with
whom it conducts business, and holds all material Permits, authorizations, and approvals necessary to carry on a mortgage banking
business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Material
Contracts and Change of Control</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the purposes
of this Agreement, the term &ldquo;<B><I>Chemical Material Contract</I></B>&rdquo; means any of the following Contracts to which
Chemical or any of the Chemical Subsidiaries is a party or bound as of the date of this Agreement:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that (A) has been or (B) would be required to be, but has not been, filed by Chemical as a material contract pursuant
to Item 601(b)(10) of Regulation S-K on Form 10-K under the Exchange Act as if such Form 10-K were filed as of the date of this
Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract, other than any Contracts contemplated by this Agreement, that limits (or purports to limit) in any material respect the
ability of Chemical or any of the Chemical Subsidiaries to engage or compete in any business (including geographic restrictions
and exclusive or preferential arrangements);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that creates a material partnership or joint venture to which Chemical or any of the Chemical Subsidiaries is a party;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">37</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract between or among Chemical and any Chemical Subsidiary;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract with a correspondent banker;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract relating to the borrowing of money by Chemical or any Chemical Subsidiary or guarantee by Chemical or any Chemical Subsidiary
of such obligation (other than Contracts evidencing deposit liabilities, purchases of federal funds, fully-secured repurchase agreements,
FHLB advances of depository institution Chemical Subsidiaries, trade payables and Contracts relating to borrowings or guarantees
made in the ordinary course of business consistent with past practice) in excess of $2,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that relates to the acquisition or disposition of any material business (whether by merger, sale of stock, sale of assets
or otherwise) or material asset, other than this Agreement, pursuant to which Chemical or any of the Chemical Subsidiaries has
any material continuing obligations, contingent or otherwise;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that grants any right of first refusal or right of first offer or similar right or that limits or purports to limit the
ability of Chemical or any of the Chemical Subsidiaries to own, operate, sell, transfer, pledge or otherwise dispose of any material
amount of assets or businesses;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
voting agreement or registration rights agreement with respect to the capital stock of Chemical or any of the Chemical Subsidiaries;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract granting Chemical or any Chemical Subsidiary the right to use, restricting Chemical&rsquo;s or any Chemical Subsidiary&rsquo;s
right to use, or granting any other Person the right to use Intellectual Property that is material to the conduct of Chemical&rsquo;s
or any Chemical Subsidiary&rsquo;s business (including any license, franchise agreement, co-existence agreement, concurrent-use
agreement, settlement agreement or other similar type Contract);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that limits the payment of dividends by Chemical or any Chemical Subsidiary;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract involving a standstill or similar obligation of Chemical or any of the Chemical Subsidiaries relating to the purchase
of securities of Chemical or any other Person;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
transactions made in accordance with Regulation O and agreements entered into in the ordinary course of business consistent with
past practice for compensation or indemnity, any Contract between Chemical or any Chemical Subsidiary, on the one hand, and, on
the other hand (A) any officer or director of Chemical or a Chemical Subsidiary, or (B) to the Knowledge of Chemical, any (1) record
or beneficial owner of five percent (5%) or more of the voting securities of Chemical, (2) Affiliate or family member of any such
officer, director, or record or beneficial owner, or (3) other Affiliate of Chemical, except those Contracts of a type available
to employees of Chemical generally;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">38</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract for any one capital expenditure or a series of capital expenditures, the aggregate amount of which is in excess of $1,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract or commitment to make a loan not yet fully disbursed or funded to any Person, wherein the undisbursed or unfunded amount
exceeds $10,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract or commitment for a loan participation agreement with any other Person in excess of $10,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
employment Contract with an employee of Chemical or any Chemical Subsidiary or any other compensatory Contract or plan in which
any executive officer of Chemical or any Chemical Subsidiary participates (other than any compensatory Contract or plan which pursuant
to its terms is available to employees, officers or directors generally and which in operation provides for the same method of
allocation of benefits between management and non-management participants); and </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Contract that is material to the financial condition, results of operations or business of Chemical or any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the
date of this Agreement, Chemical has provided or made available to Talmer a true and complete copy of each Chemical Material Contract
in effect as of the date of this Agreement. Except for matters that have not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on Chemical, (i) all Chemical Material Contracts are in full force
and effect as of the date of this Agreement, (ii) neither Chemical nor any of the Chemical Subsidiaries is in violation or breach
of or default under (or with notice or lapse of time, or both, would be in violation or breach of or default under) the terms of
any Chemical Material Contract, (iii) to the Knowledge of Chemical, no other party to any Chemical Material Contract is in breach
of or in default under any Chemical Material Contract, and (iv) neither Chemical nor any Chemical Subsidiary has received written
notice of breach or termination (or proposed breach or termination) of any Chemical Material Contract.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
Chemical Material Contract under which (i) a consent or approval is required, (ii) a prohibited assignment by operation of Law
could occur, (iii) a waiver or loss of any right could occur, or (iv) an acceleration of any obligation could occur, in each case
as a result of the execution and delivery of this Agreement or the consummation of the transactions contemplated herein, where
any such occurrence would reasonably be expected to (A) materially interfere with the ordinary course of business conducted by
Chemical, any Chemical Subsidiary or the Surviving Corporation or (B) have a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
All data processing Contracts of Chemical or any of the Chemical Subsidiaries are cancelable by Chemical or a Chemical Subsidiary
on or immediately after the Effective Time without cost, penalty or further obligation, except for costs, penalties or further
obligations that, in the aggregate with respect to any Contract, do not exceed $1,000,000; and (ii) </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">39</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="background-color: white">neither Chemical nor any Chemical
Subsidiary is party to any Contract that would require any payment to another party upon termination in excess of $1,000,000.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor
and Employment Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Chemical
and all of the Chemical Subsidiaries are in compliance with all applicable Laws relating to labor and employment practices, including
those relating to wages, employee benefits, hours and overtime, workplace safety and health, immigration, individual and collective
termination, non-discrimination and data privacy, workers&rsquo; compensation, the identification of particular employees or job
classifications as &ldquo;exempt&rdquo; or &ldquo;non-exempt&rdquo; for purposes of such obligations, and any and all other matters
involving compensation or benefits afforded to or not afforded to employees, contractors or consultants except for such noncompliance
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical;
(ii) as of the date of this Agreement, there is no unfair labor practice charge or complaint pending before the NLRB or, to the
Knowledge of Chemical, threatened against Chemical or any of the Chemical Subsidiaries; (iii) as of the date of this Agreement
and during the past three (3) years, there has been no labor strike, slowdown, work stoppage or lockout pending or, to the Knowledge
of Chemical, threatened against or affecting Chemical or any of the Chemical Subsidiaries; (iv) there is no representation claim
or petition pending before the NLRB or any similar foreign agency relating to the employees of Chemical or any Chemical Subsidiary;
(v) as of the date of this Agreement, Chemical has not received written notice of charges with respect to or relating to Chemical
or any Chemical Subsidiary pending before the Equal Employment Opportunity Commission or other Governmental Entity responsible
for the prevention of unlawful employment practices, nor is there any claim pending before any court or administrative agency regarding
any unlawful employment practices relating to Chemical or any Chemical Subsidiary; and (vi) neither Chemical nor any Chemical Subsidiary
has received any written notice from any Governmental Entity responsible for the enforcement of labor or employment laws of an
intention to conduct an investigation of Chemical or any Chemical Subsidiary and, to the Knowledge of Chemical, no such investigation
is in progress.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical
nor any Chemical Subsidiary is party to, bound by, or negotiating any Collective Bargaining Agreement or any other Contract with
any labor organization, union, works council, employee representative or association.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;All salaried employees, hourly employees, and temporary employees of Chemical and its Subsidiaries are employed
on an at-will basis by Chemical and/or its Subsidiaries and may be terminated at any time with or without cause and without any
severance or other liabilities to Chemical or any Chemical Subsidiary, or have signed an agreement or acknowledged in writing that
their employment is at will. There has been no written representation by Chemical or any Chemical Subsidiary made to any employee
that commits Chemical, any Chemical Subsidiary, or the Surviving Corporation to retain them as employees for any period of time
subsequent to the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since January
1, 2013, neither Chemical nor any Chemical Subsidiary has effectuated a &ldquo;plant closing&rdquo; or a &ldquo;mass lay off&rdquo;
(in each case, as defined in the WARN Act), in </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">40</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">either case affecting any site of employment or facility of Chemical or any Chemical
Subsidiary, except in compliance with the WARN Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
audit, investigation, charge or proceeding with respect to a material violation of any occupational health and safety standards
that is pending or unremedied, or, to the Knowledge of Chemical, threatened against Chemical or any Chemical Subsidiary. Chemical
and all of the Chemical Subsidiaries are in compliance with all applicable occupational health and safety Laws, except for such
failures to comply as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical
nor any Chemical Subsidiary is a party or subject to any Contract which restricts Chemical or any Chemical Subsidiary from relocating,
closing or terminating any of its operations or facilities or any portion of its operations or facilities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consummation
of the transactions contemplated by this Agreement will not create Liabilities for any act by Chemical or any Chemical Subsidiary
on or prior to the Closing under any Collective Bargaining Agreement, Contract or Chemical Benefit Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical has
implemented commercially reasonable procedures to ensure that all employees who are performing services for Chemical or any Chemical
Subsidiary in the United States are legally permitted to work in the United States and will be legally permitted to work in the
United States for the Surviving Corporation or any of its Subsidiaries following the consummation of the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The policies,
programs, and practices of Chemical and all Chemical Subsidiaries relating to equal opportunity and affirmative action, wages,
employee classifications (including independent contractor versus employee and exempt versus non-exempt), hours of work, employee
disabilities, employment termination, employment discrimination, employee safety, labor relations, and other terms and conditions
of employment are in compliance in all material respects with applicable Law governing or relating to employment and employer practices
and facilities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee
Benefits</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical has
delivered or made available to Talmer true and complete copies of all material Chemical Benefit Plans. Each Chemical Benefit Plan
is in compliance with all applicable requirements of ERISA, the Code and all other applicable Laws and has been administered in
accordance with its terms and such Laws, except for such noncompliance that has not had, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Chemical
Benefit Plan that is intended to be qualified within the meaning of Section 401 of the Code is so qualified and has at all times
since its adoption been so qualified, and, to the Knowledge of Chemical, no condition exists and no event has occurred that could
reasonably be expected to result in the loss or revocation of such qualification in any material respect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">41</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All contributions,
payments or premiums required to be made with respect to any Chemical Benefit Plan by Chemical on or before the date of this Agreement
have been timely made, and all benefits accrued under any unfunded Chemical Benefit Plan have been paid, accrued or otherwise adequately
reserved in accordance with GAAP, and each of Chemical and the Chemical Subsidiaries have performed all material obligations required
to be performed under all Chemical Benefit Plans with respect to which Chemical or any ERISA Affiliate of Chemical has an obligation
to contribute.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Chemical nor any ERISA Affiliate of Chemical (or, to Chemical&rsquo;s Knowledge, their respective
predecessors) participates in nor since December 31, 1973, has ever participated in any Multiemployer Plan, and neither Chemical
nor any ERISA Affiliate of Chemical (or, to Chemical&rsquo;s Knowledge, their respective predecessors) maintains or contributes
to, or is party to, and, at no time maintained, contributed to, or was a party to, any plan, program, agreement or policy that
(i) is a &ldquo;defined benefit plan&rdquo; within the meaning of Section 414(j) of the Code or Section 3(35) of ERISA, (ii) is
a &ldquo;multiple employer plan&rdquo; as defined in ERISA or the Code (whether or not subject thereto), (iii) is described in
Section 401(a)(1) of ERISA (whether or not subject thereto), (iv) is a multiple employer welfare arrangement within the meaning
of Section 3(40)(A) of ERISA, (v) is a voluntary employees beneficiary association within the meaning of Code Section 501(c)(9),
or (vi) is primarily for the benefit of employees who reside outside of the United States. No Liability under Title IV of ERISA
has been or is expected to be incurred by Chemical or any Chemical Subsidiary with respect to any applicable Chemical Benefit Plan.
Except as may arise in connection with the transactions contemplated by this Agreement, there has been no &ldquo;reportable event,&rdquo;
within the meaning of ERISA Section 4043, for which the 30-day reporting requirement has not been waived in relation to any applicable
Chemical Benefit Plan. In relation to each applicable Chemical Benefit Plan, (A) all contributions required to be made under one
or both of Section 412 and 430 of the Code have been timely made, (B) there has been no application for any waiver of the minimum
funding premium standards imposed by Section 412 of the Code, and such minimum funding standards have been met to date, and (C)
there is no &ldquo;amount of unfunded benefit liabilities&rdquo; as defined in Section 4001(a)(18) of ERISA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as required
by Part 6 of Subtitle B of Title I of ERISA or Section 4980B of the Code or any state Laws requiring continuation of benefits coverage
following termination of employment, neither Chemical nor any Chemical Subsidiary provides health or welfare benefits for any retired
or former employee following such employee&rsquo;s retirement or other termination of service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution,
delivery of, and performance by Chemical of its obligations under the transactions contemplated by this Agreement (either alone
or upon the occurrence of any additional or subsequent event) will not (i) result in any payment (whether of severance pay or otherwise),
acceleration, forgiveness of indebtedness, vesting, distribution, increase in benefits or obligation to fund benefits with respect
to any current, former or retired employees, officers, consultants, independent contractors, agents or directors of Chemical or
any of the Chemical Subsidiaries; (ii) result in the triggering or imposition of any restrictions or limitations on the right of
Chemical or any of the Chemical Subsidiaries to amend or terminate any Chemical Benefit Plan; or (iii) result in any &ldquo;excess
parachute payments&rdquo; within the meaning </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">42</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">of Section 280G(b)(1) of the Code that would result in a deduction disallowance under
Code Section 280G(a) on the part of Chemical or any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical and
the Chemical Subsidiaries may, subject to the limitations imposed by applicable Law and the terms of the applicable Chemical Benefit
Plan, without the consent of any employee, beneficiary, or other Person, prospectively terminate, modify, or amend any such Chemical
Benefit Plan effective as of any date on or after the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect
to each Chemical Benefit Plan that is a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined under Section 409A(d)(1)
of the Code), (i) such plan has been operated and administered in compliance with Section 409A of the Code or (ii) any payments
under such plan have been earned and vested on or prior to December 31, 2004, and such plans have not been materially modified
other than modifications to comply with Code Section 409A and the regulations promulgated thereunder. Neither Chemical nor any
of the Chemical Subsidiaries have entered into any agreement or arrangement to, and do not otherwise have any obligation to, indemnify
or hold harmless any Person for any Liability that results from the failure to comply with the requirements of Section 409A of
the Code and the regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no
pending or, to the Knowledge of Chemical, threatened Action with respect to any Chemical Benefit Plans, other than ordinary and
usual claims for benefits by participants and beneficiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since January
1, 2015, neither Chemical nor any of the Chemical Subsidiaries have agreed or otherwise committed to, whether in writing or otherwise,
adopt any new plan, program, agreement or policy that would constitute a Chemical Benefit Plan or result in participation in a
Multiemployer Plan or increase or improve the compensation, benefits, or terms and conditions of employment or service of any director,
officer, employee, or consultant, except (i) in the ordinary course of business consistent with past practice with respect to individual
employees who are not officers (and not with respect to a substantial class of employees) or (ii) as required by applicable Law
or any applicable Chemical Benefit Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the
Chemical Benefit Plans which is an &ldquo;employee welfare benefit plan&rdquo; within the meaning of Section 3(1) of ERISA is in
compliance with the Patient Protection and Affordable Care Act and its companion bill, the Health Care and Education Reconciliation
Act of 2010, to the extent applicable, except for such noncompliance that has not had, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on Chemical. Additionally, Chemical and the Chemical Subsidiaries
operate such Chemical Benefit Plans to avoid assessable payments under Code Sections 4980H(a) and (b).<FONT STYLE="color: #1F497D">&nbsp;
</FONT>Neither Chemical nor any of the Chemical Subsidiaries have any liability in the nature of a retroactive rate adjustment,
loss sharing arrangement or other material Liability arising wholly or partially out of events occurring on or before the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No stock options,
stock appreciation rights or other grants of stock-based awards by Chemical or any Chemical Subsidiaries were backdated, spring-loaded,
or granted at less than fair market value.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">43</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental
Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for
any matters that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect on Chemical: (i) Chemical and each of the Chemical Subsidiaries is and has been in compliance with and has no Liability
under applicable Environmental Laws; (ii) Chemical and each of the Chemical Subsidiaries possesses, has possessed and is and has
been in compliance with all required Environmental Permits; (iii) there are no Environmental Claims pending or, to the Knowledge
of Chemical, threatened against Chemical or any of the Chemical Subsidiaries, and, to the Knowledge of Chemical, there are no facts
or circumstances which could reasonably be expected to form the basis for any Environmental Claim against Chemical or any of the
Chemical Subsidiaries; (iv) no Releases of Hazardous Materials have occurred and no Person has been exposed to any Hazardous Materials
at, from, in, to, on, or under any Chemical Site and no Hazardous Materials are present in, on, about or migrating to or from any
Chemical Site in quantities or concentrations or under circumstances that could give rise to an Environmental Claim against Chemical
or any of the Chemical Subsidiaries; (v) neither Chemical nor any of the Chemical Subsidiaries has entered into or is subject to,
any judgment, decree, order or other similar requirement of or agreement with any Governmental Entity under any Environmental Laws;
(vi) neither Chemical nor any of the Chemical Subsidiaries has assumed responsibility for or agreed to indemnify or hold harmless
any Person for any Liability, arising under or relating to Environmental Laws; and (vii) neither Chemical nor any of the Chemical
Subsidiaries, any predecessors of Chemical or any of the Chemical Subsidiaries, nor any entity previously owned by Chemical or
any of the Chemical Subsidiaries, has transported or arranged for the treatment, storage, handling, disposal, or transportation
of any Hazardous Material to any off-Site location which has or could result in an Environmental Claim against Chemical or any
of the Chemical Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge
of Chemical, each underground storage tank presently or previously located on any Chemical Site has been operated, maintained and
removed or closed in place, as applicable, in compliance with all applicable Environmental Laws, and has not been the source of
any Release of a Hazardous Material to the environment that has not been fully remediated as required by applicable Environmental
Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Duties
as Fiduciary</U>. To the Knowledge of Chemical, Chemical and each Chemical Subsidiary has performed all of its respective duties
in any capacity as trustee, executor, administrator, registrar, guardian, custodian, escrow agent, receiver, or other fiduciary
in a fashion that complies in all material respects with all applicable Laws, Contracts, wills, instruments and common law standards.
Neither Chemical nor any Chemical Subsidiary has received any notice of any Action, claim, allegation or complaint from any Person
that Chemical or any Chemical Subsidiary failed to perform these duties in a manner that complies in all material respects with
all applicable Laws, Contracts, wills, instruments and common law standards, except for notices involving matters that have been
resolved and any cost of such resolution is reflected in the Chemical Financial Statements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Bankers and Brokers</U>. Chemical has employed Sandler O&rsquo;Neill &amp; Partners, L.P. (the &ldquo;<B><I>Chemical Investment
Banker</I></B>&rdquo;) in connection with the Merger. Chemical, the Chemical Subsidiaries, and their respective Representatives
have not employed, engaged, or </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">44</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">consulted with any broker, finder, or investment banker other than the Chemical Investment Banker
in connection with this Agreement or the Merger. Other than the fees and expenses payable by Chemical to the Chemical Investment
Banker in connection with the Merger, as described in <U>Section 4.22</U> of the Chemical Disclosure Schedules, there is no investment
banking fee, financial advisory fee, brokerage fee, finder&rsquo;s fee, commission, or compensation of a similar type payable by
Chemical or any Chemical Subsidiary to any Person with respect to the Agreement or the consummation of the Merger. Chemical has
provided to Talmer true and complete copies of each agreement, arrangement, and understanding between Chemical and the Chemical
Investment Banker prior to the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fairness
Opinion</U>. The Chemical Board has received the opinion (which, if initially rendered orally, has been or will be confirmed
by a written opinion, dated the same date) of the Chemical Investment Banker, to the effect that, as of the date of such opinion
and based on and subject to the assumptions, qualifications and limitations contained therein, the Merger Consideration is fair
to Chemical from a financial point of view. Such opinion has not rescinded as of the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Chemical-Related
Persons</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Chemical-Related
Person has any loan, credit or other Contract outstanding with Chemical or any Chemical Subsidiary that does not conform to applicable
rules and regulations of the FDIC, the Federal Reserve Board, or any other Governmental Entity with jurisdiction over Chemical
or any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than
in a capacity as a shareholder, director, or executive officer of Chemical or any Chemical Subsidiary, no Chemical-Related Person
owns or controls any assets or properties that are used in the business of Chemical or any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than
ordinary and customary banking relationships, no Chemical-Related Person has any contractual relationship with Chemical or any
Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No Chemical-Related
Person has any outstanding loan or loan commitment from, or on whose behalf an irrevocable letter of credit has been issued by,
Chemical or any Chemical Subsidiary in a principal amount of $2,000,000 or more.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change
in Business Relationships</U>. As of the date of this Agreement, no director or executive officer of Chemical has Knowledge, whether
on account of the Merger or otherwise, that any customer, agent, representative, supplier of Chemical or any Chemical Subsidiary,
or other Person with whom Chemical or any Chemical Subsidiary has a contractual relationship, intends to discontinue, diminish,
or change its relationship with Chemical or any Chemical Subsidiary, the effect of which would reasonably be expected to have a
Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
Chemical and the Chemical Subsidiaries maintain in full force and effect insurance on their respective assets, properties, premises,
operations, and personnel in such amounts and against such risks and losses as are customary and adequate for comparable entities
engaged in the same business and industry. There is no unsatisfied claim of $400,000 or more under such insurance as to which the
insurance carrier has denied liability. Since January 1, </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">45</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">2014, no insurance company has canceled or refused to renew a policy of
insurance covering Chemical&rsquo;s or any Chemical Subsidiary&rsquo;s assets, properties, premises, operations, directors or personnel.
Chemical and the Chemical Subsidiaries have given adequate and timely notice to each insurance carrier, and have complied with
all policy provisions, with respect to any material known claim for which a defense or indemnification or both may be available
to Chemical or the Chemical Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Books
and Records</U>. The books of account, minute books, stock record books, and other records of Chemical are complete and correct
in all material respects, represent bona fide transactions, and have been maintained in accordance with sound business practices,
including the maintenance of an adequate internal control system. The corporate minute books of Chemical and the Chemical Subsidiaries
contain accurate and complete records of all meetings of, and corporate action taken by, their shareholders, boards, and committees
in all material respects. Since January 1, 2013, the minutes of each meeting (or corporate action without a meeting) of any such
shareholders, boards, or committees have been duly prepared and are contained in such minute books. All such minute books and related
exhibits or attachments for all meetings since January 1, 2013, have been made available for Talmer&rsquo;s review prior to the
date of this Agreement without material omission or redaction (other than with respect to the minutes relating to (a) the Merger
or recent and similarly proposed transactions or (b) matters which Chemical is prohibited from disclosing pursuant to applicable
Law).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loan
Guarantees</U>. Except as have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect on Chemical, all guarantees of indebtedness owed to Chemical or any Chemical Subsidiary, including without limitation
those of the Federal Housing Administration, the Small Business Administration, and any other Governmental Entity, are valid and
enforceable, except as limited by bankruptcy, insolvency, moratorium, reorganization, or similar laws affecting the rights of creditors
generally and the availability of equitable remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Data
Security and Customer Privacy</U>. Chemical and each Chemical Subsidiary is in compliance in all material respects with (a) all
applicable Laws and applicable requirements of Governmental Entities regarding the security of each of their customers&rsquo; data
and the systems operated by Chemical and each Chemical Subsidiary, and (b) their respective privacy policies, including as relates
to the use of individually identifiable personal information relating to identifiable or identified natural persons.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Allowance
for Loan and Lease Losses</U>. The allowance for loan and lease losses as reflected in Chemical&rsquo;s consolidated financial
statements and the Chemical Call Reports as of December 31, 2014 and as of each quarter ended after December 31, 2014 was, in the
reasonable opinion of Chemical&rsquo;s management, (a) adequate to meet all reasonably anticipated loan and lease losses, net of
recoveries related to loans previously charged off as of those dates, (b) consistent with GAAP and reasonable and sound banking
practices, and (c) in conformance with recommendations and comments in reports of examination in all material respects.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loans
and Investments</U>. All investments and, except as would not reasonably be expected to have a Material Adverse Effect on Chemical,
all loans of Chemical and each Chemical Subsidiary are: (a) evidenced by notes, agreements or other evidences of indebtedness </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">46</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">that
are true, genuine and what they purport to be; (b) legal and enforceable in accordance with their terms, except as may be limited
by any bankruptcy, insolvency, moratorium, or other laws affecting the rights of creditors generally or by the exercise of judicial
discretion; (c) authorized under all applicable Laws; and (d) to the extent secured, secured by valid Liens which have been perfected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loan
Origination and Servicing</U>. In originating, underwriting, servicing, selling, transferring, and discharging loans, mortgages,
land contracts, and other contractual obligations, either for its own account or for the account of others, Chemical and each Chemical
Subsidiary has complied with all applicable terms and conditions of such obligations and with all applicable Laws, Contracts, rules,
and procedures, except for incidents of noncompliance that have not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities
Laws Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since January
1, 2012, Chemical has filed or furnished all forms, documents and reports required to be filed or furnished with the SEC under
the Securities Act or the Exchange Act (collectively with any amendments thereto, but excluding the Joint Proxy Statement and the
Form S-4, the &ldquo;<B><I>Chemical SEC Reports</I></B>&rdquo;). Each of the Chemical SEC Reports, in each case as of its filing
or furnishing date, or, if amended, as finally amended prior to the date of this Agreement (with respect to those Chemical SEC
Reports filed or furnished prior to the date of this Agreement), has complied as to form in all material respects with the applicable
requirements of the Securities Act and the Exchange Act, and none of the Chemical SEC Reports, when filed or furnished or, if amended,
as finally amended prior to the date of this Agreement, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. None of the Chemical Subsidiaries are or ever have been required to file periodic reports
with the SEC. As of the date of this Agreement, there are no material outstanding or unresolved comments received from the SEC
with respect to any of the Chemical SEC Reports.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical has
established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act)
as required by Rule 13a-15(a) under the Exchange Act, and Chemical has established and maintains internal controls over financial
reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) as required by Rule 13a-15(a) under the Exchange Act.
Chemical has disclosed, based on its most recent evaluation prior to the date of this Agreement, to Chemical&rsquo;s auditors and
the audit committee of the Chemical Board (i) any significant deficiencies and material weaknesses in the design or operation of
its internal controls over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) which are reasonably likely to
adversely affect Chemical&rsquo;s ability to record, process, summarize and report financial information and (ii) any fraud that
involves management or other employees who have a significant role in Chemical&rsquo;s internal controls over financial reporting.
Since January 1, 2012, neither Chemical nor any of the Chemical Subsidiaries has Knowledge of any written </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">47</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">complaint, allegation,
assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of Chemical or any Chemical
Subsidiary or their respective internal accounting controls, including any written complaint, allegation, assertion or claim that
Chemical or any Chemical Subsidiary has engaged in questionable accounting or auditing practices, which, if true, would constitute
a significant deficiency or a material weakness. Since January 1, 2012, subject to any applicable grace periods, Chemical has been
and is in compliance with (A) the applicable provisions of the Sarbanes Oxley Act of 2002 and (B) the applicable listing and corporate
governance rules and regulations of NASDAQ, except in each case as has not had, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Joint
Ventures; Strategic Alliances</U>. Neither Chemical nor any Chemical Subsidiary is, directly or indirectly, a party to or bound
by any material joint venture, partnership, limited partnership, limited liability company, or strategic alliance agreement or
arrangement with or through any unaffiliated Person providing for their joint or cooperative development, marketing, referrals,
or sales of banking, securities, insurance, or other financial products or services, or their joint investment in and management
of any active business enterprise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Policies
and Procedures</U>. Chemical and each Chemical Subsidiary have complied in all material respects with the policies and procedures
as formally adopted and disclosed to Talmer as applicable to the periods when those policies and procedures were in effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shareholder
Rights Plan</U>. Chemical does not have in effect any shareholder rights plan, &ldquo;poison pill,&rdquo; or similar plan or arrangement.
Chemical is not an &ldquo;interested shareholder&rdquo; of Talmer as defined in Section 778 of the MBCA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">4.37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Undisclosed Liabilities</U>. There exist no Liabilities of Chemical or any Chemical Subsidiary of the type required to be
disclosed in the liabilities column of a balance sheet prepared in accordance with GAAP, other than (a) Liabilities that are
adequately reflected, reserved for or disclosed in the Chemical Financial Statements, (b) Liabilities under executory
contracts to which Chemical or a Chemical Subsidiary is a party or otherwise incurred in the ordinary course of business of
Chemical or a Chemical Subsidiary, or (c) Liabilities that have not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on Chemical.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Other
Representations and Warranties</U>. Except for the express representations and warranties made by Chemical and the Chemical Subsidiaries
in this <U>Article IV</U>, neither Chemical nor any other Person makes or has made any representation or warranty with respect
to Chemical or the Chemical Subsidiaries or their respective business, operations, assets, Liabilities, condition (financial or
otherwise) or prospects, notwithstanding the delivery or disclosure to Talmer or any of its Affiliates or Representatives of any
documentation, projections, forecasts, estimates, budgets, prospect information or other information with respect to any one or
more of the foregoing. Chemical has not relied on any representations or warranties relating to Talmer or any Talmer Subsidiary
in determining to enter into this Agreement, except for those expressly made by Talmer in <U>Article III</U>.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">48</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
V</FONT><BR>
COVENANTS RELATING TO CONDUCT OF BUSINESS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conduct
of Business Before the <FONT STYLE="color: windowtext">Effective Time</FONT></U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">Except
as expressly contemplated by or permitted by this Agreement or required by applicable Law or with the prior written consent of
the other Party, which consent shall not be unreasonably withheld, conditioned or delayed, during the period from the date of this
Agreement until the earlier of the Effective Time and the date of termination of this Agreement in accordance with <U>Article VIII</U>,
each Party shall, and shall cause each of its Subsidiaries, as applicable, to:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>conduct
its business <FONT STYLE="color: windowtext">in the ordinary course consistent with past practice </FONT>in all material respects;
and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
commercially reasonable efforts </FONT>to (i) maintain and preserve intact its business organization and advantageous business
relationships, and (ii) retain the services of its key officers and key employees.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Talmer
</U></FONT><U>Forbearances</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">During the period from the date of this
<FONT STYLE="color: windowtext">Agreement </FONT>until the earlier of the <FONT STYLE="color: windowtext">Effective Time </FONT>and
the date of termination of this <FONT STYLE="color: windowtext">Agreement </FONT>in accordance with <U>Article <FONT STYLE="color: windowtext">VIII</FONT></U>,
except as expressly contemplated or permitted by this <FONT STYLE="color: windowtext">Agreement</FONT>, or as set forth on the
correspondingly labeled section of the <FONT STYLE="color: windowtext">Talmer Disclosure Schedules </FONT>or required by applicable
<FONT STYLE="color: windowtext">Law</FONT>, <FONT STYLE="color: windowtext">Talmer </FONT>shall not, and shall not <FONT STYLE="color: windowtext">permit
</FONT>any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to, without the prior written consent of <FONT STYLE="color: windowtext">Chemical
</FONT>(which consent shall not be unreasonably withheld, conditioned, or delayed):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other
than in the ordinary course of business consistent with past practice</FONT>, incur any indebtedness for borrowed money, assume,
guarantee, endorse, or otherwise as an accommodation become responsible for the obligations of, or make any loan or advance or
capital contribution to, or investment in, any other <FONT STYLE="color: windowtext">Person </FONT>(it being understood and agreed
that incurrence of <FONT STYLE="color: windowtext">indebtedness in the ordinary course of business consistent with past practice
</FONT>shall <FONT STYLE="color: windowtext">include </FONT>the creation of deposit liabilities, purchases of federal funds, borrowings
from the Federal Home Loan Bank, sales of certificates of deposit, and entry into repurchase agreements);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>adjust,
split, combine or reclassify any of its capital stock;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make,
declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase, or otherwise acquire,
any shares of its capital stock or any securities or obligations convertible (whether currently convertible or convertible only
after the passage of time or the occurrence of certain events) into or exchangeable for any shares of its capital stock (except
(i) dividends paid by any of the Talmer <FONT STYLE="color: windowtext">Subsidiaries </FONT>to <FONT STYLE="color: windowtext">Talmer
</FONT>or to any of its wholly-owned <FONT STYLE="color: windowtext">Subsidiaries</FONT>, (ii) regular quarterly dividends on <FONT STYLE="color: windowtext">Talmer
Common Stock as set forth in <U>Section 5.2(c)</U> of the Talmer Disclosure Schedules</FONT>, (iii) dividends in respect of the
outstanding trust preferred securities of <FONT STYLE="color: windowtext">Talmer </FONT>as of the date of this <FONT STYLE="color: windowtext">Agreement</FONT>,
and (iv) the acceptance of shares of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>in payment of the exercise price
or withholding <FONT STYLE="color: windowtext">taxes </FONT>incurred by any employee or director in connection with the vesting
of equity-based awards in respect of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>granted under <FONT STYLE="color: windowtext">Talmer
Stock Plans</FONT>, in each case in </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">49</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">accordance with past practice and the terms of the applicable <FONT STYLE="color: windowtext">Talmer
Stock Plans </FONT>and related award agreements);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>grant
any stock options, restricted shares, or other equity-based award with respect to shares of <FONT STYLE="color: windowtext">Talmer
Common Stock </FONT>under the <FONT STYLE="color: windowtext">Talmer Stock Plans</FONT>, or otherwise, or grant any <FONT STYLE="color: windowtext">Person
</FONT>any right to acquire any shares of <FONT STYLE="color: windowtext">Talmer Capital Stock</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>issue
any additional shares of <FONT STYLE="color: windowtext">Talmer Capital Stock </FONT>or other securities except pursuant to the
settlement of equity-based awards previously granted under the <FONT STYLE="color: windowtext">Talmer Stock Plans; </FONT><I>provided,
however</I>, <FONT STYLE="color: windowtext">Talmer </FONT>may in its reasonable discretion engage in a bona fide capital raising
transaction under this <U>Section <FONT STYLE="color: windowtext">5.2(e)</FONT></U><FONT STYLE="color: windowtext"><B> </B></FONT>without
the prior written consent of <FONT STYLE="color: windowtext">Chemical</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>amend
any existing employment, consulting, severance, termination or change in <FONT STYLE="color: windowtext">control </FONT>agreements
or enter into any new employment, consulting, severance, termination or change in <FONT STYLE="color: windowtext">control </FONT>agreements;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>except
as required by applicable <FONT STYLE="color: windowtext">Law </FONT>or in accordance with the terms of any <FONT STYLE="color: windowtext">Talmer
Benefit Plan </FONT>as in effect on the date of this <FONT STYLE="color: windowtext">Agreement</FONT>, and except for normal increases
<FONT STYLE="color: windowtext">made in the ordinary course of business consistent with past practice</FONT>, (i) increase the
wages, salaries, incentive compensation, incentive compensation opportunities of, or benefits provided to, any current, former,
or retired employee or director of <FONT STYLE="color: windowtext">Talmer </FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>or <FONT STYLE="color: windowtext">ERISA Affiliates</FONT>; (ii) establish, adopt, or become a <FONT STYLE="color: windowtext">party
</FONT>to any new employee benefit or compensation plan, program, commitment, or <FONT STYLE="color: windowtext">agreement</FONT>,
or amend, modify, change, or terminate, or accelerate any rights under, any <FONT STYLE="color: windowtext">Talmer Benefit Plan</FONT>;
(iii) grant any stock options, stock appreciation rights, stock-based or stock-related awards, performance stock, or phantom or
restricted stock unit awards; (iv) take any <FONT STYLE="color: windowtext">action other than in the ordinary course of business
consistent with past practice</FONT>, to fund or in any way secure the payment of compensation or benefits under any <FONT STYLE="color: windowtext">Talmer
Benefit Plan</FONT>; (v) amend, alter, or modify any warrant or other equity-based right to purchase any shares of <FONT STYLE="color: windowtext">Talmer
Capital Stock </FONT>or other equity interests in <FONT STYLE="color: windowtext">Talmer </FONT>or any securities exchangeable
for or convertible into <FONT STYLE="color: windowtext">Talmer Capital Stock </FONT>outstanding on the date hereof, except as otherwise
permitted in this <FONT STYLE="color: windowtext">Agreement</FONT>; (vi) enter into any <FONT STYLE="color: windowtext">Collective
Bargaining Agreement</FONT>; (vii) enter into, amend, modify, alter, terminate, or change any third-<FONT STYLE="color: windowtext">party
</FONT>vendor or service <FONT STYLE="color: windowtext">agreement </FONT>related to any <FONT STYLE="color: windowtext">Talmer
Benefit Plan; or (viii) </FONT>grant any severance or termination pay unless provided under any <FONT STYLE="color: windowtext">Talmer
Benefit Plan or unless such grant is in the ordinary course of business consistent with past practice;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>sell,
transfer, mortgage, encumber, or otherwise dispose of any material amount of its properties or assets to any <FONT STYLE="color: windowtext">Person
</FONT>other than a Talmer <FONT STYLE="color: windowtext">Subsidiary</FONT>, or cancel, <FONT STYLE="color: windowtext">release</FONT>,
or assign any material amount of indebtedness to any such <FONT STYLE="color: windowtext">Person </FONT>or any claims held by any
such <FONT STYLE="color: windowtext">Person</FONT>, in each case <FONT STYLE="color: windowtext">other than in the ordinary course
of business consistent with past practice </FONT>or pursuant to contracts in force at the date of this <FONT STYLE="color: windowtext">Agreement</FONT>;
<I>provided, however</I>, that <FONT STYLE="color: windowtext">Talmer </FONT>shall be permitted to divest of immaterial amounts
of deposit liabilities, banking offices, and/or loans as required by <FONT STYLE="color: windowtext">Governmental Entities </FONT>to
consummate the <FONT STYLE="color: windowtext">Merger </FONT>and which do not constitute, individually or in the aggregate, a <FONT STYLE="color: windowtext">Materially
Burdensome Regulatory Condition; </FONT><I>provided, further</I>, that, if <FONT STYLE="color: windowtext">Talmer </FONT>or any
of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>shall request the prior approval of <FONT STYLE="color: windowtext">Chemical
</FONT>in accordance with this <U>Section <FONT STYLE="color: windowtext">5.2</FONT></U><FONT STYLE="color: windowtext"> </FONT>to
make, sell, transfer, or dispose of any &ldquo;Other </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">50</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Real Estate Owned&rdquo; of <FONT STYLE="color: windowtext">Talmer outside
of the ordinary course of business consistent with past practice, </FONT>and <FONT STYLE="color: windowtext">Chemical </FONT>shall
not have disapproved such request in writing within five (5) <FONT STYLE="color: windowtext">Business Days </FONT>upon receipt
of such request from <FONT STYLE="color: windowtext">Talmer </FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries</FONT>,
as applicable, then such request shall be deemed to be approved by <FONT STYLE="color: windowtext">Chemical </FONT>in writing,
and <FONT STYLE="color: windowtext">Talmer </FONT>or its <FONT STYLE="color: windowtext">Subsidiary</FONT>, as applicable, may
effect the sale, transfer, or disposal <FONT STYLE="color: windowtext">referenced in such request on the terms described therein;
</FONT><I>provided</I>, <I>further</I>, that the foregoing shall not apply to dealings with financial assets or investment securities
nor prohibit <FONT STYLE="color: windowtext">Talmer </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>from transferring,
licensing, selling, leasing or disposing of obsolete or unused equipment, fixtures or assets, in each <FONT STYLE="color: windowtext">case
in the ordinary course of business consistent with past practice</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make any application for
the opening, relocation, or closing of any branch office, loan production office or other material office or facility, or open,
relocate or close any branch office, loan production office or other material office or facility;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>acquire,
by <FONT STYLE="color: windowtext">merger</FONT>, consolidation, acquisition of stock or assets, or otherwise, any business or
division of a business or enter into any new line of business or change in any material respect its lending, investment, underwriting,
risk and asset <FONT STYLE="color: windowtext">liability </FONT>management, and other banking, operating, and servicing policies,
except as required by applicable <FONT STYLE="color: windowtext">Law</FONT>, regulation, recommendation of or policies imposed
by any <FONT STYLE="color: windowtext">Governmental Entity</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make
any material investment either by purchase of stock or securities, contributions to capital, property transfers, or purchase of
any property or assets of any other <FONT STYLE="color: windowtext">Person outside of the ordinary course of business consistent
with past practice</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>take
any <FONT STYLE="color: windowtext">action</FONT>, or knowingly fail to take any <FONT STYLE="color: windowtext">action</FONT>,
which <FONT STYLE="color: windowtext">action </FONT>or failure to act is reasonably likely to prevent the <FONT STYLE="color: windowtext">Merger
</FONT>from qualifying for the <FONT STYLE="color: windowtext">Intended Tax Treatment</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>amend
the <FONT STYLE="color: windowtext">Talmer Articles </FONT>or <FONT STYLE="color: windowtext">Talmer Bylaws</FONT>, or otherwise
take any <FONT STYLE="color: windowtext">action </FONT>to exempt any <FONT STYLE="color: windowtext">Person </FONT>(other than
<FONT STYLE="color: windowtext">Chemical </FONT>or its <FONT STYLE="color: windowtext">Subsidiaries</FONT>) or any <FONT STYLE="color: windowtext">action
</FONT>taken by any <FONT STYLE="color: windowtext">Person </FONT>from any <FONT STYLE="color: windowtext">Takeover Statute </FONT>or
similarly restrictive provisions of its organizational documents or terminate, amend, or waive any provisions of any confidentiality
or standstill agreements in place with any third parties;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>other
than after prior consultation with <FONT STYLE="color: windowtext">Chemical</FONT>, materially change or restructure its investment
securities portfolio or its gap position, through purchases, sales, or otherwise, or the manner in which the portfolio is classified
or reported;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>other
than commencement or settlement of foreclosure or debt collection <FONT STYLE="color: windowtext">actions in the ordinary course
of business consistent with past practice</FONT>, commence or settle any <FONT STYLE="color: windowtext">claim</FONT>, <FONT STYLE="color: windowtext">action</FONT>,
or proceeding where the amount in dispute is in excess of $<FONT STYLE="color: windowtext">500,000 </FONT>or subjects <FONT STYLE="color: windowtext">Talmer
</FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to any material restrictions on its current or future
business operations (<FONT STYLE="color: windowtext">including </FONT>the future business and operations of the Surviving Corporation
or the <FONT STYLE="color: windowtext">Surviving Bank</FONT>);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>take
any <FONT STYLE="color: windowtext">action </FONT>or fail to take any <FONT STYLE="color: windowtext">action </FONT>that is intended
or may reasonably be expected to result in any of the conditions to the <FONT STYLE="color: windowtext">Merger </FONT>set forth
in <U>Article <FONT STYLE="color: windowtext">VII</FONT></U><FONT STYLE="color: windowtext"> </FONT>not being satisfied;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">51</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>implement
or adopt any material change in its <FONT STYLE="color: windowtext">tax </FONT>accounting or financial accounting principles, practices
or methods, change any <FONT STYLE="color: windowtext">tax </FONT>accounting period, or surrender in writing any right to <FONT STYLE="color: windowtext">claim
</FONT>a <FONT STYLE="color: windowtext">Tax </FONT>refund, offset or other reduction in <FONT STYLE="color: windowtext">Tax liability
</FONT>or consent to any extension or waiver of the limitation period applicable to any <FONT STYLE="color: windowtext">Tax claim
</FONT>or assessment relating to <FONT STYLE="color: windowtext">Talmer </FONT>or its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>and involving in excess of $1,000,000, in each case other than as may be required by applicable <FONT STYLE="color: windowtext">Law</FONT>,
<FONT STYLE="color: windowtext">GAAP</FONT>, or regulatory guidelines;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>file
or amend any <FONT STYLE="color: windowtext">Tax Return other than in the ordinary course of business, </FONT>make any significant
change in any method of <FONT STYLE="color: windowtext">Tax </FONT>or accounting (other than as may be required by applicable <FONT STYLE="color: windowtext">Law</FONT>,
<FONT STYLE="color: windowtext">GAAP </FONT>or regulatory guidelines), make or change any <FONT STYLE="color: windowtext">Tax </FONT>election,
or settle or compromise any disputed <FONT STYLE="color: windowtext">Tax liability </FONT>in excess of $1,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;extend
the term of any Talmer Material Contract (except for the extension of any such term for one year or less due to the automatic renewal
of such term in accordance with the terms of the Talmer Material Contract), and </FONT>except for <FONT STYLE="color: windowtext">transactions
in the ordinary course of business consistent with past practice</FONT>, terminate or waive any material provision of any <FONT STYLE="color: windowtext">Talmer
Material Contract</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter into or amend any Contract
or other transaction with any Talmer-Related Person, except as contemplated or permitted by this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take any action to enter
into, or commit to enter into, any Contract for trust, consulting, professional, or other services to Talmer or any Talmer Subsidiary
that is not terminable by Talmer or such Talmer Subsidiary without penalty upon thirty (30) days&rsquo; or less notice, except
for contracts for services under which the aggregate required payments do not exceed $500,000, and except for legal, accounting,
and other ordinary expenses (not including expenses of financial advisors) related to this Agreement or the transactions contemplated
hereby;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take any action to enter
into, or commit to enter into, any joint venture, strategic alliance, or material relationship with any Person to jointly develop,
market, or offer any product or service;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fail to promptly notify Chemical
of the threat (to the Knowledge of Talmer) or the commencement of any material Action against, relating to, or affecting (i) Talmer
or any Talmer Subsidiary, (ii) Talmer&rsquo;s or any Talmer Subsidiary&rsquo;s directors, officers or employees in their capacities
as such, (iii) Talmer&rsquo;s or any Talmer Subsidiary&rsquo;s assets, liabilities, businesses or operations, or (iv) the Merger
or this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except for (i) capital expenditures
of amounts set forth in Talmer&rsquo;s capital expenditure plan included in <U>Section 5.2(x)</U> of the Talmer Disclosure Schedules,
or (ii) capital expenditures required by Law or Governmental Entities or incurred in connection with the repair or replacement
of facilities destroyed or damaged due to casualty or accident (whether or not covered by insurance), make any capital expenditure
or permit any Talmer Subsidiary to make any capital expenditure;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">52</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make or renew any charitable
contributions, gifts, commitments, or pledges of cash or other assets except in the ordinary course of business consistent with
past practice and not in excess of Talmer&rsquo;s 2016 budget for such charitable contributions, gifts, commitments or pledges;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take any action that would
materially impede or materially delay the completion of the transactions contemplated by this Agreement or the ability of the Parties
to obtain any necessary approvals of any Regulatory Agency or Governmental Entity required for the transactions contemplated hereby;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>enter
into any <FONT STYLE="color: windowtext">Contract </FONT>that (i) is <FONT STYLE="color: windowtext">outside the ordinary course
of business consistent with past practice </FONT>and (ii) would constitute a <FONT STYLE="color: windowtext">Talmer Material Contract</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
for transactions in the ordinary course of business consistent with past practice, </FONT>enter into any <FONT STYLE="color: windowtext">Derivative
Transaction</FONT>; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>agree
or commit to do any of the foregoing<FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Chemical
</U></FONT><U>Forbearances</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">During the period from the date of this
<FONT STYLE="color: windowtext">Agreement </FONT>until the earlier of the <FONT STYLE="color: windowtext">Effective Time </FONT>and
the date of termination of this <FONT STYLE="color: windowtext">Agreement </FONT>in accordance with <U>Article <FONT STYLE="color: windowtext">VIII</FONT></U>,
except as expressly contemplated or permitted by this <FONT STYLE="color: windowtext">Agreement</FONT>, or as set forth on the
correspondingly labeled section of the <FONT STYLE="color: windowtext">Chemical Disclosure Schedules </FONT>or required by applicable
<FONT STYLE="color: windowtext">Law</FONT>, <FONT STYLE="color: windowtext">Chemical </FONT>shall not, and shall not <FONT STYLE="color: windowtext">permit
</FONT>any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to, without the prior written consent of <FONT STYLE="color: windowtext">Talmer
</FONT>(which consent shall not be unreasonably withheld, conditioned, or delayed):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other
than in the ordinary course of business consistent with past practice</FONT>, incur any indebtedness for borrowed money, assume,
guarantee, endorse, or otherwise as an accommodation become responsible for the obligations of, or make any loan or advance or
capital contribution to, or investment in, any other <FONT STYLE="color: windowtext">Person </FONT>(it being understood and agreed
that incurrence of <FONT STYLE="color: windowtext">indebtedness in the ordinary course of business consistent with past practice
</FONT>shall <FONT STYLE="color: windowtext">include </FONT>the creation of deposit liabilities, purchases of federal funds, borrowings
from the Federal Home Loan Bank, sales of certificates of deposit, and entry into repurchase agreements);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>adjust,
split, combine or reclassify any of its capital stock;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make,
declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase, or otherwise acquire,
any shares of its capital stock or any securities or obligations convertible (whether currently convertible or convertible only
after the passage of time or the occurrence of certain events) into or exchangeable for any shares of its capital stock (except
(i) dividends paid by any of the Chemical <FONT STYLE="color: windowtext">Subsidiaries </FONT>to <FONT STYLE="color: windowtext">Chemical
</FONT>or to any of its wholly-owned <FONT STYLE="color: windowtext">Subsidiaries</FONT>, (ii) regular quarterly dividends on <FONT STYLE="color: windowtext">Chemical
Common Stock as set forth in <U>Section 5.3(c)</U> of the Chemical Disclosure Schedules, (iii) the payoff of, or</FONT> dividends
in respect of, the outstanding trust preferred securities of <FONT STYLE="color: windowtext">Chemical </FONT>as of the date of
this <FONT STYLE="color: windowtext">Agreement</FONT>, and <FONT STYLE="color: windowtext">(iv) </FONT>the acceptance of shares
of <FONT STYLE="color: windowtext">Chemical Common Stock </FONT>in payment of the exercise price or withholding <FONT STYLE="color: windowtext">taxes
</FONT>incurred by any employee or director in connection with the vesting of equity-based awards in respect of <FONT STYLE="color: windowtext">Chemical
Common Stock </FONT>granted under <FONT STYLE="color: windowtext">Chemical </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">53</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">Stock Plans</FONT>, in each case in accordance with
past practice and the terms of the applicable <FONT STYLE="color: windowtext">Chemical Stock Plans </FONT>and related award agreements);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>grant
any stock options, restricted shares, or other equity-based award with respect to shares of <FONT STYLE="color: windowtext">Chemical
Common Stock </FONT>under the <FONT STYLE="color: windowtext">Chemical Stock Plans</FONT>, or otherwise, or grant any <FONT STYLE="color: windowtext">Person
</FONT>any right to acquire any shares of <FONT STYLE="color: windowtext">Chemical Capital Stock</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>issue
any additional shares of <FONT STYLE="color: windowtext">Chemical Capital Stock </FONT>or other securities except pursuant to the
settlement of equity-based awards previously granted under the <FONT STYLE="color: windowtext">Chemical Stock Plans</FONT>;<I>
provided, however</I>, <FONT STYLE="color: windowtext">Chemical </FONT>may in its reasonable discretion engage in a bona fide capital
raising transaction under this <U>Section <FONT STYLE="color: windowtext">5.3(e)</FONT></U><FONT STYLE="color: windowtext"><B>
</B></FONT>without the prior written consent of <FONT STYLE="color: windowtext">Talmer</FONT>,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>amend
any existing employment, consulting, severance, termination or change in <FONT STYLE="color: windowtext">control </FONT>agreements
or enter into any new employment, consulting, severance, termination or change in <FONT STYLE="color: windowtext">control </FONT>agreements;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>except
as required by applicable <FONT STYLE="color: windowtext">Law </FONT>or in accordance with the terms of any <FONT STYLE="color: windowtext">Chemical
Benefit Plan </FONT>as in effect on the date of this <FONT STYLE="color: windowtext">Agreement,</FONT> and except for normal increases
<FONT STYLE="color: windowtext">made in the ordinary course of business consistent with past practice</FONT>, (i) increase the
wages, salaries, incentive compensation, incentive compensation opportunities of, or benefits provided to, any current, former,
or retired employee or director of <FONT STYLE="color: windowtext">Chemical </FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>or <FONT STYLE="color: windowtext">ERISA Affiliates</FONT>; (ii) establish, adopt, or become a <FONT STYLE="color: windowtext">party
</FONT>to any new employee benefit or compensation plan, program, commitment, or <FONT STYLE="color: windowtext">agreement</FONT>,
or amend, modify, change, or terminate, or accelerate any rights under, any <FONT STYLE="color: windowtext">Chemical Benefit Plan</FONT>;
(iii) grant any stock options, stock appreciation rights, stock-based or stock-related awards, performance stock, or phantom or
restricted stock unit awards; (iv) take any <FONT STYLE="color: windowtext">action other than in the ordinary course of business
consistent with past practice</FONT>, to fund or in any way secure the payment of compensation or benefits under any <FONT STYLE="color: windowtext">Chemical
Benefit Plan</FONT>; (v) amend, alter, or modify any warrant or other equity-based right to purchase any <FONT STYLE="color: windowtext">Chemical
Capital Stock </FONT>or other equity interests in <FONT STYLE="color: windowtext">Chemical </FONT>or any securities exchangeable
for or convertible into <FONT STYLE="color: windowtext">Chemical Capital Stock </FONT>outstanding on the date hereof, except as
otherwise permitted in this <FONT STYLE="color: windowtext">Agreement</FONT>; (vi) enter into any <FONT STYLE="color: windowtext">Collective
Bargaining Agreement</FONT>; (vii) enter into, amend, modify, alter, terminate, or change any third-<FONT STYLE="color: windowtext">party
</FONT>vendor or service <FONT STYLE="color: windowtext">agreement </FONT>related to any <FONT STYLE="color: windowtext">Chemical
Benefit Plan; or (viii) </FONT>grant any severance or termination pay unless provided under any <FONT STYLE="color: windowtext">Chemical
Benefit Plan or unless such grant is in the ordinary course of business consistent with past practice</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>sell,
transfer, mortgage, encumber, or otherwise dispose of any material amount of its properties or assets to any <FONT STYLE="color: windowtext">Person
</FONT>other than a Chemical <FONT STYLE="color: windowtext">Subsidiary</FONT>, or cancel, <FONT STYLE="color: windowtext">release</FONT>,
or assign any material amount of indebtedness to any such <FONT STYLE="color: windowtext">Person </FONT>or any claims held by any
such <FONT STYLE="color: windowtext">Person</FONT>, in each case <FONT STYLE="color: windowtext">other than in the ordinary course
of business consistent with past practice </FONT>or pursuant to contracts in force at the date of this <FONT STYLE="color: windowtext">Agreement</FONT>;
<I>provided, however</I>, that <FONT STYLE="color: windowtext">Chemical </FONT>shall be permitted to divest of immaterial amounts
of deposit liabilities, banking offices, and/or loans as required by <FONT STYLE="color: windowtext">Governmental Entities </FONT>to
consummate the <FONT STYLE="color: windowtext">Merger </FONT>and which do not constitute, individually or in the aggregate, a <FONT STYLE="color: windowtext">Materially
Burdensome Regulatory Condition; </FONT><I>provided, further</I>, that, if <FONT STYLE="color: windowtext">Chemical </FONT>or any
of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>shall request the prior approval of <FONT STYLE="color: windowtext">Talmer
</FONT>in accordance with this <U>Section <FONT STYLE="color: windowtext">5.3</FONT></U><FONT STYLE="color: windowtext"> </FONT>to
make, sell, transfer, or dispose of any &ldquo;Other Real Estate Owned&rdquo; of <FONT STYLE="color: windowtext">Chemical outside
of the ordinary course of business consistent </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">54</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">with past practice, </FONT>and <FONT STYLE="color: windowtext">Talmer </FONT>shall
not have disapproved such request in writing within five (5) <FONT STYLE="color: windowtext">Business Days </FONT>upon receipt
of such request from <FONT STYLE="color: windowtext">Chemical </FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries</FONT>,
as applicable, then such request shall be deemed to be approved by <FONT STYLE="color: windowtext">Talmer </FONT>in writing, and
<FONT STYLE="color: windowtext">Chemical </FONT>or its <FONT STYLE="color: windowtext">Subsidiary</FONT>, as applicable, may effect
the sale, transfer, or disposal <FONT STYLE="color: windowtext">referenced in such request on the terms described therein; </FONT><I>provided</I>,
<I>further</I>, that the foregoing shall not apply to dealings with financial assets or investment securities nor prohibit <FONT STYLE="color: windowtext">Chemical
</FONT>and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>from transferring, licensing, selling, leasing or disposing
of obsolete or unused equipment, fixtures or assets, in each <FONT STYLE="color: windowtext">case in the ordinary course of business
consistent with past practice</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
any application for the opening, relocation, or closing of any branch office, loan production office or other material office
or facility, or open, relocate or close any branch office, loan production office or other material office or facility;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>acquire,
by <FONT STYLE="color: windowtext">merger</FONT>, consolidation, acquisition of stock or assets, or otherwise, any business or
division of a business or enter into any new line of business or change in any material respect its lending, investment, underwriting,
risk and asset <FONT STYLE="color: windowtext">liability </FONT>management, and other banking, operating, and servicing policies,
except as required by applicable <FONT STYLE="color: windowtext">Law</FONT>, regulation, recommendation of or policies imposed
by any <FONT STYLE="color: windowtext">Governmental Entity</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make
any material investment either by purchase of stock or securities, contributions to capital, property transfers, or purchase of
any property or assets of any other <FONT STYLE="color: windowtext">Person outside the ordinary course of business consistent with
past practice</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>take
any <FONT STYLE="color: windowtext">action</FONT>, or knowingly fail to take any <FONT STYLE="color: windowtext">action</FONT>,
which <FONT STYLE="color: windowtext">action </FONT>or failure to act is reasonably likely to prevent the <FONT STYLE="color: windowtext">Merger
</FONT>from qualifying for the <FONT STYLE="color: windowtext">Intended Tax Treatment</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
for the Chemical Articles Amendment, </FONT>amend the <FONT STYLE="color: windowtext">Chemical Articles </FONT>or <FONT STYLE="color: windowtext">Chemical
Bylaws</FONT>, or otherwise take any <FONT STYLE="color: windowtext">action </FONT>to exempt any <FONT STYLE="color: windowtext">Person
</FONT>(other than <FONT STYLE="color: windowtext">Talmer </FONT>or its <FONT STYLE="color: windowtext">Subsidiaries</FONT>) or
any <FONT STYLE="color: windowtext">action </FONT>taken by any <FONT STYLE="color: windowtext">Person </FONT>from any <FONT STYLE="color: windowtext">Takeover
Statute </FONT>or similarly restrictive provisions of its organizational documents or terminate, amend, or waive any provisions
of any confidentiality or standstill agreements in place with any third parties;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>other
than after prior consultation with <FONT STYLE="color: windowtext">Talmer</FONT>, materially change or restructure its investment
securities portfolio or its gap position, through purchases, sales, or otherwise, or the manner in which the portfolio is classified
or reported;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>other
than commencement or settlement of foreclosure or debt collection <FONT STYLE="color: windowtext">actions in the ordinary course
of business consistent with past practice</FONT>, commence or settle any <FONT STYLE="color: windowtext">claim</FONT>, <FONT STYLE="color: windowtext">action</FONT>,
or proceeding where the amount in dispute is in excess of $<FONT STYLE="color: windowtext">500,000 </FONT>or subjects <FONT STYLE="color: windowtext">Chemical
</FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to any material restrictions on its current or future
business operations (<FONT STYLE="color: windowtext">including </FONT>the future business and operations of the Surviving Corporation
or the <FONT STYLE="color: windowtext">Surviving Bank</FONT>);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>take
any <FONT STYLE="color: windowtext">action </FONT>or fail to take any <FONT STYLE="color: windowtext">action </FONT>that is intended
or may reasonably be expected to result in any of the conditions to the <FONT STYLE="color: windowtext">Merger </FONT>set forth
in <U>Article <FONT STYLE="color: windowtext">VII</FONT></U><FONT STYLE="color: windowtext"> </FONT>not being satisfied;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">55</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>implement
or adopt any material change in its <FONT STYLE="color: windowtext">tax </FONT>accounting or financial accounting principles, practices
or methods, change any <FONT STYLE="color: windowtext">tax </FONT>accounting period, or surrender in writing any right to <FONT STYLE="color: windowtext">claim
</FONT>a <FONT STYLE="color: windowtext">Tax </FONT>refund, offset or other reduction in <FONT STYLE="color: windowtext">Tax liability
</FONT>or consent to any extension or waiver of the limitation period applicable to any <FONT STYLE="color: windowtext">Tax claim
</FONT>or assessment relating to <FONT STYLE="color: windowtext">Chemical </FONT>or its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>and involving in excess of $1,000,000, in each case other than as may be required by applicable <FONT STYLE="color: windowtext">Law</FONT>,
<FONT STYLE="color: windowtext">GAAP</FONT>, or regulatory guidelines;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>file
or amend any <FONT STYLE="color: windowtext">Tax Return other than in the ordinary course of business, </FONT>make any significant
change in any method of <FONT STYLE="color: windowtext">Tax </FONT>or accounting (other than as may be required by applicable <FONT STYLE="color: windowtext">Law</FONT>,
<FONT STYLE="color: windowtext">GAAP </FONT>or regulatory guidelines), make or change any <FONT STYLE="color: windowtext">Tax </FONT>election,
or settle or compromise any disputed <FONT STYLE="color: windowtext">Tax liability </FONT>in excess of $1,000,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;extend
the term of any Chemical Material Contract (except for the extension of any such term for one year or less due to the automatic
renewal of such term in accordance with the terms of the Chemical Material Contract), and </FONT>except for <FONT STYLE="color: windowtext">transactions
in the ordinary course of business consistent with past practice</FONT> terminate or waive any material provision of any <FONT STYLE="color: windowtext">Chemical
Material Contract;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into or amend any Contract or other transaction with any Chemical-Related Person, except as contemplated or permitted by this
Agreement;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
take any action to enter into, or commit to enter into, any Contract for trust, consulting, professional, or other services to
Chemical or any Chemical Subsidiary that is not terminable by Chemical or Chemical Subsidiary without penalty upon thirty (30)
days&rsquo; or less notice, except for contracts for services under which the aggregate required payments do not exceed $500,000,
and except for legal, accounting, and other ordinary expenses (not including expenses of financial advisors) related to this Agreement
or the transactions contemplated hereby;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take
any action to enter into, or commit to enter into, any joint venture, strategic alliance, or material relationship with any Person
to jointly develop, market, or offer any product or service;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fail
to promptly notify Talmer of </FONT>the threat (to the Knowledge of Chemical)<FONT STYLE="background-color: white"> the commencement
of any material Action against, relating to, or affecting (i) Chemical or any Chemical Subsidiary, (ii) Chemical&rsquo;s or any
Chemical Subsidiary&rsquo;s directors, officers or employees in their capacities as such, (iii) Chemical&rsquo;s or any Chemical
Subsidiary&rsquo;s assets, liabilities, businesses or operations, or (iv) the Merger or this Agreement;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
for (i) capital expenditures of amounts set forth in Chemical&rsquo;s capital expenditure plan included in <U>Section 5.3(x)</U>
of the Chemical Disclosure Schedules, or (ii) capital expenditures required by Law or Governmental Entities or incurred in connection
with the repair or replacement of facilities destroyed or damaged due to casualty or accident (whether or not covered by insurance),
make any capital expenditure or permit any Chemical Subsidiary to make any capital expenditure;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
or renew any charitable contributions, gifts, commitments, or pledges of cash or other assets except in the ordinary course of
business consistent with past </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">56</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="background-color: white">practice and not in excess of Chemical&rsquo;s 2016 budget for such charitable contributions, gifts,
commitments or pledges;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>take
any <FONT STYLE="color: windowtext">action </FONT>that would materially impede or materially delay the completion of the transactions
contemplated by this <FONT STYLE="color: windowtext">Agreement </FONT>or the ability of the <FONT STYLE="color: windowtext">Parties
</FONT>to obtain any necessary approvals of any Regulatory Agency or <FONT STYLE="color: windowtext">Governmental Entity </FONT>required
for the transactions contemplated hereby;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>enter
into any <FONT STYLE="color: windowtext">Contract </FONT>that (i) is <FONT STYLE="color: windowtext">outside the ordinary course
of business consistent with past practice </FONT>and (ii) would constitute a <FONT STYLE="color: windowtext">Chemical Material
Contract</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
for transactions in the ordinary course of business consistent with past practice, </FONT>enter into any <FONT STYLE="color: windowtext">Derivative
Transaction</FONT>; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>agree
or commit to do any of the foregoing<FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
VI</FONT><BR>
ADDITIONAL <FONT STYLE="color: windowtext">AGREEMENTS</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Regulatory
Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
<FONT STYLE="color: windowtext">Parties </FONT>shall cooperate with each other and use their respective commercially reasonable
efforts to promptly prepare and file all necessary documentation, to effect all applications, notices, petitions and filings, to
obtain as promptly as practicable all permits, consents, approvals, and authorizations of all third parties and <FONT STYLE="color: windowtext">Governmental
Entities </FONT>that are necessary or advisable <FONT STYLE="color: windowtext">to consummate the transactions contemplated by
</FONT>this <FONT STYLE="color: windowtext">Agreement </FONT>(<FONT STYLE="color: windowtext">including </FONT>the <FONT STYLE="color: windowtext">Merger
</FONT>and the <FONT STYLE="color: windowtext">Bank Merger</FONT>), and to comply with the terms and conditions of all such permits,
consents, approvals and authorizations of all such third parties or <FONT STYLE="color: windowtext">Governmental Entities </FONT>(collectively,
the &ldquo;<FONT STYLE="color: windowtext"><B><I>Regulatory Approvals</I></B></FONT>&rdquo;). <FONT STYLE="color: windowtext">As
soon as practicable after the date of this Agreement (but in no event more than 75 days after the date hereof), Chemical shall
prepare and file with the Federal Reserve Board and each other Governmental Entity having jurisdiction all applications and documents
required to obtain the Regulatory Approvals (excluding the Regulatory Approvals applicable solely to the Bank Merger), and shall
use its commercially reasonable efforts to obtain each necessary approval of or consent to consummate the Merger. Chemical shall
provide Talmer with reasonable opportunities to review and comment upon such documents before filing and to make such amendments
and file such supplements thereto as Talmer may reasonably request. Chemical shall provide Talmer with copies of all material correspondence
received from such Governmental Entities and all material responsive correspondence sent thereto.</FONT> <FONT STYLE="color: windowtext">Chemical
</FONT>and <FONT STYLE="color: windowtext">Talmer </FONT>shall have the right to review in advance, and each will consult the other
on, in each case subject to applicable laws relating to the confidentiality of information, all other information relating to <FONT STYLE="color: windowtext">Chemical
</FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, as the case may be, and any of their respective <FONT STYLE="color: windowtext">Subsidiaries</FONT>,
that appears in any filing made with, or written materials submitted to, any third <FONT STYLE="color: windowtext">party </FONT>or
any <FONT STYLE="color: windowtext">Governmental Entity </FONT>in connection with the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>.
In exercising the foregoing right, each of the <FONT STYLE="color: windowtext">Parties </FONT>shall act reasonably and as promptly
as practicable. Each <FONT STYLE="color: windowtext">Party </FONT>shall consult with the other in advance of any meeting or conference
with any <FONT STYLE="color: windowtext">Governmental Entity </FONT>in connection with the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement
</FONT>and, to the extent permitted by such <FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">57</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">Governmental Entity</FONT>, give the other <FONT STYLE="color: windowtext">Party
</FONT>and its counsel the opportunity to attend and participate in such meetings and conferences. The <FONT STYLE="color: windowtext">Parties
</FONT>shall consult with each other with respect to the obtaining of all permits, consents, approvals, and authorizations of all
third parties and <FONT STYLE="color: windowtext">Governmental Entities </FONT>necessary or advisable <FONT STYLE="color: windowtext">to
consummate the transactions contemplated by </FONT>this <FONT STYLE="color: windowtext">Agreement</FONT>, and each <FONT STYLE="color: windowtext">Party
</FONT>will keep the other apprised of the status of matters relating to completion of the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>.
Notwithstanding the foregoing, nothing contained herein shall be deemed to require <FONT STYLE="color: windowtext">Chemical</FONT>,
<FONT STYLE="color: windowtext">Talmer</FONT>, or any of their respective <FONT STYLE="color: windowtext">Subsidiaries </FONT>to
take any <FONT STYLE="color: windowtext">action</FONT>, or commit to take any <FONT STYLE="color: windowtext">action</FONT>, or
agree to any condition or restriction, in connection with obtaining the foregoing permits, consents, approvals, and authorizations
of third parties or <FONT STYLE="color: windowtext">Governmental Entities</FONT>, that would have a <FONT STYLE="color: windowtext">Material
Adverse Effect on the Surviving Corporation (a &ldquo;<B><I>Materially Burdensome Regulatory Condition</I></B>&rdquo;)</FONT>;
<I>provided</I>,<I> </I>that a <FONT STYLE="color: windowtext">Materially Burdensome Regulatory Condition </FONT>shall not be deemed
to <FONT STYLE="color: windowtext">include </FONT>(i) the applicability of any regulatory condition or requirement affecting the
<FONT STYLE="color: windowtext">Surviving Corporation </FONT>as a result of its expected asset size following the <FONT STYLE="color: windowtext">Merger</FONT>;
or (ii) except as would have a Material Adverse Effect on the Surviving Corporation, any requirement by a <FONT STYLE="color: windowtext">Governmental
Entity that, as a condition to the Parties consummating the Merger, </FONT>either <FONT STYLE="color: windowtext">Party </FONT>or
the Surviving Corporation divest of any amount of deposit liabilities, banking offices and/or loans<FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
of <FONT STYLE="color: windowtext">Chemical </FONT>and <FONT STYLE="color: windowtext">Talmer </FONT>shall, upon request, furnish
to the other all information concerning itself and its <FONT STYLE="color: windowtext">Subsidiaries</FONT>, directors, officers,
and shareholders, and such other matters as may be reasonably necessary or advisable in connection with the applications necessary
to obtain the <FONT STYLE="color: windowtext">Regulatory Approvals</FONT>, the <FONT STYLE="color: windowtext">Joint Proxy Statement</FONT>,
the <FONT STYLE="color: windowtext">Form S-4</FONT>, or any other statement, filing, notice, or application made by or on behalf
of <FONT STYLE="color: windowtext">Chemical</FONT>, <FONT STYLE="color: windowtext">Talmer</FONT>, or any of their respective <FONT STYLE="color: windowtext">Subsidiaries
</FONT>to any <FONT STYLE="color: windowtext">Governmental Entity </FONT>in connection with the <FONT STYLE="color: windowtext">Merger
</FONT>and the other transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
of <FONT STYLE="color: windowtext">Chemical </FONT>and <FONT STYLE="color: windowtext">Talmer </FONT>shall promptly advise the
other upon receiving any communication from any <FONT STYLE="color: windowtext">Governmental Entity</FONT>, the consent or approval
of which is required for consummation of the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>,
that causes such <FONT STYLE="color: windowtext">Party </FONT>to believe that there is a reasonable likelihood that any <FONT STYLE="color: windowtext">Regulatory
Approval </FONT>will not be obtained or that the receipt of any such approval may be materially delayed or subject to a <FONT STYLE="color: windowtext">Materially
Burdensome Regulatory Condition</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained in this
Agreement shall give Chemical or Talmer, directly or indirectly, the right to control or direct the operations of the other Party
prior to the Effective Time. Prior to the Effective Time, subject to <U>Article V</U>, as applicable, Chemical and Talmer each
shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over their respective
business operations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From the date of this Agreement
until the Effective Time, each Party shall promptly notify the other Party in writing of any pending or, to the Knowledge of either
Party (as the case may be), threatened Action or Order by any Governmental Entity or any other Person (a)&nbsp;challenging or seeking
material damages in connection with the Merger or the other transactions contemplated by this Agreement or (b)&nbsp;seeking to
restrain or prohibit the consummation of the Merger or the other transactions contemplated by this Agreement. If any Action or
Order is instituted (or threatened to be instituted) challenging any of the transactions contemplated by this Agreement as violative
of any Law, each Party shall, and shall cause their </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">58</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">respective Representatives to, cooperate and use their commercially reasonable
efforts to contest and resist, except insofar as the Parties may otherwise agree, any such Action or Order, including any Action
or Order that seeks a temporary restraining order or preliminary injunction that would prohibit, prevent or restrict consummation
of the Merger or the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Access
to Information; Confidentiality</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Upon
reasonable notice and subject to applicable laws relating to the confidentiality of information, each <FONT STYLE="color: windowtext">Party
</FONT>shall, and shall cause each of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to, afford to the officers, employees,
accountants, counsel, advisors, agents, and other R<FONT STYLE="color: windowtext">epresentatives </FONT>of the other <FONT STYLE="color: windowtext">Party
</FONT>reasonable access, during normal business hours throughout the period before the <FONT STYLE="color: windowtext">Effective
Time</FONT>, to all its properties, books, contracts, commitments and records, and, during such period, such <FONT STYLE="color: windowtext">Party
</FONT>shall, and shall cause its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to, make available to the other <FONT STYLE="color: windowtext">Party
</FONT>(i) a copy of each report, schedule, registration statement, and other document filed or received by it during such period
pursuant to the requirements of federal securities laws or federal or state banking or insurance laws (other than reports or documents
that such <FONT STYLE="color: windowtext">Party </FONT>is not permitted to disclose under applicable <FONT STYLE="color: windowtext">Law</FONT>)
and (ii) all other information concerning its business, properties, and personnel as the other <FONT STYLE="color: windowtext">Party
</FONT>may reasonably request. Neither <FONT STYLE="color: windowtext">Party</FONT>, nor any of its <FONT STYLE="color: windowtext">Subsidiaries</FONT>,
shall be required to provide access to or to disclose information where such access or disclosure would jeopardize the attorney-client
privilege of such <FONT STYLE="color: windowtext">Party </FONT>or its <FONT STYLE="color: windowtext">Subsidiaries </FONT>or contravene
any <FONT STYLE="color: windowtext">Law</FONT>, rule, regulation, <FONT STYLE="color: windowtext">order</FONT>, judgment, decree,
fiduciary duty, or binding <FONT STYLE="color: windowtext">agreement </FONT>entered into before the date of this <FONT STYLE="color: windowtext">Agreement</FONT>.
The <FONT STYLE="color: windowtext">Parties </FONT>shall make appropriate substitute disclosure arrangements under circumstances
in which the restrictions of the preceding sentence apply.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
<FONT STYLE="color: windowtext">Party </FONT>shall, and shall cause its respective agents and R<FONT STYLE="color: windowtext">epresentatives
</FONT>to, maintain in confidence all information received from the other <FONT STYLE="color: windowtext">Party </FONT>(other than
disclosure to that <FONT STYLE="color: windowtext">Party</FONT>&rsquo;s agents and R<FONT STYLE="color: windowtext">epresentatives
</FONT>in connection with the evaluation and consummation of the <FONT STYLE="color: windowtext">Merger</FONT>) in connection with
this <FONT STYLE="color: windowtext">Agreement </FONT>or the <FONT STYLE="color: windowtext">Merger </FONT>pursuant to the provisions
of the <FONT STYLE="color: windowtext">Confidentiality Agreement </FONT>and use such information solely to evaluate the <FONT STYLE="color: windowtext">Merger;
<I>provided that</I></FONT>, <FONT STYLE="color: windowtext">the disclosure of such information shall be permitted if (i) the receiving
Party in good faith believes that the use of such information is necessary or appropriate in making any filing or obtaining any
consent required for the Merger (in which case the receiving Party shall advise the other Party before making the disclosure) or
(ii) the receiving Party in good faith believes that the furnishing or use of such information is required by or necessary or appropriate
in connection with any applicable laws or any listing or trading requirement concerning its publicly traded securities (in which
case the receiving Party shall advise the other Party before making the disclosure)</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
investigation by a <FONT STYLE="color: windowtext">Party </FONT>or its agents or R<FONT STYLE="color: windowtext">epresentatives
</FONT>shall affect the representations and warranties of the other <FONT STYLE="color: windowtext">Party </FONT>set forth in this
<FONT STYLE="color: windowtext">Agreement</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">59</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Preparation
of the Joint Proxy Statement and Registration Statement; Shareholders&rsquo; Meetings</U><I>.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
promptly as practicable following the date of this <FONT STYLE="color: windowtext">Agreement</FONT>, <FONT STYLE="color: windowtext">Chemical
</FONT>and <FONT STYLE="color: windowtext">Talmer </FONT>shall <FONT STYLE="color: windowtext">use commercially reasonable efforts
</FONT>to: (i) jointly prepare and cause to be filed with the <FONT STYLE="color: windowtext">SEC </FONT>a <FONT STYLE="color: windowtext">joint
proxy statement </FONT>to be sent to the<FONT STYLE="color: windowtext"> Chemical Shareholders </FONT>and the <FONT STYLE="color: windowtext">Talmer
Shareholders </FONT>relating to the <FONT STYLE="color: windowtext">Chemical Shareholder Meeting </FONT>and the <FONT STYLE="color: windowtext">Talmer
Shareholder Meeting </FONT>(together with any amendments or supplements thereto, the &ldquo;<FONT STYLE="color: windowtext"><B><I>Joint
Proxy Statement</I></B></FONT>&rdquo;) and (ii) jointly prepare, and <FONT STYLE="color: windowtext">Chemical </FONT>shall cause
to be filed with the <FONT STYLE="color: windowtext">SEC (not later than 75 days following the date of this Agreement), </FONT>a
registration statement on <FONT STYLE="color: windowtext">Form S-4 </FONT>(together with any amendments or supplements thereto,
the &ldquo;<FONT STYLE="color: windowtext"><B><I>Form S-4</I></B></FONT>&rdquo;), in which the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>will be included, and <FONT STYLE="color: windowtext">Chemical </FONT>and <FONT STYLE="color: windowtext">Talmer
</FONT>shall use their respective commercially reasonable efforts to have the <FONT STYLE="color: windowtext">Form S-4 </FONT>declared
effective under the <FONT STYLE="color: windowtext">Securities Act </FONT>as promptly as practicable after such filing and <FONT STYLE="color: windowtext">use
all commercially reasonable efforts </FONT>to keep the <FONT STYLE="color: windowtext">Form S-4 </FONT>effective as long as reasonably
necessary to consummate the <FONT STYLE="color: windowtext">Merger</FONT>. Prior to the filing of the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>or the <FONT STYLE="color: windowtext">Form S-4</FONT>, each of <FONT STYLE="color: windowtext">Chemical
</FONT>and <FONT STYLE="color: windowtext">Talmer </FONT>shall consult with the other <FONT STYLE="color: windowtext">Party </FONT>with
respect to such filings and shall afford the other <FONT STYLE="color: windowtext">Party </FONT>and its R<FONT STYLE="color: windowtext">epresentatives
</FONT>reasonable opportunity to comment thereon. Each of <FONT STYLE="color: windowtext">Chemical </FONT>and <FONT STYLE="color: windowtext">Talmer
</FONT>shall furnish all information concerning itself and its <FONT STYLE="color: windowtext">Affiliates </FONT>to the other and
provide such other assistance as may be reasonably requested in connection with the preparation, filing, and distribution of the
<FONT STYLE="color: windowtext">Joint Proxy Statement </FONT>and the <FONT STYLE="color: windowtext">Form S-4</FONT>, and the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>and the <FONT STYLE="color: windowtext">Form S-4 </FONT>shall <FONT STYLE="color: windowtext">include </FONT>all
information reasonably requested by each <FONT STYLE="color: windowtext">Party </FONT>to be included.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
of <FONT STYLE="color: windowtext">Talmer </FONT>and <FONT STYLE="color: windowtext">Chemical </FONT>shall promptly provide to
the other copies of all correspondence between it or its <FONT STYLE="color: windowtext">Representatives</FONT>, on the one hand,
and the <FONT STYLE="color: windowtext">SEC</FONT>, on the other hand, related to the <FONT STYLE="color: windowtext">Joint Proxy
Statement </FONT>or the <FONT STYLE="color: windowtext">Form S-4</FONT>. Each of <FONT STYLE="color: windowtext">Talmer </FONT>and
<FONT STYLE="color: windowtext">Chemical </FONT>shall promptly notify the other upon the receipt of any comments from the <FONT STYLE="color: windowtext">SEC
</FONT>or any request from the <FONT STYLE="color: windowtext">SEC </FONT>for amendments or supplements to the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>or the <FONT STYLE="color: windowtext">Form S-4 </FONT>and shall provide the other with copies of all such
<FONT STYLE="color: windowtext">SEC </FONT>comments or requests. Each of <FONT STYLE="color: windowtext">Talmer </FONT>and <FONT STYLE="color: windowtext">Chemical
</FONT>shall <FONT STYLE="color: windowtext">use its commercially reasonable efforts </FONT>to respond as promptly as practicable
to and resolve any comments from the <FONT STYLE="color: windowtext">SEC </FONT>with respect to the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>or the <FONT STYLE="color: windowtext">Form S-4</FONT>. Notwithstanding the foregoing, prior to filing the
<FONT STYLE="color: windowtext">Form S-4 </FONT>(or any amendment or supplement thereto) or mailing the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>(or any amendment or supplement thereto) or responding to any comments of the <FONT STYLE="color: windowtext">SEC
</FONT>with respect thereto, each of <FONT STYLE="color: windowtext">Talmer </FONT>and <FONT STYLE="color: windowtext">Chemical
</FONT>(i) shall provide the other an opportunity to review and comment on such document or response (<FONT STYLE="color: windowtext">including
</FONT>the proposed final version of such document or response), (ii) shall <FONT STYLE="color: windowtext">include </FONT>in such
document or response all comments reasonably proposed by the other and (iii) shall not file or mail such document or respond to
the <FONT STYLE="color: windowtext">SEC </FONT>prior to receiving the approval of the other, which approval shall not be unreasonably
withheld, conditioned or delayed. Each of <FONT STYLE="color: windowtext">Talmer </FONT>and <FONT STYLE="color: windowtext">Chemical
</FONT>shall advise the other, promptly after receipt of notice thereof, of the time of effectiveness of the <FONT STYLE="color: windowtext">Form
S-4</FONT>, the issuance of any stop <FONT STYLE="color: windowtext">order </FONT>relating thereto or the suspension of the registration
or qualification of the <FONT STYLE="color: windowtext">Stock Consideration </FONT>for offering or sale in any jurisdiction, and
each of <FONT STYLE="color: windowtext">Talmer </FONT>and <FONT STYLE="color: windowtext">Chemical </FONT>shall <FONT STYLE="color: windowtext">use
its commercially reasonable efforts </FONT>to have any such stop <FONT STYLE="color: windowtext">order </FONT>or suspension lifted,
reversed or otherwise terminated. Each of the Parties agrees to correct any information provided by it for use in the <FONT STYLE="color: windowtext">Joint
Proxy Statement </FONT>or the <FONT STYLE="color: windowtext">Form S-4 </FONT>that shall have become false or misleading in any
material respect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">60</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer shall, as soon as practicable following the effective date of the Form S-4, duly call, give proper
notice of, convene, and hold a meeting of the Talmer Shareholders (the &ldquo;<B><I>Talmer Shareholder Meeting</I></B>&rdquo;)
for the purpose of (i) obtaining the approval of this Agreement by the holders of a majority of the outstanding shares of Talmer
Common Stock entitled to vote thereon; (ii) obtaining the approval by a majority of the votes cast thereon of the Chemical Articles
Amendment, if required (such approvals in clauses (i) and (ii), collectively, the &ldquo;<B><I>Talmer Shareholder Approval</I></B>&rdquo;);
and (iii) submitting a proposal to the Talmer Shareholders to approve, on an advisory (non-binding) basis, the compensation that
may be paid or become payable to Talmer&rsquo;s named executive officers that is based on or otherwise related to the transactions
contemplated by this Agreement. Talmer shall use commercially reasonable efforts to (A)&nbsp;cause the Joint Proxy Statement to
be mailed to the Talmer Shareholders and to hold the Talmer Shareholder Meeting as promptly as practicable after the Form S-4 is
declared effective under the Securities Act and (B)&nbsp;except if the Talmer Board shall have made a Talmer Adverse Recommendation
Change as permitted by <U>Section 6.9</U>, solicit the Talmer Shareholder Approval. Talmer shall, through the Talmer Board, recommend
to the Talmer Shareholders that they vote for the Talmer Shareholder Approval and shall include such recommendation (the &ldquo;<B><I>Talmer
Board Recommendation</I></B>&rdquo;) in the Joint Proxy Statement, except to the extent that the Talmer Board shall have made a
Talmer Adverse Recommendation Change as permitted by <U>Section 6.9</U></FONT><FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer
</FONT>may adjourn or postpone the <FONT STYLE="color: windowtext">Talmer Shareholder Meeting </FONT>(i) to the extent necessary
to ensure that any necessary supplement or amendment to the <FONT STYLE="color: windowtext">Joint Proxy Statement </FONT>is provided
to the <FONT STYLE="color: windowtext">Talmer Shareholders </FONT>in advance of a vote on the <FONT STYLE="color: windowtext">Talmer
Shareholder Approval </FONT>or (ii) if, as of the time for which the <FONT STYLE="color: windowtext">Talmer Shareholder Meeting
</FONT>is originally scheduled (as set forth in the <FONT STYLE="color: windowtext">Joint Proxy Statement</FONT>), there are insufficient
<FONT STYLE="color: windowtext">Talmer Shareholders </FONT>represented (either in <FONT STYLE="color: windowtext">person </FONT>or
by proxy) to constitute a quorum necessary to conduct the business of such <FONT STYLE="color: windowtext">Talmer Shareholder Meeting
</FONT>or there are insufficient votes to obtain the <FONT STYLE="color: windowtext">Talmer Shareholder Approval</FONT>, (A) at
the request of <FONT STYLE="color: windowtext">Chemical</FONT>, <FONT STYLE="color: windowtext">Talmer </FONT>shall adjourn or
postpone the <FONT STYLE="color: windowtext">Talmer Shareholder Meeting </FONT>to a date no more than ten (10) <FONT STYLE="color: windowtext">Business
Days </FONT>later than the date of the initial <FONT STYLE="color: windowtext">Talmer Shareholder Meeting</FONT>; <I>provided</I>,
that <FONT STYLE="color: windowtext">Chemical </FONT>may not request that <FONT STYLE="color: windowtext">Talmer </FONT>make such
an adjournment or postponement more than once, and (B) <FONT STYLE="color: windowtext">Talmer </FONT>may adjourn or postpone the
<FONT STYLE="color: windowtext">Talmer Shareholder Meeting</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical
shall, as soon as practicable following the effective date of the Form S-4, duly call, give proper notice of, convene, and
hold a special meeting of the Chemical Shareholders (the &ldquo;<B><I>Chemical Shareholder Meeting</I></B>&rdquo;) for the
purpose of (i) obtaining the approval by the holders of a majority of the outstanding shares of Chemical Common Stock
entitled to vote thereon of (A) this Agreement, and (B) the amendment of the Chemical Articles to increase the number of
authorized shares of Chemical Common Stock to 100,000,000 (the &ldquo;<B><I>Chemical Articles Amendment</I></B>&rdquo;);
  (ii) obtaining the approval by a majority of the votes cast thereon of the issuance of the Stock Consideration (such
approvals in clauses (i) and (ii), collectively, the &ldquo;<B><I>Chemical Shareholder Approval</I></B>&rdquo;); and (iii)
submitting a proposal to the Chemical Shareholders to approve, on an advisory (non-binding) basis, the compensation that may
be paid or become payable to Chemical&rsquo;s named executive officers that is based on or otherwise related to the
transactions contemplated by this Agreement. Chemical shall use commercially reasonable efforts to (A)&nbsp;cause the Joint
Proxy Statement to be mailed to the Chemical Shareholders and to hold the Chemical Shareholder Meeting as promptly as
practicable </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">61</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">after the Form S-4 is declared effective under the Securities Act and (B)&nbsp;except if the Chemical Board shall
have made a Chemical Adverse Recommendation Change as permitted by <U>Section 6.10</U>, solicit the Chemical Shareholder
Approval. Chemical shall, through the Chemical Board, recommend to the Chemical Shareholders that they vote for the Chemical
Shareholder Approval and shall include such recommendation (the &ldquo;<B><I>Chemical Board Recommendation</I></B>&rdquo;) in
the Joint Proxy Statement, except to the extent that the Chemical Board shall have made a Chemical Adverse Recommendation
Change as permitted by <U>Section 6.10</U></FONT><FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical may
adjourn or postpone the Chemical Shareholder Meeting (i) to the extent necessary to ensure that any necessary supplement or amendment
to the Joint Proxy Statement is provided to the Chemical Shareholders in advance of a vote on the Chemical Shareholder Approval
or (ii) if, as of the time for which the Chemical Shareholder Meeting is originally scheduled (as set forth in the Joint Proxy
Statement), there are insufficient Chemical Shareholders represented (either in person or by proxy) to constitute a quorum necessary
to conduct the business of such Chemical Shareholder Meeting or there are insufficient votes to obtain the Chemical Shareholder
Approval, (A) at the request of Talmer, Chemical shall adjourn or postpone the Chemical Shareholder Meeting to a date no more than
ten (10) Business Days later than the date of the initial Chemical Shareholder Meeting; <I>provided</I>, that Talmer may not request
that Chemical make such an adjournment or postponement more than once and (B) Chemical may adjourn or postpone the Chemical Shareholder
Meeting.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NASDAQ
</U></FONT><U>Listing</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">Chemical shall cause the shares of Chemical
Common Stock to be issued in the Merger to be approved for listing on NASDAQ prior to the Effective Time.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Employee
Matters</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
individuals employed by, or on an authorized leave of absence from, <FONT STYLE="color: windowtext">Talmer </FONT>or any of <FONT STYLE="color: windowtext">Talmer
Subsidiaries </FONT>immediately before the <FONT STYLE="color: windowtext">Effective Time </FONT>(collectively, the &ldquo;<FONT STYLE="color: windowtext"><B><I>Covered
Employees</I></B></FONT>&rdquo;) shall automatically become employees of the <FONT STYLE="color: windowtext">Surviving Corporation
</FONT>and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>as of the <FONT STYLE="color: windowtext">Effective Time</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The <FONT STYLE="color: windowtext">Surviving Corporation </FONT>shall provide the <FONT STYLE="color: windowtext">Covered
Employees </FONT>rates of base salary or hourly wages that are substantially similar, in the aggregate, to the rates of base salary
or hourly wages provided to such <FONT STYLE="color: windowtext">Covered Employees </FONT>as in effect immediately before the <FONT STYLE="color: windowtext">Effective
Time</FONT>. Except as provided in the foregoing, the <FONT STYLE="color: windowtext">Surviving Corporation </FONT>shall provide
each <FONT STYLE="color: windowtext">Covered Employee </FONT>with the same employee benefits then provided to similarly situated
employees at <FONT STYLE="color: windowtext">Chemical </FONT>and consistent with this <U>Section <FONT STYLE="color: windowtext">6.5</FONT></U>;
<I>provided, however</I>, that, notwithstanding the foregoing, nothing contained herein shall (i) be treated as an amendment of
any particular <FONT STYLE="color: windowtext">Chemical Benefit Plan </FONT>or <FONT STYLE="color: windowtext">Talmer Benefit Plan</FONT>,
(ii) give any third <FONT STYLE="color: windowtext">party </FONT>any right to enforce the provisions of this <U>Section <FONT STYLE="color: windowtext">6.5</FONT></U>,
(iii) limit the right of the Surviving Corporation or any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to terminate
the employment of any <FONT STYLE="color: windowtext">Covered Employee </FONT>at any time or require the Surviving Corporation
or any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to provide any such employee benefits, rates of base salary or
hourly wage or annual bonus opportunities for any period following any such termination, or (iv) obligate <FONT STYLE="color: windowtext">Chemical
</FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>to (A) maintain any particular <FONT STYLE="color: windowtext">Chemical
Benefit Plan </FONT>or <FONT STYLE="color: windowtext">Talmer Benefit Plan</FONT>, as applicable, or (B) retain the employment
of any particular <FONT STYLE="color: windowtext">Covered Employee</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">62</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The <FONT STYLE="color: windowtext">Surviving Corporation </FONT>shall pay severance payments to all employees of one
or more of <FONT STYLE="color: windowtext">Talmer and any Talmer Subsidiaries </FONT>whose jobs are eliminated as a result of the
<FONT STYLE="color: windowtext">Merger </FONT>and whose employment is terminated by the <FONT STYLE="color: windowtext">Surviving
Corporation </FONT>other than for cause within nine (9) months after the <FONT STYLE="color: windowtext">Effective Time</FONT>,
in accordance with <FONT STYLE="color: windowtext">Talmer</FONT>&rsquo;s practices as described on <U>Section 6.5(c)</U> of the
<FONT STYLE="color: windowtext">Talmer Disclosure Schedules</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Surviving Corporation
shall provide credit for years of service at Talmer or any Talmer Subsidiary (and their respective predecessors if currently honored
by Talmer) for all purposes, including, without limitation, for purposes of eligibility to participate, vesting credit, entitlement
to benefits, and levels of benefits of any Chemical Benefit Plan (including, but not limited to, any 401(k) plan and vacation leave
policy but excluding the Chemical Financial Corporation Employees' Pension Plan and any other plan that has been frozen) or any
other employee benefit plan of the Surviving Corporation commencing after the Effective Time, and for purposes of determining seniority
in connection with employment with the Surviving Corporation and its Affiliates.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer will cooperate with
Chemical in its efforts to cause certain employees of Talmer identified by Chemical to enter into retention or stay bonus agreements
(in a form mutually agreed to by Chemical and the employee) prior to the Effective Time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Surviving Corporation
shall honor and discharge all of Talmer&rsquo;s obligations and assume all of its defenses under existing severance, change of
control or employment agreements to which Talmer or any Talmer Subsidiary is a party and which are listed on <U>Section 6.5(f)</U>
of the Talmer Disclosure Schedules in accordance with the terms thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On and after the date of
this Agreement, Talmer shall not make or cause to be made any discretionary employer contributions to participants, and shall prohibit
any new participant elections to defer compensation, under Talmer&rsquo;s deferred compensation plans. Any preexisting deferral
elections that are irrevocable as of the date of this Agreement shall remain in effect for compensation paid through the end of
the periods covered by such deferral elections. Talmer&rsquo;s deferred compensation plans shall remain in full force and effect
and payments of any benefits to participants shall be made in accordance with the terms of Talmer&rsquo;s deferred compensation
plans.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Surviving
Corporation shall maintain all accruals existing as of the Effective Time under Talmer&rsquo;s and its Subsidiaries&rsquo; non-equity
incentive and/or bonus plans consistent with Talmer&rsquo;s and its Subsidiaries&rsquo; 2016 budget approved by its board of directors.&nbsp;
Benefits accrued thereunder as of the Effective Time shall be paid by the Surviving Corporation to employees of Talmer and its
Subsidiaries in accordance with Talmer&rsquo;s and its Subsidiaries&rsquo; historic payment practices for such benefits, with approval
of such payments to be made in consultation with the Chairman of the Surviving Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Talmer
Board shall, prior to the Effective Time, adopt resolutions terminating its 401(k) Plan effective as of immediately prior to the
Effective Time.&nbsp; The accounts of all participants and beneficiaries in the Talmer 401(k) Plan shall become fully vested upon
termination of the Talmer 401(k) Plan.&nbsp; As soon as practicable following the Effective Time, all account balances in the Talmer
401(k) Plan shall be either distributed to participants and </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">63</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">beneficiaries or rolled over to an eligible tax-qualified retirement
plan or individual retirement account as a participant or beneficiary may direct.&nbsp; Chemical agrees to permit participants
in the Talmer 401(k) Plan who become employees of Chemical or any of its Subsidiaries to roll over their 401(k) account balances
in the Talmer 401(k) Plan to the Chemical 401(k) Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indemnification;
Directors&rsquo; and Officers&rsquo; Insurance</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of any threatened
or actual claim, action, suit, proceeding or investigation, whether civil, criminal, or administrative (a &ldquo;<B><I>Claim</I></B>&rdquo;),
including any such Claim in which any individual who is now, or has been at any time before the date of this Agreement, or who
becomes before the Effective Time, a director or officer of Talmer or any of its Subsidiaries (each, an &ldquo;<B><I>Indemnified
Party</I></B>&rdquo;), is, or is threatened to be, made a party based in whole or in part on, or arising in whole or in part out
of, or pertaining to this Agreement or any of the transactions contemplated by this Agreement, whether asserted or arising before
or after the Effective Time, the Parties shall cooperate and use their commercially reasonable efforts to defend against and respond
thereto. All rights to indemnification (including advancement of expenses) and exculpation from liabilities for acts or omissions
occurring at or before the Effective Time now existing in favor of any Indemnified Party as provided in the Talmer Articles and/or
the Talmer Bylaws, and any existing indemnification agreements, shall survive the Merger and shall continue in full force and effect
in accordance with their terms, and shall not be amended, repealed, or otherwise modified after the Effective Time in any manner
that would adversely affect the rights thereunder of such individuals for acts or omissions occurring at or before the Effective
Time or taken at the request of Chemical pursuant to <U>Section 6.7</U>, it being understood that nothing in this sentence shall
require any amendment to the Articles of Incorporation or Bylaws of the Surviving Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From and after the Effective
Time, the Surviving Corporation shall, to the fullest extent permitted by applicable Law, indemnify, defend, and hold harmless,
and provide advancement of reasonable expenses to, each Indemnified Party against all losses, claims, damages, costs, expenses,
liabilities, or judgments, or amounts that are paid in settlement of or in connection with any Claim based in whole or in part
on or arising in whole or in part out of the fact that such Person was a director or officer of Talmer or any Talmer Subsidiary
(or was serving at the request of Talmer or any of its Subsidiaries as a director, officer, employee, or trustee of another Person)
and pertaining to any matter existing or occurring, or any acts or omissions occurring, at or before the Effective Time, whether
asserted or claimed before, or at or after, the Effective Time (including matters, acts or omissions occurring in connection with
the approval of this Agreement and the consummation of the transactions contemplated hereby) or taken at the request of Chemical
pursuant to <U>Section 6.7</U>; <I>provided</I>,<I> </I>that, and without limitation to the covenants set forth in <U>Section 6.6(a)</U>,
with respect to any predecessor entities of Talmer Bank, only matters arising from acts or omissions occurring after the acquisition
by Talmer of such entities shall be covered by this <U>Section 6.6(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Surviving Corporation
shall maintain in effect for not less than six (6) years from the Effective Time the current policies of directors&rsquo; and officers&rsquo;
liability insurance and fiduciary liability insurance maintained by Talmer and the Talmer Subsidiaries for the Indemnified Parties
prior to the Effective Time with respect to matters occurring at or prior to the Effective Time, including the transactions contemplated
by this Agreement. Alternatively, the </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">64</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Surviving Corporation may substitute therefor policies of substantially the same coverage
containing terms and conditions that, taken as a whole, are no less advantageous to the Indemnified Parties. After the Effective
Time, the Surviving Corporation shall not be required to pay premiums for insurance coverages in excess of 300% of the last annual
premium (such 300% threshold, the &ldquo;<B><I>Maximum Amount</I></B>&rdquo;) paid by Talmer prior to the date of this Agreement
in respect of the coverages required to be obtained pursuant to this <U>Section 6.6(c)</U>, but in such case shall purchase the
greatest coverage available for a cost not exceeding the Maximum Amount. Alternatively, the Surviving Corporation may purchase
at or after the Effective Time, at a cost not exceeding the Maximum Amount, a six-year prepaid &ldquo;tail&rdquo; policy on terms
and conditions providing substantially equivalent benefits as the current policies of directors&rsquo; and officers&rsquo; liability
insurance and fiduciary liability insurance maintained by Talmer and the Talmer Subsidiaries for the Indemnified Parties with respect
to matters occurring at or prior to the Effective Time, including the transactions contemplated by this Agreement. If such &ldquo;tail&rdquo;
prepaid policy has been obtained, the Surviving Corporation shall maintain it in full force and effect for its full term and honor
all obligations thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The provisions of this <U>Section
6.6</U> shall survive the Effective Time and are intended to be for the benefit of, and shall be enforceable by, each Indemnified
Party and his or her heirs and representatives.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Additional
<FONT STYLE="color: windowtext">Agreements</FONT></U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">In case at any
time after the Effective Time any further action is necessary or desirable to carry out the purposes of this Agreement (including
any merger between a Chemical Subsidiary and a Talmer Subsidiary) or to vest the Surviving Corporation with full title to all properties,
assets, rights, approvals, immunities, and franchises of either Party to the Merger, the proper officers and directors of each
Party and their respective Subsidiaries shall take all such necessary action as may be reasonably requested by Chemical.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Advice
of Changes</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">Each of Chemical and Talmer shall promptly advise the
other of any change or event (a) having or reasonably likely to have a Material Adverse Effect on it or (b) that it believes would
or would be reasonably likely to cause or constitute a material breach of any of its representations, warranties, or covenants
contained in this Agreement; <I>provided, however</I>, that no such notification shall affect the representations, warranties,
covenants, or agreements of the Parties (or remedies with respect thereto) or the conditions to the obligations of the Parties
under this Agreement; <I>provided, further</I>, that a failure to comply with this <U>Section 6.8</U> shall not constitute a breach
of this Agreement or the failure of any condition set forth in <U>Article VII</U> to be satisfied unless the underlying Material
Adverse Effect or material breach would independently result in the failure of a condition set forth in <U>Article VII</U> to be
satisfied.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Solicitation by <FONT STYLE="color: windowtext">Talmer</FONT></U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as specifically permitted by this <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U>, <FONT STYLE="color: windowtext">Talmer
</FONT>shall not, and shall cause each of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>not to, and shall not authorize
or knowingly <FONT STYLE="color: windowtext">permit </FONT>any of its <FONT STYLE="color: windowtext">Representatives </FONT>to,
during the period from the date of this <FONT STYLE="color: windowtext">Agreement </FONT>until the earlier of the <FONT STYLE="color: windowtext">Effective
Time </FONT>and the termination of this <FONT STYLE="color: windowtext">Agreement </FONT>in accordance with <U>Section <FONT STYLE="color: windowtext">8.1</FONT></U>,
directly or indirectly, (i)&nbsp;solicit or initiate, or knowingly facilitate or knowingly encourage (<FONT STYLE="color: windowtext">including
</FONT>by way of furnishing non-public information), any inquiries regarding, or the making of any </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">65</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">proposal or offer that constitutes
or would reasonably be expected to lead to, a <FONT STYLE="color: windowtext">Talmer Takeover Proposal</FONT>, or (ii)&nbsp;engage
or enter into, continue, or otherwise participate in any discussions or negotiations regarding, or furnish to any other <FONT STYLE="color: windowtext">Person
</FONT>material non-public information in connection with, any <FONT STYLE="color: windowtext">Talmer Takeover Proposal</FONT>,
or otherwise cooperate with or assist or participate in, or knowingly encourage or knowingly facilitate, any such inquiries, proposals,
discussions, or negotiations or any effort or attempt to make a <FONT STYLE="color: windowtext">Talmer Takeover Proposal</FONT>.
<FONT STYLE="color: windowtext">Talmer </FONT>shall, and shall cause each of the <FONT STYLE="color: windowtext">Talmer Subsidiaries
and each of its </FONT>and the <FONT STYLE="color: windowtext">Talmer Subsidiaries</FONT>&rsquo; <FONT STYLE="color: windowtext">Representatives
</FONT>to, (A)&nbsp;immediately upon execution of this <FONT STYLE="color: windowtext">Agreement</FONT>, cease any solicitation,
encouragement, discussions, or negotiations with any <FONT STYLE="color: windowtext">Person </FONT>that may be ongoing with respect
to a <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>as of the date of this <FONT STYLE="color: windowtext">Agreement</FONT>,
and (B)&nbsp;immediately upon execution of this <FONT STYLE="color: windowtext">Agreement</FONT>, terminate all physical and electronic
data room access previously granted to any such <FONT STYLE="color: windowtext">Person </FONT>or its <FONT STYLE="color: windowtext">Representatives</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding
anything to the contrary contained herein, if at any time prior to obtaining the <FONT STYLE="color: windowtext">Talmer Shareholder
Approval</FONT>, <FONT STYLE="color: windowtext">Talmer </FONT>or any of its <FONT STYLE="color: windowtext">Representatives </FONT>receives
a bona fide written <FONT STYLE="color: windowtext">Talmer Takeover </FONT>Proposal from any <FONT STYLE="color: windowtext">Person
</FONT>or <FONT STYLE="color: windowtext">group of Persons</FONT>, which <FONT STYLE="color: windowtext">Talmer Takeover </FONT>Proposal
did not result from any breach of this <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U>, then <FONT STYLE="color: windowtext">Talmer
</FONT>and its Representatives may, (i) contact such <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group
of Persons </FONT>and their <FONT STYLE="color: windowtext">Representatives </FONT>to request that such <FONT STYLE="color: windowtext">Person
</FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>provide clarification of any term or condition of such <FONT STYLE="color: windowtext">Talmer
Takeover Proposal </FONT>that the <FONT STYLE="color: windowtext">Talmer Board </FONT>determines in good faith to be ambiguous
or unclear, and (ii) if the <FONT STYLE="color: windowtext">Talmer Board </FONT>determines in good faith, after consultation with
its financial advisors and outside legal counsel, that such <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>constitutes
or is reasonably likely to result in a <FONT STYLE="color: windowtext">Talmer Superior Proposal, </FONT>(A)&nbsp;furnish, pursuant
to an <FONT STYLE="color: windowtext">Acceptable Talmer Confidentiality Agreement</FONT>, information (<FONT STYLE="color: windowtext">including
</FONT>non-public information) with respect to <FONT STYLE="color: windowtext">Talmer </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>to the <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>who has
made such <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>and their respective <FONT STYLE="color: windowtext">Representatives</FONT>;
<I>provided that</I>, <FONT STYLE="color: windowtext">Talmer </FONT>shall (subject to the terms of the <FONT STYLE="color: windowtext">Confidentiality
Agreement</FONT>) promptly make available to <FONT STYLE="color: windowtext">Chemical </FONT>(through an electronic data room or
otherwise), and provide express written notification via electronic mail notification to <FONT STYLE="color: windowtext">Chemical
</FONT>in accordance with the applicable provisions of <U>Section 10.3</U> of, the availability of any written material non-public
information that is provided to any such <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group
of Persons </FONT>or their respective <FONT STYLE="color: windowtext">Representatives</FONT>, if such information was not previously
provided or made available to <FONT STYLE="color: windowtext">Chemical </FONT>or its <FONT STYLE="color: windowtext">Representatives</FONT>,
and <FONT STYLE="color: windowtext">(B)&nbsp;</FONT>engage in or otherwise participate in discussions or negotiations with the
<FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>making such <FONT STYLE="color: windowtext">Talmer
Takeover Proposal </FONT>and their respective <FONT STYLE="color: windowtext">Representatives</FONT>; <I>provided</I>, <I>further</I>
that <FONT STYLE="color: windowtext">Talmer </FONT>shall promptly provide to <FONT STYLE="color: windowtext">Chemical </FONT>(1)&nbsp;a
copy of any <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>made in writing by any such <FONT STYLE="color: windowtext">Person
</FONT>or group of <FONT STYLE="color: windowtext">Persons </FONT>to <FONT STYLE="color: windowtext">Talmer</FONT>, any of its
<FONT STYLE="color: windowtext">Subsidiaries</FONT>, or any of their respective <FONT STYLE="color: windowtext">Representatives</FONT>,
together with the identity of the <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons
</FONT>making the <FONT STYLE="color: windowtext">Talmer Takeover Proposal</FONT>, and (2)&nbsp;a written summary of the material
terms of any such <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>not made in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Talmer
</FONT>shall keep <FONT STYLE="color: windowtext">Chemical </FONT>promptly informed of any material developments, discussions,
or negotiations regarding any <FONT STYLE="color: windowtext">Talmer Takeover Proposal</FONT>, <FONT STYLE="color: windowtext">including
</FONT>any such proposal first made to or discussed with <FONT STYLE="color: windowtext">Talmer </FONT>prior to the date of this
<FONT STYLE="color: windowtext">Agreement and remade after the date of this Agreement </FONT>(<FONT STYLE="color: windowtext">including
</FONT>forwarding to <FONT STYLE="color: windowtext">Chemical </FONT>any written materials provided to <FONT STYLE="color: windowtext">Talmer
</FONT>or its <FONT STYLE="color: windowtext">Representatives </FONT>in connection with any such <FONT STYLE="color: windowtext">Talmer
Takeover Proposal</FONT>) on a reasonably prompt basis. Any such disclosure shall be subject to the terms of the <FONT STYLE="color: windowtext">Confidentiality
Agreement</FONT>. <FONT STYLE="color: windowtext">Talmer </FONT>agrees that it and its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>will not to enter into any </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">66</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">confidentiality or other <FONT STYLE="color: windowtext">agreement </FONT>with any <FONT STYLE="color: windowtext">Person
</FONT>subsequent to the date of this <FONT STYLE="color: windowtext">Agreement </FONT>which would prohibit <FONT STYLE="color: windowtext">Talmer
</FONT>from providing any information to <FONT STYLE="color: windowtext">Chemical </FONT>in accordance with this <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U><FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as permitted by <U>Section <FONT STYLE="color: windowtext">6.9(e)</FONT></U>, the <FONT STYLE="color: windowtext">Talmer Board
</FONT>shall not <FONT STYLE="color: windowtext">(i)(</FONT>A)&nbsp;fail to recommend to the <FONT STYLE="color: windowtext">Talmer
Shareholders </FONT>that the <FONT STYLE="color: windowtext">Talmer Shareholder Approval </FONT>be given or fail to <FONT STYLE="color: windowtext">include
</FONT>the <FONT STYLE="color: windowtext">Talmer Board Recommendation </FONT>in the <FONT STYLE="color: windowtext">Joint Proxy
Statement</FONT>, (B)&nbsp;change, qualify, withhold, withdraw, or modify, or publicly propose to change, qualify, withhold, withdraw,
or modify, in a manner adverse to <FONT STYLE="color: windowtext">Chemical</FONT>, the <FONT STYLE="color: windowtext">Talmer Board
Recommendation</FONT>, (C)&nbsp;take any formal <FONT STYLE="color: windowtext">action </FONT>or make any recommendation or public
statement in connection with a tender offer or exchange offer other than a recommendation of rejection of such offer or a temporary
&ldquo;stop, look, and listen&rdquo; communication by the <FONT STYLE="color: windowtext">Talmer Board </FONT>pursuant to Rule
14d-9(f) of the <FONT STYLE="color: windowtext">Exchange Act</FONT>, or (D)&nbsp;adopt, approve, or recommend, or publicly propose
to approve or recommend to the <FONT STYLE="color: windowtext">Talmer Shareholders</FONT>, a <FONT STYLE="color: windowtext">Talmer
Takeover Proposal </FONT>(each of the actions described in this clause <FONT STYLE="color: windowtext">(i)&nbsp;</FONT>being referred
to as a &ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer Adverse Recommendation Change</I></B></FONT>&rdquo;); or (ii)&nbsp;cause
or <FONT STYLE="color: windowtext">permit Talmer </FONT>or any of the <FONT STYLE="color: windowtext">Talmer Subsidiaries </FONT>to
enter into any letter of intent, <FONT STYLE="color: windowtext">agreement</FONT>, or <FONT STYLE="color: windowtext">agreement
</FONT>in principle with respect to any <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>(other than an <FONT STYLE="color: windowtext">Acceptable
Talmer Confidentiality Agreement</FONT>) (each, a &ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer Acquisition Agreement</I></B></FONT>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding
anything to the contrary herein, prior to the time the <FONT STYLE="color: windowtext">Talmer Shareholder Approval </FONT>is obtained,
the <FONT STYLE="color: windowtext">Talmer Board </FONT>may, in connection with a bona fide written <FONT STYLE="color: windowtext">Talmer
Takeover Proposal</FONT>, which <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>was made after the date of this
<FONT STYLE="color: windowtext">Agreement </FONT>(or that was made prior to the date of this <FONT STYLE="color: windowtext">Agreement
</FONT>and remade after the date of this <FONT STYLE="color: windowtext">Agreement</FONT>) and that did not result from any breach
of this <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U>, make a <FONT STYLE="color: windowtext">Talmer Adverse Recommendation
Change </FONT>or terminate this <FONT STYLE="color: windowtext">Agreement </FONT>pursuant to <U>Section <FONT STYLE="color: windowtext">8.1(i)</FONT></U><FONT STYLE="color: windowtext">
</FONT>to enter into a definitive <FONT STYLE="color: windowtext">merger agreement </FONT>or other definitive purchase or acquisition
<FONT STYLE="color: windowtext">agreement </FONT>with respect to such <FONT STYLE="color: windowtext">Talmer Takeover Proposal</FONT>,
if and only if, prior to taking such <FONT STYLE="color: windowtext">action</FONT>, <FONT STYLE="color: windowtext">Talmer </FONT>has
complied with its obligations under this <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U><FONT STYLE="color: windowtext">
</FONT>and the <FONT STYLE="color: windowtext">Talmer Board </FONT>has determined in good faith, after consultation with its financial
advisors and outside legal counsel,&nbsp;that such <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>constitutes
a <FONT STYLE="color: windowtext">Talmer Superior Proposal</FONT>; <I>provided</I>, <I>however</I>, that prior to taking any such
<FONT STYLE="color: windowtext">action (i)&nbsp;Talmer </FONT>has given <FONT STYLE="color: windowtext">Chemical </FONT>at least
three (3) <FONT STYLE="color: windowtext">Business Days </FONT>prior written notice of its intention to take such <FONT STYLE="color: windowtext">action
</FONT>(which notice shall specify the material terms and conditions of any such <FONT STYLE="color: windowtext">Talmer Superior
Proposal</FONT>, <FONT STYLE="color: windowtext">including </FONT>the identity of the <FONT STYLE="color: windowtext">Person </FONT>or
<FONT STYLE="color: windowtext">group of Persons </FONT>making such <FONT STYLE="color: windowtext">Talmer Superior Proposal</FONT>)
and has contemporaneously provided a copy to <FONT STYLE="color: windowtext">Chemical </FONT>of all written materials (<FONT STYLE="color: windowtext">including
</FONT>all transaction agreements and related documents) with or from the <FONT STYLE="color: windowtext">party </FONT>making such
<FONT STYLE="color: windowtext">Talmer Superior Proposal</FONT>, (ii)&nbsp;<FONT STYLE="color: windowtext">Talmer </FONT>has negotiated,
and has caused its <FONT STYLE="color: windowtext">Representatives </FONT>to negotiate, in good faith with <FONT STYLE="color: windowtext">Chemical
</FONT>during such notice period, to the extent <FONT STYLE="color: windowtext">Chemical </FONT>wishes to negotiate, to enable
<FONT STYLE="color: windowtext">Chemical </FONT>to revise the terms of this <FONT STYLE="color: windowtext">Agreement </FONT>such
that it would cause such <FONT STYLE="color: windowtext">Talmer Superior Proposal </FONT>to no longer constitute a <FONT STYLE="color: windowtext">Talmer
Superior Proposal</FONT>, and (iii)&nbsp;following the end of such notice period, the <FONT STYLE="color: windowtext">Talmer Board
</FONT>shall have considered in good faith any changes to this <FONT STYLE="color: windowtext">Agreement </FONT>proposed in writing
by <FONT STYLE="color: windowtext">Chemical</FONT>, and shall have determined that the <FONT STYLE="color: windowtext">Talmer Superior
Proposal </FONT>would continue to constitute a <FONT STYLE="color: windowtext">Talmer Superior Proposal </FONT>if such revisions
were to be given effect. In the event of any material revisions to a <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>that
could have an impact, influence, or other effect on the <FONT STYLE="color: windowtext">Talmer Board</FONT>&rsquo;s decision or
discussion with respect to whether such proposal is a <FONT STYLE="color: windowtext">Talmer Superior Proposal</FONT>, <FONT STYLE="color: windowtext">Talmer
</FONT>shall deliver a new written notice to <FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">67</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">Chemical </FONT>pursuant to the foregoing clause&nbsp;<FONT STYLE="color: windowtext">(i)
</FONT>and again comply with the requirements of this <U>Section <FONT STYLE="color: windowtext">6.9(e</FONT></U><FONT STYLE="color: windowtext">)
</FONT>with respect to such new written notice; <I>provided</I>, <I>however</I>, that references herein to the three (3) <FONT STYLE="color: windowtext">Business
Day </FONT>period shall be deemed to be references to a two (2) <FONT STYLE="color: windowtext">Business Day </FONT>period with
respect thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Provided
that <FONT STYLE="color: windowtext">Talmer </FONT>and the <FONT STYLE="color: windowtext">Talmer Board </FONT>comply with their
respective obligations under <U>Section <FONT STYLE="color: windowtext">6.9(e)</FONT>,</U> nothing in this <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U><FONT STYLE="color: windowtext">
</FONT>shall prohibit the <FONT STYLE="color: windowtext">Talmer Board </FONT>from <FONT STYLE="color: windowtext">(i)&nbsp;</FONT>taking
and disclosing to the <FONT STYLE="color: windowtext">Talmer Shareholders </FONT>a position contemplated by Rule 14e-2(a), Rule
14d-9, or Item&nbsp;1012(a) of Regulation M-A promulgated under the <FONT STYLE="color: windowtext">Exchange Act</FONT>, <FONT STYLE="color: windowtext">(ii)&nbsp;</FONT>making
any &ldquo;stop, look, and listen&rdquo; communications to <FONT STYLE="color: windowtext">Talmer Shareholders </FONT>pursuant
to Section&nbsp;14d-9(f) promulgated under the <FONT STYLE="color: windowtext">Exchange Act (or any similar communications to the
Talmer Shareholders), or (iii) making any disclosure to the Talmer Shareholders if the Talmer Board determines in good faith, after
consultation with its outside legal counsel, that failure to take such action would be reasonably likely to be inconsistent with
the Talmer Boards&rsquo; fiduciary duties under applicable Law</FONT>; <I>provided, however</I>, that the taking of any <FONT STYLE="color: windowtext">action
</FONT>pursuant to any of the preceding clauses <FONT STYLE="color: windowtext">(i), (ii),&nbsp;</FONT>or <FONT STYLE="color: windowtext">(iii)&nbsp;</FONT>shall
in no way limit or modify the effect of this <FONT STYLE="color: windowtext">Agreement </FONT>with respect to any such <FONT STYLE="color: windowtext">action
</FONT>taken.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Solicitation by <FONT STYLE="color: windowtext">Chemical</FONT></U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as specifically permitted by this <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U>, <FONT STYLE="color: windowtext">Chemical
</FONT>shall not, and shall cause each of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>not to, and shall not authorize
or knowingly <FONT STYLE="color: windowtext">permit </FONT>any of its <FONT STYLE="color: windowtext">Representatives </FONT>to,
during the period from the date of this <FONT STYLE="color: windowtext">Agreement </FONT>until the earlier of the <FONT STYLE="color: windowtext">Effective
Time </FONT>and the termination of this <FONT STYLE="color: windowtext">Agreement </FONT>in accordance with <U>Section <FONT STYLE="color: windowtext">8.1</FONT></U>,
directly or indirectly, (i)&nbsp;solicit or initiate, or knowingly facilitate or knowingly encourage (<FONT STYLE="color: windowtext">including
</FONT>by way of furnishing non-public information), any inquiries regarding, or the making of any proposal or offer that constitutes
or would reasonably be expected to lead to, a <FONT STYLE="color: windowtext">Chemical Takeover Proposal</FONT>, or (ii)&nbsp;engage
or enter into, continue, or otherwise participate in any discussions or negotiations regarding, or furnish to any other <FONT STYLE="color: windowtext">Person
</FONT>material non-public information in connection with, any <FONT STYLE="color: windowtext">Chemical Takeover Proposal</FONT>,
or otherwise cooperate with or assist or participate in, or knowingly encourage or knowingly facilitate, any such inquiries, proposals,
discussions, or negotiations or any effort or attempt to make a <FONT STYLE="color: windowtext">Chemical Takeover Proposal</FONT>.
<FONT STYLE="color: windowtext">Chemical </FONT>shall, and shall cause each of the <FONT STYLE="color: windowtext">Chemical Subsidiaries
</FONT>and each of its and the <FONT STYLE="color: windowtext">Chemical Subsidiaries</FONT>&rsquo; <FONT STYLE="color: windowtext">Representatives
</FONT>to (A)&nbsp;immediately upon execution of this <FONT STYLE="color: windowtext">Agreement</FONT>, cease any solicitation,
encouragement, discussions, or negotiations with any <FONT STYLE="color: windowtext">Person </FONT>that may be ongoing with respect
to a <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>as of the date of this <FONT STYLE="color: windowtext">Agreement</FONT>,
and (B)&nbsp;immediately upon execution of this <FONT STYLE="color: windowtext">Agreement</FONT>, terminate all physical and electronic
data room access previously granted to any such <FONT STYLE="color: windowtext">Person </FONT>or its <FONT STYLE="color: windowtext">Representatives</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding
anything to the contrary contained herein, if at any time prior to obtaining the <FONT STYLE="color: windowtext">Chemical Shareholder
Approval</FONT>, <FONT STYLE="color: windowtext">Chemical </FONT>or any of its <FONT STYLE="color: windowtext">Representatives
</FONT>receives a bona fide written <FONT STYLE="color: windowtext">Chemical Takeover </FONT>Proposal from any <FONT STYLE="color: windowtext">Person
</FONT>or <FONT STYLE="color: windowtext">group of Persons</FONT>, which <FONT STYLE="color: windowtext">Chemical Takeover </FONT>Proposal
did not result from any breach of this <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U>, then <FONT STYLE="color: windowtext">Chemical
</FONT>and its Representatives may, (i) contact such <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group
of Persons </FONT>and their <FONT STYLE="color: windowtext">Representatives </FONT>to request that such <FONT STYLE="color: windowtext">Person
</FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>provide clarification of any term or condition of such <FONT STYLE="color: windowtext">Chemical
Takeover Proposal </FONT>that the <FONT STYLE="color: windowtext">Chemical Board </FONT>determines in good faith to be ambiguous
or unclear and (ii) if the <FONT STYLE="color: windowtext">Chemical Board </FONT>determines in good faith, after </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">68</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">consultation with
its financial advisors and outside legal counsel, that such <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>constitutes
or is reasonably likely to result in a <FONT STYLE="color: windowtext">Chemical Superior Proposal, </FONT>(A)&nbsp;furnish, pursuant
to an <FONT STYLE="color: windowtext">Acceptable Chemical Confidentiality Agreement</FONT>, information (<FONT STYLE="color: windowtext">including
</FONT>non-public information) with respect to <FONT STYLE="color: windowtext">Chemical </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries
</FONT>to the <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>who has
made such <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>and their respective <FONT STYLE="color: windowtext">Representatives</FONT>;
<I>provided</I>, that <FONT STYLE="color: windowtext">Chemical </FONT>shall (subject to the terms of the <FONT STYLE="color: windowtext">Confidentiality
Agreement</FONT>) promptly make available to <FONT STYLE="color: windowtext">Talmer </FONT>(through an electronic data room or
otherwise), and provide express written notification via electronic mail notification to <FONT STYLE="color: windowtext">Talmer
</FONT>in accordance with the applicable provisions of <U>Section 10.3</U> of the availability of, any written material non-public
information that is provided to any such <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group
of Persons </FONT>or their respective <FONT STYLE="color: windowtext">Representatives</FONT>, if such information was not previously
provided or made available to <FONT STYLE="color: windowtext">Talmer </FONT>or its <FONT STYLE="color: windowtext">Representatives</FONT>,
and <FONT STYLE="color: windowtext">(B)&nbsp;</FONT>engage in or otherwise participate in discussions or negotiations with the
<FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>making such <FONT STYLE="color: windowtext">Chemical
Takeover Proposal </FONT>and their respective <FONT STYLE="color: windowtext">Representatives</FONT>; <I>provided</I>, <I>further</I>
that <FONT STYLE="color: windowtext">Chemical </FONT>shall promptly provide to <FONT STYLE="color: windowtext">Talmer </FONT>(1)&nbsp;a
copy of any <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>made in writing by any such <FONT STYLE="color: windowtext">Person
</FONT>or group of <FONT STYLE="color: windowtext">Persons </FONT>to <FONT STYLE="color: windowtext">Chemical</FONT>, any of its
<FONT STYLE="color: windowtext">Subsidiaries</FONT>, or any of their respective <FONT STYLE="color: windowtext">Representatives</FONT>,
together with the identity of the <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons
</FONT>making the <FONT STYLE="color: windowtext">Chemical Takeover Proposal</FONT>, and (2)&nbsp;a written summary of the material
terms of any such <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>not made in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical
</FONT>shall keep <FONT STYLE="color: windowtext">Talmer </FONT>promptly informed of any material developments, discussions, or
negotiations regarding any <FONT STYLE="color: windowtext">Chemical Takeover Proposal, including any such proposal first made to
or discussed with Chemical prior to </FONT>the date of this <FONT STYLE="color: windowtext">Agreement and remade after the date
of this Agreement </FONT>(<FONT STYLE="color: windowtext">including </FONT>forwarding to <FONT STYLE="color: windowtext">Talmer
</FONT>any written materials provided to <FONT STYLE="color: windowtext">Chemical </FONT>or its <FONT STYLE="color: windowtext">Representatives
</FONT>in connection with any such <FONT STYLE="color: windowtext">Chemical Takeover Proposal</FONT>) on a reasonably prompt basis.
Any such disclosure shall be subject to the terms of the <FONT STYLE="color: windowtext">Confidentiality Agreement</FONT>. <FONT STYLE="color: windowtext">Chemical
</FONT>agrees that it and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>will not enter into any confidentiality or other
<FONT STYLE="color: windowtext">agreement </FONT>with any <FONT STYLE="color: windowtext">Person </FONT>subsequent to the date
of this <FONT STYLE="color: windowtext">Agreement </FONT>which would prohibit <FONT STYLE="color: windowtext">Chemical </FONT>from
providing any information to <FONT STYLE="color: windowtext">Talmer </FONT>in accordance with this <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U><FONT STYLE="color: windowtext">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as permitted by <U>Section <FONT STYLE="color: windowtext">6.10(e)</FONT></U>, the <FONT STYLE="color: windowtext">Chemical Board
</FONT>shall not <FONT STYLE="color: windowtext">(i)(</FONT>A)&nbsp;fail to recommend to the <FONT STYLE="color: windowtext">Chemical
Shareholders </FONT>that the <FONT STYLE="color: windowtext">Chemical Shareholder Approval </FONT>be given or fail to <FONT STYLE="color: windowtext">include
</FONT>the <FONT STYLE="color: windowtext">Chemical Board Recommendation </FONT>in the <FONT STYLE="color: windowtext">Joint Proxy
Statement</FONT>; (B)&nbsp;change, qualify, withhold, withdraw, or modify, or publicly propose to change, qualify, withhold, withdraw,
or modify, in a manner adverse to <FONT STYLE="color: windowtext">Talmer</FONT>, the <FONT STYLE="color: windowtext">Chemical Board
Recommendation</FONT>; (C)&nbsp;take any formal <FONT STYLE="color: windowtext">action </FONT>or make any recommendation or public
statement in connection with a tender offer or exchange offer other than a recommendation of rejection of such offer or a temporary
&ldquo;stop, look, and listen&rdquo; communication by the <FONT STYLE="color: windowtext">Chemical Board </FONT>pursuant to Rule
14d-9(f) of the <FONT STYLE="color: windowtext">Exchange Act</FONT>; or (D)&nbsp;adopt, approve, or recommend, or publicly propose
to approve or recommend to the <FONT STYLE="color: windowtext">Chemical Shareholders</FONT>, a <FONT STYLE="color: windowtext">Chemical
Takeover Proposal </FONT>(each of the actions described in this clause <FONT STYLE="color: windowtext">(i)&nbsp;</FONT>being referred
to as a &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical Adverse Recommendation Change</I></B></FONT>&rdquo;) or (ii)&nbsp;cause
or <FONT STYLE="color: windowtext">permit Chemical </FONT>or any of the <FONT STYLE="color: windowtext">Chemical Subsidiaries </FONT>to
enter into any letter of intent, <FONT STYLE="color: windowtext">agreement</FONT>, or <FONT STYLE="color: windowtext">agreement
</FONT>in principle with respect to any <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>(other than an <FONT STYLE="color: windowtext">Acceptable
Chemical Confidentiality Agreement</FONT>) (each, a &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical Acquisition Agreement</I></B></FONT>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">69</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding
anything to the contrary herein, prior to the time the <FONT STYLE="color: windowtext">Chemical Shareholder Approval </FONT>is
obtained, the <FONT STYLE="color: windowtext">Chemical Board </FONT>may, in connection with a bona fide written <FONT STYLE="color: windowtext">Chemical
Takeover Proposal</FONT>, which <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>was made after the date of this
<FONT STYLE="color: windowtext">Agreement </FONT>(or that was made prior to the date of this <FONT STYLE="color: windowtext">Agreement
</FONT>and remade after the date of this <FONT STYLE="color: windowtext">Agreement</FONT>) and that did not result from any breach
of this <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U>, make a <FONT STYLE="color: windowtext">Chemical Adverse Recommendation
Change </FONT>or terminate this <FONT STYLE="color: windowtext">Agreement </FONT>pursuant to <U>Section <FONT STYLE="color: windowtext">8.1(j)</FONT></U><FONT STYLE="color: windowtext">
</FONT>to enter into a definitive <FONT STYLE="color: windowtext">merger agreement </FONT>or other definitive purchase or acquisition
<FONT STYLE="color: windowtext">agreement </FONT>with respect to such <FONT STYLE="color: windowtext">Chemical Takeover Proposal</FONT>,
if and only if, prior to taking such <FONT STYLE="color: windowtext">action</FONT>, <FONT STYLE="color: windowtext">Chemical </FONT>has
complied with its obligations under this <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U><FONT STYLE="color: windowtext">
</FONT>and the <FONT STYLE="color: windowtext">Chemical Board </FONT>has determined in good faith, after consultation with its
financial advisors and outside legal counsel,&nbsp;that such <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>constitutes
a <FONT STYLE="color: windowtext">Chemical Superior Proposal</FONT>; <I>provided</I>, <I>however</I>, that prior to taking any
such <FONT STYLE="color: windowtext">action (i)&nbsp;Chemical </FONT>has given <FONT STYLE="color: windowtext">Talmer </FONT>at
least three (3) <FONT STYLE="color: windowtext">Business Days </FONT>prior written notice of its intention to take such <FONT STYLE="color: windowtext">action
</FONT>(which notice shall specify the material terms and conditions of any such <FONT STYLE="color: windowtext">Chemical Superior
Proposal</FONT>, <FONT STYLE="color: windowtext">including </FONT>the identity of the <FONT STYLE="color: windowtext">Person </FONT>or
<FONT STYLE="color: windowtext">group of Persons </FONT>making such <FONT STYLE="color: windowtext">Chemical Superior Proposal</FONT>)
and has contemporaneously provided a copy to <FONT STYLE="color: windowtext">Talmer </FONT>of all written materials (<FONT STYLE="color: windowtext">including
</FONT>all transaction agreements and related documents) with or from the <FONT STYLE="color: windowtext">party </FONT>making such
<FONT STYLE="color: windowtext">Chemical Superior Proposal</FONT>; (ii)&nbsp;<FONT STYLE="color: windowtext">Chemical </FONT>has
negotiated, and has caused its <FONT STYLE="color: windowtext">Representatives </FONT>to negotiate, in good faith with <FONT STYLE="color: windowtext">Talmer
</FONT>during such notice period, to the extent <FONT STYLE="color: windowtext">Talmer </FONT>wishes to negotiate, to enable <FONT STYLE="color: windowtext">Talmer
</FONT>to revise the terms of this <FONT STYLE="color: windowtext">Agreement </FONT>such that it would cause such <FONT STYLE="color: windowtext">Chemical
Superior Proposal </FONT>to no longer constitute a <FONT STYLE="color: windowtext">Chemical Superior Proposal</FONT>; and (iii)&nbsp;following
the end of such notice period, the <FONT STYLE="color: windowtext">Chemical Board </FONT>shall have considered in good faith any
changes to this <FONT STYLE="color: windowtext">Agreement </FONT>proposed in writing by <FONT STYLE="color: windowtext">Talmer</FONT>,
and shall have determined that the <FONT STYLE="color: windowtext">Chemical Superior Proposal </FONT>would continue to constitute
a <FONT STYLE="color: windowtext">Chemical Superior Proposal </FONT>if such revisions were to be given effect. In the event of
any material revisions to a <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>that could have an impact, influence,
or other effect on the <FONT STYLE="color: windowtext">Chemical Board</FONT>&rsquo;s decision or discussion with respect to whether
such proposal is a <FONT STYLE="color: windowtext">Chemical Superior Proposal</FONT>, <FONT STYLE="color: windowtext">Chemical
</FONT>shall deliver a new written notice to <FONT STYLE="color: windowtext">Talmer </FONT>pursuant to the foregoing clause&nbsp;<FONT STYLE="color: windowtext">(i)
</FONT>and again comply with the requirements of this <U>Section <FONT STYLE="color: windowtext">6.10(e</FONT></U><FONT STYLE="color: windowtext">)
</FONT>with respect to such new written notice; <I>provided</I>, <I>however</I>, that references herein to the three (3) <FONT STYLE="color: windowtext">Business
Day </FONT>period shall be deemed to be references to a two (2) <FONT STYLE="color: windowtext">Business Day </FONT>period with
respect thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Provided
that <FONT STYLE="color: windowtext">Chemical </FONT>and the <FONT STYLE="color: windowtext">Chemical Board </FONT>comply with
their respective obligations under <U>Section <FONT STYLE="color: windowtext">6.10(e)</FONT>,</U> nothing in this <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U><FONT STYLE="color: windowtext">
</FONT>shall prohibit the <FONT STYLE="color: windowtext">Chemical Board </FONT>from <FONT STYLE="color: windowtext">(i)&nbsp;</FONT>taking
and disclosing to the <FONT STYLE="color: windowtext">Chemical Shareholders </FONT>a position contemplated by Rule 14e-2(a), Rule
14d-9, or Item&nbsp;1012(a) of Regulation M-A promulgated under the <FONT STYLE="color: windowtext">Exchange Act</FONT>, <FONT STYLE="color: windowtext">(ii)&nbsp;</FONT>making
any &ldquo;stop, look, and listen&rdquo; communications to <FONT STYLE="color: windowtext">Chemical Shareholders </FONT>pursuant
to Section&nbsp;14d-9(f) promulgated under the <FONT STYLE="color: windowtext">Exchange Act (or any similar communications to the
Chemical Shareholders), or (iii) making any disclosure to the Chemical Shareholders if the Chemical Board determines in good faith,
after consultation with its outside legal counsel, that failure to take such action would be reasonably likely to be inconsistent
with the Chemical Boards&rsquo; fiduciary duties under applicable Law</FONT>; <I>provided, however</I>, that the taking of any
<FONT STYLE="color: windowtext">action </FONT>pursuant to any of the preceding clauses <FONT STYLE="color: windowtext">(i),&nbsp;(ii)&nbsp;or
(iii) </FONT>shall in no way limit or modify the effect of this <FONT STYLE="color: windowtext">Agreement </FONT>with respect to
any such <FONT STYLE="color: windowtext">action </FONT>taken.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">70</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Corporate
Governance</U><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Effective as of the <FONT STYLE="color: windowtext">Effective Time</FONT>, <FONT STYLE="color: windowtext">Chemical </FONT>shall
take all actions necessary to cause the size of the <FONT STYLE="color: windowtext">Board of Directors </FONT>of the Surviving
Corporation to be twelve (12) directors. The then-current seven (7) members of the <FONT STYLE="color: windowtext">Chemical Board
</FONT>(the &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical Continuing Directors</I></B></FONT>&rdquo;) shall continue in
office and shall serve on the <FONT STYLE="color: windowtext">Board of Directors </FONT>of the Surviving Corporation <FONT STYLE="color: windowtext">until
such time as their successors are duly elected and qualified</FONT>. As of the <FONT STYLE="color: windowtext">Effective Time</FONT>,
the <FONT STYLE="color: windowtext">Chemical Continuing Directors </FONT>shall immediately appoint five (5) of the then-current
members of the <FONT STYLE="color: windowtext">Talmer Board </FONT>(two of whom shall be Gary Torgow and David Provost) (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Continuing Directors</I></B></FONT>&rdquo;) to serve on the Board of Directors of the Surviving Corporation <FONT STYLE="color: windowtext">until
such time as their successors are duly elected and qualified</FONT>. The <FONT STYLE="color: windowtext">Board of Directors </FONT>of
the Surviving Corporation (or the appropriate committee thereof) shall cause the Talmer Continuing Directors to be nominated for
election at the 2017 annual meeting of shareholders of the <FONT STYLE="color: windowtext">Surviving Corporation</FONT>. The <FONT STYLE="color: windowtext">Parties
</FONT>shall confer with regard to the individuals constituting the Talmer Continuing Directors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Effective as of the <FONT STYLE="color: windowtext">effective time </FONT>of the <FONT STYLE="color: windowtext">Bank Merger</FONT>,
<FONT STYLE="color: windowtext">Chemical </FONT>Bank shall take all actions necessary to cause the size of the <FONT STYLE="color: windowtext">Board
of Directors </FONT>of the Surviving Bank to be fourteen (<FONT STYLE="color: windowtext">14) </FONT>directors. The then-current
twelve (<FONT STYLE="color: windowtext">12) </FONT>members of the <FONT STYLE="color: windowtext">Chemical </FONT>Bank Board of
Directors (the &ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical Bank Continuing Directors</I></B></FONT>&rdquo;) shall continue
in office and shall serve on the <FONT STYLE="color: windowtext">Board of Directors </FONT>of the Surviving Bank <FONT STYLE="color: windowtext">until
such time as their successors are duly elected and qualified</FONT>. As of the <FONT STYLE="color: windowtext">effective time </FONT>of
the <FONT STYLE="color: windowtext">Bank Merger</FONT>, the <FONT STYLE="color: windowtext">Chemical Bank Continuing Directors
</FONT>shall immediately appoint <FONT STYLE="color: windowtext">two individuals mutually agreed upon by the Parties </FONT>to
serve on the <FONT STYLE="color: windowtext">Board of Directors </FONT>of the Surviving Bank <FONT STYLE="color: windowtext">until
such time as their successors are duly elected and qualified</FONT>. The <FONT STYLE="color: windowtext">Board of Directors </FONT>of
the Surviving Bank (or the appropriate committee thereof) shall cause those two individuals to be nominated for election at the
2017 annual meeting of the shareholder of the <FONT STYLE="color: windowtext">Surviving Bank</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Effective as of the <FONT STYLE="color: windowtext">Effective Time (and, with respect to positions with the Surviving Bank,
effective as of the effective time of the Bank Merger)</FONT>, (i) David Ramaker shall continue as Chief Executive Officer of the
<FONT STYLE="color: windowtext">Surviving Corporation </FONT>and Chairman, Chief Executive Officer, and President of the Surviving
Bank; (ii) Gary Torgow shall become and serve as Chairman of the Surviving Corporation; (iii) David Provost shall become and serve
as a consultant to the <FONT STYLE="color: windowtext">Surviving Corporation </FONT>and a member of the Board of Directors of the
Surviving Corporation; (iv) <FONT STYLE="color: windowtext">Lori Gwizdala </FONT>shall continue as the Chief Financial Officer
of the Surviving Corporation and the Surviving Bank; (v) Dennis Klaeser shall become and serve as a consultant to the Surviving
Corporation and the Surviving Bank; and (vi) Thomas Shafer shall become and serve as Executive Vice President of the Surviving
Bank. Dennis Klaeser shall continue to serve as the Chief Financial Officer of <FONT STYLE="color: windowtext">Talmer Bank </FONT>until
the <FONT STYLE="color: windowtext">effective time </FONT>of the <FONT STYLE="color: windowtext">Bank Merger</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On the date hereof, each of Gary Torgow, David Provost, and Dennis Klaeser shall enter into a mutually acceptable
services agreement with the Surviving Corporation and Talmer Bank, which shall become effective at the Effective Time. In addition,
prior to the Effective Time, Thomas Shafer shall enter into a mutually acceptable employment agreement with the Surviving Bank, which shall become effective at the effective time
of the Bank Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">71</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Restructuring
Efforts</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">If either Talmer or Chemical shall have failed to obtain
the requisite vote or votes of the Talmer Shareholders or the Chemical Shareholders, respectively, for the consummation of the
transactions contemplated by this Agreement at a duly held shareholders&rsquo; meeting or at any adjournment thereof, then, unless
this Agreement shall have been terminated pursuant to its terms, each of the Parties shall in good faith use its commercially reasonable
efforts to negotiate a restructuring of the transaction provided for herein (it being understood that neither Party shall have
any obligation to alter or change the amount or kind of the Merger Consideration in a manner adverse to such Party or its shareholders)
and to resubmit the transaction to its shareholders for approval, with the timing of such resubmission to be determined at the
request of the other Party.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exemption
from <FONT STYLE="color: windowtext">Liability </FONT>Under Section 16(b)</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to the Effective Time, Talmer and Chemical each shall take all such steps as may be required to cause (a) any dispositions of Talmer
Common Stock (including derivative securities with respect to Talmer Common Stock, options and other stock-based awards) resulting
from the Merger and the other transactions contemplated by this Agreement, by each individual who will be subject to the reporting
requirements of Section 16(a) of the Exchange Act with respect to Talmer immediately prior to the Effective Time, to be exempt
under Rule 16b-3 promulgated under the Exchange Act and (b) any acquisitions or dispositions of Chemical Common Stock (including
derivative securities with respect to Chemical Common Stock, options and other stock-based awards) resulting from the Merger and
the other transactions contemplated by this Agreement, by each individual who may become or is reasonably expected to become subject
to the reporting requirements of Section 16(a) of the Exchange Act with respect to Chemical immediately following the Effective
Time, to be exempt under Rule 16b-3 promulgated under the Exchange Act.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Trust Preferred Securities;
Senior Debt Facility</U>.<FONT STYLE="font-family: Times New Roman, Times, Serif"> At the Effective Time, the Surviving Corporation
shall assume (a)&nbsp;the obligations of Talmer to make all payments of the principal and interest on all of the debt securities
issued to First Place Capital Trust, First Place Capital Trust II, First Place Capital Trust III, and First of Huron Capital Trust
I (collectively, the &ldquo;<B><I>Capital Trusts</I></B>&rdquo;), and (b)&nbsp;the performance and observance of all covenants
and conditions to be performed or observed by Talmer under indentures held by or for the benefit of the Capital Trusts. In connection
therewith, the Surviving Corporation shall execute and deliver such supplemental indentures as are required to make such assumptions
effective, all in a form reasonably acceptable to the Surviving Corporation. The parties hereto shall provide such opinions of
counsel and officer&rsquo;s certificates to the trustees of the Capital Trusts for such assumptions in a form reasonably acceptable
to the Parties. The Parties also agree to use commercially reasonable efforts to cooperate with U.S. Bank National Association
in an attempt to obtain its consent for Chemical to retain Talmer&rsquo;s current senior unsecured revolving credit facility with
U.S. Bank National Association following the Merger. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Data Conversion</U>.
The Parties intend to convert their respective information and data onto a common information technology system (the &ldquo;<B><I>Data
Conversion</I></B>&rdquo;). The Parties agree to use all commercially reasonable efforts to promptly commence preparations for
implementation of the Data Conversion, with the goal of effecting the Data Conversion after the Effective Time and at such later
time as mutually agreed upon by the Parties. The Parties agree to cooperate in preparing for the Data Conversion, including by
providing reasonable access to </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">72</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">data, information systems, and personnel having expertise with their and their respective Subsidiaries&rsquo;
information and data systems; <I>provided, however</I>, that neither Party shall be required to terminate any third-party service
provider arrangements prior to the Effective Time. In the event that either Party takes, at the request of the other Party, any
action relative to third parties to facilitate the Data Conversion that results in the imposition of any termination fees or other
charges or expenses, the Party that requested such action shall indemnify the other Party for all such fees, charges and expenses,
and the costs of reversing the Data Conversion process, if the Merger is not consummated for any reason, other than the breach
of this Agreement by the party otherwise entitled to indemnification under this <U>Section 6.15</U> or the termination by Talmer
under <U>Section 8.1(i)</U> (in the case of Talmer being otherwise entitled to indemnification under this <U>Section 6.15</U>)
or by Chemical under <U>Section 8.1(j)</U> (in the case of Chemical being otherwise entitled to indemnification under this <U>Section
6.15</U>).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">6.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Commercially
Reasonable Efforts; Cooperation</U>.<FONT STYLE="font-family: Times New Roman, Times, Serif"> Each of Chemical and Talmer agrees
to exercise good faith and use its commercially reasonable efforts to satisfy the various covenants and conditions to Closing in
this Agreement, and to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper, or advisable
on its part under this Agreement and applicable Law to consummate and make effective the Merger and the other transactions contemplated
by this Agreement as soon as reasonably practicable, including preparing and filing as promptly as practicable all documentation
to effect all necessary notices, reports, and other filings, and to obtain as promptly as reasonably practicable all consents,
registrations, approvals, permits, and authorizations necessary or advisable to be obtained from any Governmental Entity or other
third party in order to consummate the Merger or any of the other transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securityholder Litigation</U>.
Each Party shall keep the other Party reasonably informed with respect to the defense or settlement of any securityholder Action
against it or its directors or officers relating to the Merger or the other transactions contemplated by this Agreement. Each Party
shall give the other Party the opportunity to consult with it regarding the defense or settlement of any such securityholder Action
and shall not settle any such Action without the other Party&rsquo;s prior written consent (such consent not to be unreasonably
withheld, conditioned or delayed).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. Whether
or not the Merger is consummated, except as otherwise provided in this Agreement, all costs and expenses incurred in connection
with this Agreement and the transactions contemplated by this Agreement shall be paid by the party incurring such expenses, except
that Talmer and Chemical shall each pay and bear one-half of (a)&nbsp;each regulatory filing, notification, registration or similar
fee required to be paid by any party in connection with this Agreement and the transactions contemplated by this Agreement under
the Securities Act, the Exchange Act, applicable banking Laws and other applicable Laws and (b) any fees and expenses (excluding
each Party&rsquo;s internal costs and fees and expenses of attorneys, accountants and financial and other advisors) incurred in
respect of printing, filing and mailing of the Registration Statement and Proxy Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fairness Opinions</U>.
Talmer will use commercially reasonable efforts to provide Chemical with a copy of the written fairness opinion
referred to in <U>Section 3.23</U> solely for informational purposes within ten (10) Business Days of the date of this Agreement.
Chemical </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">73</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">will use commercially reasonable efforts to provide Talmer with a copy of the written fairness opinion referred to in
<U>Section 4.23</U> solely for informational purposes within ten (10) Business Days of the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends</U>. Talmer
and Chemical shall coordinate with each other regarding the declaration, setting of record dates, and payment dates of dividends
with respect to shares of Talmer Common Stock and Chemical Common Stock for the purpose of minimizing the risk that holders of
shares of Talmer Common Stock (a) in respect of any calendar quarter, receive dividends on both shares of Talmer Common Stock and
shares of Chemical Common Stock received as Merger Consideration, or (b) in respect of any calendar quarter, fail to receive a
dividend on shares of Talmer Common Stock or shares of Chemical Common Stock received as Merger Consideration.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
VII</FONT><BR>
CONDITIONS PRECEDENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions
to Each <FONT STYLE="color: windowtext">Party</FONT>&rsquo;s Obligation To Effect the <FONT STYLE="color: windowtext">Merger</FONT></U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">The respective obligations of the Parties to effect the Merger shall be
subject to the satisfaction at or before the Effective Time of the following conditions:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Shareholder
Approvals</U>. The <FONT STYLE="color: windowtext">Chemical Shareholder Approval </FONT>and the <FONT STYLE="color: windowtext">Talmer
Shareholder Approval </FONT>shall have been obtained by the requisite affirmative votes of <FONT STYLE="color: windowtext">Chemical
Shareholders </FONT>and <FONT STYLE="color: windowtext">Talmer Shareholders </FONT>entitled to vote thereon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>The
<FONT STYLE="color: windowtext">NASDAQ </FONT>Listing</U>. The shares of <FONT STYLE="color: windowtext">Chemical Common Stock
</FONT>to be issued to the holders of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>upon consummation of the <FONT STYLE="color: windowtext">Merger
</FONT>shall have been authorized for listing on <FONT STYLE="color: windowtext">NASDAQ </FONT>(or such other national securities
exchange mutually agreed upon by the <FONT STYLE="color: windowtext">Parties</FONT>).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Form
S-4</U></FONT>. The <FONT STYLE="color: windowtext">Form S-4 </FONT>shall have become effective under the <FONT STYLE="color: windowtext">Securities
Act</FONT>, no stop <FONT STYLE="color: windowtext">order </FONT>suspending the effectiveness of the <FONT STYLE="color: windowtext">Form
S-4 </FONT>shall have been issued, and no proceedings for that purpose shall have been initiated or threatened by the <FONT STYLE="color: windowtext">SEC</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
<FONT STYLE="color: windowtext">Injunctions </FONT>or Restraints; Illegality</U>. No <FONT STYLE="color: windowtext">order</FONT>,
<FONT STYLE="color: windowtext">injunction </FONT>or decree issued by any court or agency of competent jurisdiction or other legal
restraint or prohibition (an &ldquo;<FONT STYLE="color: windowtext"><B><I>Injunction</I></B></FONT>&rdquo;) preventing the consummation
of the <FONT STYLE="color: windowtext">Merger </FONT>or any of the other transactions contemplated by this <FONT STYLE="color: windowtext">Agreement
</FONT>shall be in effect. No statute, rule, regulation, <FONT STYLE="color: windowtext">order</FONT>, or decree shall have been
enacted, entered, promulgated, or enforced by any <FONT STYLE="color: windowtext">Governmental Entity </FONT>that prohibits or
makes illegal the consummation of the <FONT STYLE="color: windowtext">Merger</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Approvals</U></FONT>. All <FONT STYLE="color: windowtext">Regulatory Approvals (excluding the Regulatory Approvals applicable solely
to the Bank Merger) </FONT>shall have been obtained and shall remain in full force and effect, all statutory notice and waiting
periods in respect thereof shall have expired, and no such <FONT STYLE="color: windowtext">Regulatory Approval </FONT>shall have
resulted in the imposition of any <FONT STYLE="color: windowtext">Materially Burdensome Regulatory Condition</FONT>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">74</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions
to Obligations of <FONT STYLE="color: windowtext">Talmer</FONT></U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">The
obligation of Talmer to effect the Merger is also subject to the satisfaction (or waiver by Talmer), at or before the Effective
Time, of the following conditions:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations
and Warranties</U>. (i) The representations and warranties of <FONT STYLE="color: windowtext">Chemical </FONT>set forth in this
<FONT STYLE="color: windowtext">Agreement (other than <U>Sections 4.1(a)</U>, <U>4.2</U>, <U>4.4</U>, and <U>4.6</U>) </FONT>shall
be true and correct (without giving effect to any limitation as to &ldquo;materiality&rdquo; or &ldquo;<FONT STYLE="color: windowtext">Material
Adverse Effect</FONT>&rdquo; contained therein) as of the date of this <FONT STYLE="color: windowtext">Agreement </FONT>and as
of the <FONT STYLE="color: windowtext">Effective Time </FONT>as though made on and as of the <FONT STYLE="color: windowtext">Effective
Time </FONT>(except that representations and warranties that by their terms speak specifically as of the date of this <FONT STYLE="color: windowtext">Agreement
</FONT>or another date shall be true and correct as of such date), except where the failure of such representations and warranties
to be so true and correct <FONT STYLE="color: windowtext">does not have, and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Chemical</FONT>; and (ii) the representations and warranties of <FONT STYLE="color: windowtext">Chemical
</FONT>set forth in <FONT STYLE="color: windowtext"><U>Sections 4.1(a)</U>, <U>4.2</U>, <U>4.4</U>, and <U>4.6</U> shall be true
and correct as of the date of this Agreement and the Effective Time as though made on and as of the Effective Time </FONT>(except
that representations and warranties that by their terms speak specifically as of the date of this <FONT STYLE="color: windowtext">Agreement
</FONT>or another date shall be true and correct as of such date) in all material respects.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Performance
of Obligations of <FONT STYLE="color: windowtext">Chemical</FONT></U>. <FONT STYLE="color: windowtext">Chemical </FONT>shall have
performed in all material respects the obligations required to be performed by it under this <FONT STYLE="color: windowtext">Agreement
</FONT>at or before the <FONT STYLE="color: windowtext">Effective Time</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Officer&rsquo;s Certificate</U>.
Chemical shall have delivered to Talmer a certificate, dated as of the Closing Date and signed on behalf of Chemical by its Chief
Executive Officer or Chief Financial Officer certifying to the effect that the conditions set forth in <U>Sections 7.2(a)</U> and
<U>7.2(b)</U> have been satisfied.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Adverse Effect</U>.
Since September 30, 2015, there shall not have been any change, state of facts, event, development or effect that has had, or would
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Chemical.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Federal
Tax Opinion</U>. Talmer shall have received the opinion of its counsel, Nelson Mullins Riley &amp; Scarborough LLP, in form and
substance customary in transactions of the type contemplated hereby, dated as of the Closing Date, substantially to the effect
that, on the basis of facts, representations, and assumptions set forth in such opinion that are consistent with the state of facts
existing at the Effective Time, (i) the Merger will be treated as a reorganization within the meaning of Section 368(a) of the
Code and (ii) Talmer and Chemical will each be a party to that reorganization within the meaning of Section 368(b) of the Code.
In rendering such opinion, counsel may require and rely upon customary representations contained in certificates of officers of
Chemical and Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions
to Obligations of <FONT STYLE="color: windowtext">Chemical</FONT></U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">The
obligation of Chemical to effect the Merger is also subject to the satisfaction (or waiver by Chemical) at or before the Effective
Time of the following conditions:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">75</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations
and Warranties</U>. (i) The representations and warranties of <FONT STYLE="color: windowtext">Talmer </FONT>set forth in this <FONT STYLE="color: windowtext">Agreement
(other than <U>Sections 3.1(a)</U>, <U>3.2</U>, <U>3.4</U>, and <U>3.6</U>) </FONT>shall be true and correct (without giving effect
to any limitation as to &ldquo;materiality&rdquo; or &ldquo;<FONT STYLE="color: windowtext">Material Adverse Effect</FONT>&rdquo;
contained therein) as of the date of this <FONT STYLE="color: windowtext">Agreement </FONT>and as of the <FONT STYLE="color: windowtext">Effective
Time </FONT>as though made on and as of the <FONT STYLE="color: windowtext">Effective Time </FONT>(except that representations
and warranties that by their terms speak specifically as of the date of this <FONT STYLE="color: windowtext">Agreement </FONT>or
another date shall be true and correct as of such date), except where the failure of such representations and warranties to be
so true and correct <FONT STYLE="color: windowtext">does not have, and would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect on Talmer</FONT>; and (ii) the representations and warranties of <FONT STYLE="color: windowtext">Talmer
</FONT>set forth in <FONT STYLE="color: windowtext"><U>Sections 3.1(a)</U>, <U>3.2</U>, <U>3.4</U>, and <U>3.6</U> shall be true
and correct as of the date of this Agreement and the Effective Time as though made on and as of the Effective Time </FONT>(except
that representations and warranties that by their terms speak specifically as of the date of this <FONT STYLE="color: windowtext">Agreement
</FONT>or another date shall be true and correct as of such date) in all material respects.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Performance
of Obligations of <FONT STYLE="color: windowtext">Talmer</FONT></U>. <FONT STYLE="color: windowtext">Talmer </FONT>shall have performed
in all material respects the obligations required to be performed by it under this <FONT STYLE="color: windowtext">Agreement </FONT>at
or before the <FONT STYLE="color: windowtext">Effective Time</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Officer&rsquo;s Certificate</U>.
Talmer shall have delivered to Chemical a certificate, dated as of the Closing Date and signed on behalf of Talmer by its Chief
Executive Officer or Chief Financial Officer certifying to the effect that the conditions set forth in <U>Sections 7.3(a)</U> and
<U>7.3(b)</U> have been satisfied.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Adverse Effect</U>.
Since September 30, 2015, there shall not have been any change, state of facts, event, development or effect that has had, or would
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Federal
Tax Opinion</U>. Chemical shall have received the opinion of its counsel, Warner Norcross &amp; Judd LLP, in form and substance
customary in transactions of the type contemplated hereby, dated as of the Closing Date, substantially to the effect that, on the
basis of facts, representations, and assumptions set forth in such opinion that are consistent with the state of facts existing
at the Effective Time, (i) the Merger will be treated as a reorganization within the meaning of Section 368(a) of the Code and
(ii) Talmer and Chemical will each be a party to that reorganization within the meaning of Section 368(b) of the Code. In rendering
such opinion, counsel may require and rely upon customary representations contained in certificates of officers of Chemical and
Talmer.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase; color: windowtext">Article
VIII</FONT><BR>
TERMINATION AND AMENDMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding anything contained in this Agreement to the contrary,
this Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time, whether before or, subject
to the terms of this Agreement, after receipt of the Chemical Shareholder Approval or the Talmer Shareholder Approval, as follows:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
mutual written consent of <FONT STYLE="color: windowtext">Chemical </FONT>and <FONT STYLE="color: windowtext">Talmer</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">76</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
either <FONT STYLE="color: windowtext">Chemical </FONT>or <FONT STYLE="color: windowtext">Talmer</FONT>, if any <FONT STYLE="color: windowtext">Governmental
Entity </FONT>has issued an <FONT STYLE="color: windowtext">order </FONT>or taken any other <FONT STYLE="color: windowtext">action
</FONT>permanently enjoining, restraining, or otherwise prohibiting the consummation of the <FONT STYLE="color: windowtext">Merger</FONT>,
and such <FONT STYLE="color: windowtext">order </FONT>or other <FONT STYLE="color: windowtext">action </FONT>is final and nonappealable.
The right to terminate this <FONT STYLE="color: windowtext">Agreement </FONT>pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.1(b)</FONT></U><FONT STYLE="color: windowtext">
</FONT>shall not be available to the <FONT STYLE="color: windowtext">Party </FONT>seeking to terminate if the failure of such <FONT STYLE="color: windowtext">Party
</FONT>to perform any of its obligations under this <FONT STYLE="color: windowtext">Agreement </FONT>required to be performed at
or prior to the <FONT STYLE="color: windowtext">Effective Time </FONT>has been a substantial cause of, or a substantial factor
that resulted in, the issuance of such an <FONT STYLE="color: windowtext">order </FONT>or the taking of such an <FONT STYLE="color: windowtext">action</FONT>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
either <FONT STYLE="color: windowtext">Chemical </FONT>or <FONT STYLE="color: windowtext">Talmer, </FONT>if the <FONT STYLE="color: windowtext">Merger
</FONT>does not occur on or before <FONT STYLE="color: windowtext">December 31, 2016 </FONT>(the &ldquo;<FONT STYLE="color: windowtext"><B><I>End
Date</I></B></FONT>&rdquo;); <I>provided,</I> <I>however</I>, that (i) the <FONT STYLE="color: windowtext">End Date </FONT>may
be extended by mutual written consent of the <FONT STYLE="color: windowtext">Parties, </FONT>and (ii) if on the <FONT STYLE="color: windowtext">End
Date</FONT>, any of the conditions to <FONT STYLE="color: windowtext">Closing </FONT>set forth in <U>Sections <FONT STYLE="color: windowtext">7.1(c)</FONT></U><FONT STYLE="color: windowtext">
</FONT>or <U>7.1(e)</U> shall not have been satisfied but all other conditions to <FONT STYLE="color: windowtext">Closing </FONT>set
forth in <U>Article <FONT STYLE="color: windowtext">VII</FONT></U><FONT STYLE="color: windowtext"> </FONT>shall be satisfied or
capable of being satisfied, then the <FONT STYLE="color: windowtext">End Date </FONT>shall be extended to February 28, 2017 if
either <FONT STYLE="color: windowtext">Party </FONT>notifies the other <FONT STYLE="color: windowtext">Party </FONT>in writing
on or prior to the <FONT STYLE="color: windowtext">End Date </FONT>of its election to extend the <FONT STYLE="color: windowtext">End
Date</FONT>; <I>provided</I>,<I> further</I>, that the right to extend the <FONT STYLE="color: windowtext">End Date </FONT>and
the right to terminate this <FONT STYLE="color: windowtext">Agreement </FONT>pursuant to this <U>Section <FONT STYLE="color: windowtext">8.1(c)</FONT></U><FONT STYLE="color: windowtext">
</FONT>shall not be available to the <FONT STYLE="color: windowtext">Party </FONT>seeking to extend or terminate if the failure
of such <FONT STYLE="color: windowtext">Party </FONT>to perform any of its obligations under this <FONT STYLE="color: windowtext">Agreement
</FONT>required to be performed at or prior to the <FONT STYLE="color: windowtext">Effective Time </FONT>has been a substantial
cause of, or a substantial factor that resulted in, the failure of the <FONT STYLE="color: windowtext">Effective Time </FONT>to
occur on or before the <FONT STYLE="color: windowtext">End Date;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
either <FONT STYLE="color: windowtext">Chemical </FONT>or <FONT STYLE="color: windowtext">Talmer, </FONT>if <FONT STYLE="color: windowtext">(i)
</FONT>the <FONT STYLE="color: windowtext">Chemical Shareholder Meeting </FONT>(<FONT STYLE="color: windowtext">including </FONT>any
adjournments thereof) shall have concluded and been finally adjourned and the <FONT STYLE="color: windowtext">Chemical Shareholder
Approval </FONT>shall not have been obtained or <FONT STYLE="color: windowtext">(ii) </FONT>the <FONT STYLE="color: windowtext">Talmer
Shareholder Meeting </FONT>(<FONT STYLE="color: windowtext">including </FONT>any adjournments) shall have concluded and been finally
adjourned and the <FONT STYLE="color: windowtext">Talmer Shareholder Approval </FONT>shall not have been obtained. The right to
terminate this <FONT STYLE="color: windowtext">Agreement </FONT>pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.1(d)</FONT></U><FONT STYLE="color: windowtext">
</FONT>shall not be available to the <FONT STYLE="color: windowtext">Party </FONT>seeking to terminate if the failure of such <FONT STYLE="color: windowtext">Party
</FONT>to perform any of its obligations under this <FONT STYLE="color: windowtext">Agreement </FONT>required to be performed at
or prior to the <FONT STYLE="color: windowtext">Chemical Shareholder Meeting </FONT>or the <FONT STYLE="color: windowtext">Talmer
Shareholder Meeting</FONT>, as applicable, has been a substantial cause of, or a substantial factor that resulted in, the <FONT STYLE="color: windowtext">Chemical
Shareholder Approval </FONT>or the <FONT STYLE="color: windowtext">Talmer Shareholder Approval</FONT>, as applicable, not having
been obtained;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
<FONT STYLE="color: windowtext">Talmer</FONT>, if <FONT STYLE="color: windowtext">Chemical </FONT>shall have breached or failed
to perform any of its representations, warranties, covenants, or other agreements contained in this <FONT STYLE="color: windowtext">Agreement</FONT>,
which breach or failure to perform (i)&nbsp;would result in a failure of a condition set forth in <U>Section&nbsp;<FONT STYLE="color: windowtext">7.1</FONT></U><FONT STYLE="color: windowtext">
</FONT>or <U>Section <FONT STYLE="color: windowtext">7.2</FONT></U><FONT STYLE="color: windowtext"> </FONT>and (ii)(A)&nbsp;cannot
be cured by the <FONT STYLE="color: windowtext">End Date </FONT>or <FONT STYLE="color: windowtext">(B)&nbsp;</FONT>if capable of
being cured by the <FONT STYLE="color: windowtext">End Date</FONT>, shall not have been cured within thirty (30)&nbsp;<FONT STYLE="color: windowtext">Business
Days </FONT>following receipt of written notice (which notice shall specify in reasonable detail the nature of such breach or failure
and <FONT STYLE="color: windowtext">Talmer</FONT>&rsquo;s intention to terminate this <FONT STYLE="color: windowtext">Agreement
</FONT>if such breach or failure is not cured) from <FONT STYLE="color: windowtext">Talmer </FONT>of such breach or failure; <I>provided</I>,
that <FONT STYLE="color: windowtext">Talmer </FONT>shall not have a right to terminate this <FONT STYLE="color: windowtext">Agreement
</FONT>pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.1(e)</FONT></U><FONT STYLE="color: windowtext"> </FONT>if
it is then in breach of any representation, warranty, covenant, or other <FONT STYLE="color: windowtext">agreement </FONT>contained
in this <FONT STYLE="color: windowtext">Agreement </FONT>that would result in a failure of a condition set forth in <U>Section&nbsp;<FONT STYLE="color: windowtext">7.1</FONT></U><FONT STYLE="color: windowtext">
</FONT>or <U>Section <FONT STYLE="color: windowtext">7.3</FONT></U>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">77</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
<FONT STYLE="color: windowtext">Chemical</FONT>, if <FONT STYLE="color: windowtext">Talmer </FONT>shall have breached or failed
to perform any of its representations, warranties, covenants, or other agreements contained in this <FONT STYLE="color: windowtext">Agreement</FONT>,
which breach or failure to perform (i)&nbsp;would result in a failure of a condition set forth in <U>Section&nbsp;<FONT STYLE="color: windowtext">7.1</FONT></U><FONT STYLE="color: windowtext">
</FONT>or <U>Section <FONT STYLE="color: windowtext">7.3</FONT></U><FONT STYLE="color: windowtext"> </FONT>and (ii)(A)&nbsp;cannot
be cured by the <FONT STYLE="color: windowtext">End Date</FONT>, or <FONT STYLE="color: windowtext">(B)&nbsp;</FONT>if capable
of being cured by the <FONT STYLE="color: windowtext">End Date</FONT>, shall not have been cured within thirty (30)&nbsp;<FONT STYLE="color: windowtext">Business
Days </FONT>following receipt of written notice (which notice shall specify in reasonable detail the nature of such breach or failure
and <FONT STYLE="color: windowtext">Chemical</FONT>&rsquo;s intention to terminate this <FONT STYLE="color: windowtext">Agreement
</FONT>if such breach or failure is not cured) from <FONT STYLE="color: windowtext">Chemical </FONT>of such breach or failure;
<I>provided</I>, that <FONT STYLE="color: windowtext">Chemical </FONT>shall not have a right to terminate this <FONT STYLE="color: windowtext">Agreement
</FONT>pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.1(f)</FONT></U><FONT STYLE="color: windowtext"> </FONT>if
it is then in breach of any representation, warranty, covenant, or other <FONT STYLE="color: windowtext">agreement </FONT>contained
in this <FONT STYLE="color: windowtext">Agreement </FONT>that would result in a failure of a condition set forth in <U>Section&nbsp;<FONT STYLE="color: windowtext">7.1</FONT></U><FONT STYLE="color: windowtext">
</FONT>or <U>Section <FONT STYLE="color: windowtext">7.2</FONT></U>;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
<FONT STYLE="color: windowtext">Talmer </FONT>prior to the receipt of the <FONT STYLE="color: windowtext">Chemical Shareholder
Approval </FONT>if (i)&nbsp;the <FONT STYLE="color: windowtext">Chemical Board </FONT>shall have effected a <FONT STYLE="color: windowtext">Chemical
Adverse Recommendation Change</FONT>; (ii)&nbsp;the <FONT STYLE="color: windowtext">Chemical Board </FONT>shall have failed to
reject a <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>and reaffirm the <FONT STYLE="color: windowtext">Chemical
Board Recommendation </FONT>within ten (10) <FONT STYLE="color: windowtext">Business Days </FONT>following the public announcement
of such <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>and in any event at least two (2) <FONT STYLE="color: windowtext">Business
Days </FONT>prior to the <FONT STYLE="color: windowtext">Chemical Shareholder Meeting</FONT>; (iii)&nbsp;<FONT STYLE="color: windowtext">Chemical
</FONT>enters into a Chemical Acquisition Agreement; (iv)&nbsp;<FONT STYLE="color: windowtext">Chemical </FONT>shall have materially
breached <U>Section <FONT STYLE="color: windowtext">6.10</FONT></U>; (v)&nbsp;subject to <FONT STYLE="color: windowtext">Chemical</FONT>&rsquo;s
rights to adjourn or postpone the <FONT STYLE="color: windowtext">Chemical Shareholder Meeting as permitted by <U>Section 6.3(f)</U></FONT>,
<FONT STYLE="color: windowtext">Chemical </FONT>shall have failed to call, give proper notice of, convene and hold the <FONT STYLE="color: windowtext">Chemical
Shareholder Meeting materially in accordance with <U>Section 6.3(e)</U></FONT>; or (vi)&nbsp;<FONT STYLE="color: windowtext">Chemical
</FONT>or the <FONT STYLE="color: windowtext">Chemical Board </FONT>shall have publicly announced its intention to do any of the
foregoing;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
<FONT STYLE="color: windowtext">Chemical </FONT>prior to the receipt of the <FONT STYLE="color: windowtext">Talmer Shareholder
Approval </FONT>if (i)&nbsp;the <FONT STYLE="color: windowtext">Talmer Board </FONT>shall have effected a <FONT STYLE="color: windowtext">Talmer
Adverse Recommendation Change</FONT>; (ii)&nbsp;the <FONT STYLE="color: windowtext">Talmer Board </FONT>shall have failed to reject
a <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>and reaffirm the <FONT STYLE="color: windowtext">Talmer Board
Recommendation </FONT>within ten (10) <FONT STYLE="color: windowtext">Business Days </FONT>following the public announcement of
such <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>and in any event at least two (2) <FONT STYLE="color: windowtext">Business
Days </FONT>prior to the <FONT STYLE="color: windowtext">Talmer Shareholder Meeting</FONT>; (iii)&nbsp;<FONT STYLE="color: windowtext">Talmer
</FONT>enters into a Talmer Acquisition Agreement; (iv)&nbsp;<FONT STYLE="color: windowtext">Talmer </FONT>shall have materially
breached <U>Section <FONT STYLE="color: windowtext">6.9</FONT></U>; (v)&nbsp;subject to <FONT STYLE="color: windowtext">Talmer</FONT>&rsquo;s
rights to adjourn or postpone the <FONT STYLE="color: windowtext">Talmer Shareholder Meeting as permitted by <U>Section 6.3(d)</U></FONT>,
<FONT STYLE="color: windowtext">Talmer </FONT>shall have failed to call, give proper notice of, convene, and hold the <FONT STYLE="color: windowtext">Talmer
Shareholder Meeting materially in accordance with <U>Section 6.3(c)</U></FONT>; or (vi)&nbsp;<FONT STYLE="color: windowtext">Talmer
</FONT>or the <FONT STYLE="color: windowtext">Talmer Board </FONT>shall have publicly announced its intention to do any of the
foregoing;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
<FONT STYLE="color: windowtext">Talmer </FONT>prior to receipt of the <FONT STYLE="color: windowtext">Talmer Shareholder Approval</FONT>,
in <FONT STYLE="color: windowtext">order </FONT>to enter into a definitive <FONT STYLE="color: windowtext">merger agreement </FONT>or
other definitive purchase or acquisition <FONT STYLE="color: windowtext">agreement </FONT>that constitutes a <FONT STYLE="color: windowtext">Talmer
Superior Proposal</FONT>; <I>provided</I>, <I>however</I>, that (i)&nbsp;<FONT STYLE="color: windowtext">Talmer </FONT>has complied
with <U>Section 6.9</U> in all material respects and (ii)&nbsp;<FONT STYLE="color: windowtext">Talmer </FONT>pays (or causes to
be paid) the <FONT STYLE="color: windowtext">Termination Fee </FONT>and <FONT STYLE="color: windowtext">Talmer Expense Reimbursement
</FONT>prior to or simultaneously with such termination; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
<FONT STYLE="color: windowtext">Chemical </FONT>prior to receipt of the <FONT STYLE="color: windowtext">Chemical Shareholder Approval</FONT>,
in <FONT STYLE="color: windowtext">order </FONT>to enter into a definitive <FONT STYLE="color: windowtext">merger agreement </FONT>or
other definitive purchase or acquisition <FONT STYLE="color: windowtext">agreement </FONT>that constitutes a <FONT STYLE="color: windowtext">Chemical
Superior Proposal</FONT>; <I>provided</I>, <I>however</I>, that (i)&nbsp;<FONT STYLE="color: windowtext">Chemical </FONT>has complied
with <U>Section 6.10</U> in all material respects and (ii)&nbsp;<FONT STYLE="color: windowtext">Chemical </FONT>pays (or causes
to be </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">78</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">paid) the <FONT STYLE="color: windowtext">Termination Fee </FONT>and <FONT STYLE="color: windowtext">Chemical Expense Reimbursement
</FONT>prior to or simultaneously with such termination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effect
of Termination</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In
the event that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Talmer pursuant to&nbsp;<U>Section&nbsp;8.1(g)</U>, Chemical shall pay, or cause to be paid, to Talmer
cash in an amount equal to $34,000,000 (the &ldquo;<B><I>Termination Fee</I></B>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Chemical pursuant to&nbsp;<U>Section&nbsp;8.1(h)</U>, Talmer shall pay, or cause to be paid, to Chemical
the Termination Fee;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Talmer pursuant to <U>Section 8.1(e)</U>, or by Talmer or Chemical pursuant to <U>Section 8.1(d)(i)</U>,
Chemical shall pay, or cause to be paid, to Talmer cash in an amount equal to the Talmer Expense Reimbursement, and if (A)&nbsp;any
Person or group of Persons shall have made (whether or not subsequently withdrawn) a Chemical Takeover Proposal after the date
of this Agreement and prior to (1)&nbsp;the date that this Agreement is terminated in the case of a termination pursuant to <U>Section
8.1(e)</U> or (2)&nbsp;the Chemical Shareholder Meeting in the case of a termination pursuant to <U>Section 8.1(d)(i)</U>, and
(B)&nbsp;at any time prior to the date that is 12 months after the date of any such termination, Chemical or any of its Subsidiaries
enters into any definitive agreement providing for a Chemical Takeover Proposal or consummates a Chemical Takeover Proposal <FONT STYLE="background-color: white">(<I>provided</I>&nbsp;that,
for purposes of this <U>Section 8.2(a)(iii)</U>, the references to &ldquo;ten percent (10%)&rdquo; in the definition of &ldquo;Chemical
Takeover Proposal&rdquo; shall be deemed to be references to &ldquo;fifty percent (50%)&rdquo;)</FONT>, then Chemical shall pay,
or cause to be paid, to Talmer cash in an amount equal to the Termination Fee <I>minus</I> the Talmer Expense Reimbursement (to
the extent such Talmer Expense Reimbursement has been previously paid to Talmer);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Chemical pursuant to <U>Section 8.1(f)</U>, or by Talmer or Chemical pursuant to <U>Section 8.1(d)(ii)</U>,
Talmer shall pay, or cause to be paid, to Chemical cash in an amount equal to the Chemical Expense Reimbursement, and if (A)&nbsp;any
Person or group of Persons shall have made (whether or not subsequently withdrawn) a Talmer Takeover Proposal after the date of
this Agreement and prior to (1)&nbsp;the date that this Agreement is terminated in the case of a termination pursuant to <U>Section
8.1(f)</U> or (2)&nbsp;the Talmer Shareholder Meeting in the case of a termination pursuant to <U>Section 8.1(d)(ii)</U>, and
(B)&nbsp;at any time prior to the date that is 12 months after the date of any such termination, Talmer or any of its Subsidiaries
enters into any definitive agreement providing for a Talmer Takeover Proposal or consummates a Talmer Takeover Proposal (<I>provided
</I>that, for <FONT STYLE="background-color: white">purposes of this <U>Section 8.2(a)(iv)</U>, the references to &ldquo;ten percent
(10%)&rdquo; in the definition of &ldquo;Talmer Takeover Proposal&rdquo; shall be deemed to be references to &ldquo;fifty percent
(50%)&rdquo;)</FONT>, then Talmer shall pay, or cause to be paid, to Chemical cash in an amount equal to the Termination Fee <I>minus
</I>the Chemical Expense Reimbursement (to the extent such Chemical Expense Reimbursement has been previously paid to Chemical);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">79</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
this Agreement is terminated by Talmer or Chemical pursuant to <U>Section 8.1(c)</U> (if the Chemical Shareholder Approval has
not theretofore been obtained), (B)&nbsp;any Person or group of Persons shall have made (whether or not subsequently withdrawn)
a Chemical Takeover Proposal after the date of this Agreement and prior to the date of any such termination, and (C)&nbsp;at any
time prior to the date that is 12 months after the date of any such termination, Chemical or any of its Subsidiaries enters into
any definitive agreement providing for a Chemical Takeover Proposal or consummates a Chemical Takeover Proposal (<I>provided</I>
that, for purposes of this <U>Section&nbsp;8.2(a)(v)</U>, the references to &ldquo;ten percent (10%)&rdquo; in the definition of
&ldquo;Chemical Takeover Proposal&rdquo; shall be deemed to be references to &ldquo;fifty percent (50%)&rdquo;), then Chemical
shall pay, or cause to be paid, to Talmer cash in an amount equal to the Termination Fee;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
this Agreement is terminated by Chemical or Talmer pursuant to <U>Section 8.1(c)</U> (if the Talmer Shareholder Approval has not
theretofore been obtained), (B)&nbsp;any Person or group of Persons shall have made (whether or not subsequently withdrawn) a Talmer
Takeover Proposal after the date of this Agreement and prior to the date of any such termination, and (C)&nbsp;at any time prior
to the date that is 12 months after the date of any such termination, Talmer or any of its Subsidiaries enters into any definitive
agreement providing for a Talmer Takeover Proposal or consummates a Talmer Takeover Proposal (<I>provided</I> that, for purposes
of this <U>Section&nbsp;8.2(a)(vi)</U>, the references to &ldquo;ten percent (10%)&rdquo; in the definition of &ldquo;Talmer Takeover
Proposal&rdquo; shall be deemed to be references to &ldquo;fifty percent (50%)&rdquo;), then Talmer shall pay, or cause to be paid,
to Chemical cash in an amount equal to the Termination Fee;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Talmer pursuant to <U>Section&nbsp;8.1(i)</U>, then Talmer shall pay, or cause to be paid, to Chemical,
prior to or contemporaneously with such termination, cash in an amount equal to the Termination Fee (and any purported termination
pursuant to <U>Section 8.1(i)</U> shall be void and of no force or effect unless and until Talmer shall have made such payment);
or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Chemical pursuant to <U>Section&nbsp;8.1(j)</U>, then Chemical shall pay, or cause to be paid, to Talmer,
prior to or contemporaneously with such termination, cash in an amount equal to the Termination Fee (and any purported termination
pursuant to <U>Section&nbsp;8.1(j)</U> shall be void and of no force or effect unless Chemical shall have made such payment).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
of the <FONT STYLE="color: windowtext">Parties </FONT>acknowledges and agrees that the agreements contained in this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.2</FONT></U><FONT STYLE="color: windowtext">
</FONT>are an integral part of the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>, and that
without these agreements, the other <FONT STYLE="color: windowtext">Party </FONT>would not enter into this <FONT STYLE="color: windowtext">Agreement</FONT>.
Accordingly, (i)&nbsp;if <FONT STYLE="color: windowtext">Talmer </FONT>fails to pay amounts due pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.2</FONT></U><FONT STYLE="color: windowtext">
</FONT>and, in <FONT STYLE="color: windowtext">order </FONT>to obtain such payment, <FONT STYLE="color: windowtext">Chemical </FONT>commences
a suit that results in a judgment against <FONT STYLE="color: windowtext">Talmer </FONT>for the <FONT STYLE="color: windowtext">Termination
Fee </FONT>or the <FONT STYLE="color: windowtext">Talmer Expense Reimbursement</FONT>, then <FONT STYLE="color: windowtext">Talmer
</FONT>shall pay <FONT STYLE="color: windowtext">Chemical </FONT>its costs and expenses (<FONT STYLE="color: windowtext">including
</FONT>reasonable attorneys&rsquo; fees and expenses) in connection with such suit, together with interest on the amount of the
<FONT STYLE="color: windowtext">Termination Fee </FONT>and the <FONT STYLE="color: windowtext">Chemical Expense Reimbursement</FONT>,
as applicable, from the date such payment was required to be made until the date of payment at the prime rate published in the
<FONT STYLE="color: windowtext"><I>Wall Street Journal</I> </FONT>on the date </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">80</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">such payment was required to be made and (ii)&nbsp;if
<FONT STYLE="color: windowtext">Chemical </FONT>fails to pay amounts due pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.2</FONT></U><FONT STYLE="color: windowtext">
</FONT>and, in <FONT STYLE="color: windowtext">order </FONT>to obtain such payment, <FONT STYLE="color: windowtext">Talmer </FONT>commences
a suit that results in a judgment against <FONT STYLE="color: windowtext">Chemical </FONT>for the <FONT STYLE="color: windowtext">Termination
Fee </FONT>or the <FONT STYLE="color: windowtext">Talmer Expense Reimbursement</FONT>, then <FONT STYLE="color: windowtext">Chemical
</FONT>shall pay <FONT STYLE="color: windowtext">Talmer </FONT>its costs and expenses (<FONT STYLE="color: windowtext">including
</FONT>reasonable attorneys&rsquo; fees and expenses) in connection with such suit, together with interest on the amount of the
<FONT STYLE="color: windowtext">Termination Fee </FONT>or the <FONT STYLE="color: windowtext">Talmer Expense Reimbursement</FONT>,
as applicable, from the date such payment was required to be made until the date of payment at the prime rate published in the
<I>Wall Street Journal</I> on the date such payment was required to be made.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>On
any termination of this <FONT STYLE="color: windowtext">Agreement </FONT>pursuant to <U>Section&nbsp;<FONT STYLE="color: windowtext">8.1</FONT></U>,
this <FONT STYLE="color: windowtext">Agreement </FONT>shall terminate and forthwith become void and have no further force or effect
(except for the provisions of <U>Section <FONT STYLE="color: windowtext">6.2(b)</FONT></U>, <U>Section <FONT STYLE="color: windowtext">6.18</FONT></U>,
<U>Section <FONT STYLE="color: windowtext">8.2</FONT></U>, and <U>Article <FONT STYLE="color: windowtext">X</FONT></U><FONT STYLE="color: windowtext">)</FONT>,
and, subject to the payment of any amounts owing pursuant to this <U>Section&nbsp;<FONT STYLE="color: windowtext">8.2</FONT></U>,
there shall be no other <FONT STYLE="color: windowtext">liability </FONT>on the part of <FONT STYLE="color: windowtext">Chemical
</FONT>or <FONT STYLE="color: windowtext">Talmer </FONT>to the other. Notwithstanding anything in this <FONT STYLE="color: windowtext">Agreement
</FONT>to the contrary, no <FONT STYLE="color: windowtext">Party </FONT>hereto will be relieved or released from any <FONT STYLE="color: windowtext">liability
</FONT>or damages arising from a willful or intentional breach of any provision of this <FONT STYLE="color: windowtext">Agreement
</FONT>or fraud, and the aggrieved <FONT STYLE="color: windowtext">Party </FONT>will be entitled to all rights and remedies available
at <FONT STYLE="color: windowtext">law </FONT>or in equity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any
<FONT STYLE="color: windowtext">Termination Fee </FONT>or <FONT STYLE="color: windowtext">Chemical Expense Reimbursement</FONT>,
as applicable, that is owed by <FONT STYLE="color: windowtext">Talmer </FONT>pursuant to <U>Section <FONT STYLE="color: windowtext">8.2(a)
</FONT></U>will be paid in the aggregate to <FONT STYLE="color: windowtext">Chemical </FONT>by or at the direction of <FONT STYLE="color: windowtext">Talmer
</FONT>in immediately available funds upon the occurrence of the event giving rise to the obligation to make such payment. Any
<FONT STYLE="color: windowtext">Termination Fee </FONT>or <FONT STYLE="color: windowtext">Talmer Expense Reimbursement</FONT>,
as applicable, that is owed by <FONT STYLE="color: windowtext">Chemical </FONT>pursuant to <U>Section <FONT STYLE="color: windowtext">8.2(a)</FONT></U><FONT STYLE="color: windowtext">
</FONT>will be paid in the aggregate to <FONT STYLE="color: windowtext">Talmer </FONT>by or at the direction of <FONT STYLE="color: windowtext">Chemical
</FONT>in immediately available funds upon the occurrence of the event giving rise to the obligation to make such payment. For
the avoidance of doubt, (i) in no event shall <FONT STYLE="color: windowtext">Chemical </FONT>be required to pay the <FONT STYLE="color: windowtext">Termination
Fee </FONT>or the <FONT STYLE="color: windowtext">Talmer Expense Reimbursement </FONT>on more than one occasion; and (ii) in no
event shall <FONT STYLE="color: windowtext">Talmer </FONT>be required to pay the <FONT STYLE="color: windowtext">Termination Fee
</FONT>or the <FONT STYLE="color: windowtext">Chemical Expense Reimbursement </FONT>on more than one occasion.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendment</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif; color: black">This </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreement
<FONT STYLE="color: black">may be amended by the </FONT>Parties<FONT STYLE="color: black">, by </FONT>action <FONT STYLE="color: black">taken
or authorized, in the case of </FONT>Talmer<FONT STYLE="color: black">, by the </FONT>Talmer Board <FONT STYLE="color: black">and,
in the case of </FONT>Chemical<FONT STYLE="color: black">, by the </FONT>Chemical Board<FONT STYLE="color: black">, at any time
before or after the receipt of the </FONT>Talmer Shareholder Approval <FONT STYLE="color: black">or the </FONT>Chemical Shareholder
Approval<FONT STYLE="color: black">; <I>provided, however</I>, that after receipt of any such shareholder approval, no amendment
shall be made which by </FONT>Law <FONT STYLE="color: black">or in accordance with the rules of any relevant stock exchange requires
further approval by the </FONT>Talmer Shareholders <FONT STYLE="color: black">or the </FONT>Chemical Shareholders<FONT STYLE="color: black">,
as applicable, without such further approval. This </FONT>Agreement <FONT STYLE="color: black">may not be amended except by an
instrument in writing signed on behalf of </FONT>Talmer <FONT STYLE="color: black">and </FONT>Chemical<FONT STYLE="color: black">.</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Extension;
Waiver</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">At any time before the Effective Time, the Parties, by action
taken or authorized by their respective Boards of Directors, may, to the extent legally allowed, (a) extend the time for the performance
of any of the obligations or other acts of the other Party, (b) waive any inaccuracies in the representations and warranties contained
in this Agreement, or (c) waive compliance with any of the agreements or conditions contained in this Agreement. Any agreement
on the part of a Party to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf
of such Party, but such extension or waiver or failure to insist on strict compliance with an obligation, </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">81</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">covenant, agreement or
condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure.</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
IX</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">DEFINITIONS</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As used in this
Agreement, the following terms shall have the following meanings. Unless context otherwise requires, references to Articles and
Sections shall refer to Articles and Sections of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Acceptable
Chemical Confidentiality Agreement</I></B></FONT>&rdquo; shall mean any <FONT STYLE="color: windowtext">confidentiality agreement
</FONT>or standstill <FONT STYLE="color: windowtext">agreement </FONT>that contains provisions with respect to confidentiality
matters that are no less favorable to <FONT STYLE="color: windowtext">Talmer </FONT>than those contained in the <FONT STYLE="color: windowtext">Confidentiality
Agreement and that complies with <U>Section 6.10(c)</U> hereof</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Acceptable
Talmer Confidentiality Agreement</I></B></FONT>&rdquo; shall mean any <FONT STYLE="color: windowtext">confidentiality agreement
</FONT>or standstill <FONT STYLE="color: windowtext">agreement </FONT>that contains provisions with respect to confidentiality
matters that are no less favorable to <FONT STYLE="color: windowtext">Talmer </FONT>than those contained in the <FONT STYLE="color: windowtext">Confidentiality
Agreement and that complies with <U>Section 6.9(c)</U> hereof</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Action</I></B>&rdquo;
shall mean (a) any litigation, claim, action, suit, hearing, proceeding or arbitration, (b) any material investigation by a Governmental
Entity or (c) any demand or notice of violation by a Governmental Entity (in the case of clauses (a), (b) and (c), whether civil,
criminal, administrative, labor or investigative).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Affiliate</I></B></FONT>&rdquo;
shall mean (unless otherwise specified), with respect to any <FONT STYLE="color: windowtext">Person</FONT>, any other <FONT STYLE="color: windowtext">Person
</FONT>that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common <FONT STYLE="color: windowtext">control
</FONT>with, such specified <FONT STYLE="color: windowtext">Person</FONT>, and &ldquo;<FONT STYLE="color: windowtext">control</FONT>,&rdquo;
with respect to the relationship between or among two or more <FONT STYLE="color: windowtext">Persons</FONT>, means the possession,
directly or indirectly, of the power to direct or cause the direction of the affairs or management of a <FONT STYLE="color: windowtext">Person</FONT>,
whether through the ownership of voting securities, as trustee or executor, by <FONT STYLE="color: windowtext">Contract</FONT>,
or by any other means.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Agreement</I></B>&rdquo;
shall have the meaning set forth in the <U>Preamble</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Bank
Merger</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.9</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Benefit
Plan</I></B>&rdquo; shall have the meaning set forth in <U>Section 10.10(b)</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>BHC
Act</I></B></FONT>&rdquo; shall mean the Bank Holding Company Act of 1956, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Business
Day</I></B></FONT>&rdquo; shall mean any day other than a Saturday, Sunday, or day on which banking institutions in the State of
Michigan are authorized or obligated pursuant to legal requirements or executive <FONT STYLE="color: windowtext">order </FONT>to
be closed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Cancelled
Talmer Stock Options</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Capital
Trusts</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.14</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">82</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Capitalization
Date</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.4</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Cash
Consideration</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.4(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Certificate
of Merger</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.2</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical</I></B>&rdquo;
shall have the meaning set forth in the <U>Preamble</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Acquisition Agreement</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.10(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Adverse Recommendation Change</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.10(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Articles</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.6</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Articles Amendment</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(e)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Bank</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Bank Continuing Directors</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.11(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Benefit Plans</I></B></FONT>&rdquo; shall mean (a) any &ldquo;<FONT STYLE="color: windowtext">employee benefit plan</FONT>&rdquo;
within the meaning of <FONT STYLE="color: windowtext">Section 3(3) of ERISA</FONT>, (b) any <FONT STYLE="color: windowtext">Chemical
Stock Plan</FONT>, and (c) any deferred compensation, retirement, defined contribution, defined benefit, pension, profit sharing,
employee welfare, fringe benefit, flexible spending account, stock purchase, stock option, stock ownership, phantom stock, stock
appreciation rights, restricted stock, restricted stock units, severance, separation, employment, change in <FONT STYLE="color: windowtext">control</FONT>,
vacation pay, leave of absence, layoff, salary continuation, sick leave, excess benefit, bonus or other incentive compensation,
day or dependent care, legal services, cafeteria, health, life, accident, disability, workers&rsquo; compensation or other insurance,
or other employee <FONT STYLE="color: windowtext">benefit plan</FONT>, or <FONT STYLE="color: windowtext">Contract</FONT>, program,
or practice, whether written or oral, for the benefit of <FONT STYLE="color: windowtext">Chemical</FONT>&rsquo;s current or former
officers, employees, independent contractors, or directors, in each case either (i) existing at the <FONT STYLE="color: windowtext">Closing
Date </FONT>and sponsored, maintained, or contributed to by <FONT STYLE="color: windowtext">Chemical </FONT>or any <FONT STYLE="color: windowtext">Chemical
Subsidiary</FONT>, or (ii) existing at the <FONT STYLE="color: windowtext">Closing Date </FONT>or prior thereto, in respect of
which <FONT STYLE="color: windowtext">Chemical </FONT>or any <FONT STYLE="color: windowtext">Chemical Subsidiary </FONT>has any
<FONT STYLE="color: windowtext">Liability</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Board</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Board Recommendation</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(e)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Bylaws</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.7</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Call Reports</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.5(b)(ii)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">83</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Capital Stock</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Chemical Common Stock </FONT>and the <FONT STYLE="color: windowtext">Chemical
Preferred Stock.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Certificates</I></B>&rdquo; shall have the meaning set forth in <U>Section 2.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Closing Price</I></B></FONT>&rdquo; shall mean the volume weighted average trading price on <FONT STYLE="color: windowtext">NASDAQ
</FONT>of <FONT STYLE="color: windowtext">Chemical Common Stock for the fifteen (15) full trading days ending on t</FONT>he second
trading day immediately preceding the <FONT STYLE="color: windowtext">Closing Date.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Common Stock</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.4(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Continuing Directors</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.11(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Disclosure Schedules</I></B>&rdquo; shall have the meaning set forth in <U>Article IV</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Expense Reimbursement</I></B>&rdquo; shall mean </FONT>the out-of-pocket fees and expenses (<FONT STYLE="color: windowtext">including
</FONT>fees and expenses of financial advisors, outside legal counsel, accountants, experts, consultants, and other <FONT STYLE="color: windowtext">Representatives</FONT>)
actually incurred by or on behalf of <FONT STYLE="color: windowtext">Chemical </FONT>in connection with the authorization, preparation,
negotiation, execution, or performance of this <FONT STYLE="color: windowtext">Agreement </FONT>and the transactions contemplated
by this <FONT STYLE="color: windowtext">Agreement </FONT>and the due diligence and evaluation by <FONT STYLE="color: windowtext">Chemical
</FONT>of the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>, in an aggregate amount not to
exceed $<FONT STYLE="color: windowtext">3,000,000</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Financial Statements</I></B>&rdquo;<B> </B>shall have the meaning set forth in <U>Section 4.5(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Investment Banker</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.22</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Material Contract</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.17(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical-Owned
Intellectual Property</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.15</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Preferred Stock</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.4(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical-Related
Person</I></B>&rdquo; shall mean any shareholder owning five percent (5%) or more of the issued and outstanding Chemical Common
Stock, any director or executive officer of Chemical or any Chemical Subsidiary, their spouses and children, any Affiliate of or
member of the same household as such persons, and any Person of which such persons, alone or together, have control.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
SEC Reports</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.33(a)</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Share-Based Awards</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.4(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Shareholder Approval</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(e)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Shareholder Meeting</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(e)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">84</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Shareholders</I></B></FONT>&rdquo; shall mean the shareholders of <FONT STYLE="color: windowtext">Chemical</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Chemical
Site</I></B>&rdquo; shall mean a Site with respect to Chemical or any Chemical Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&ldquo;<B><I>Chemical Stock
Option</I></B>&rdquo; means any grant of an option to purchase a share or shares of Chemical Common Stock under any Chemical Stock
Plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Stock Plan</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.4(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Subsidiary</I></B>&rdquo; shall have the meaning set forth in <U>Section 4.1(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Superior Proposal</I></B></FONT>&rdquo; shall mean any bona fide written <FONT STYLE="color: windowtext">Chemical Takeover Proposal
</FONT>that the <FONT STYLE="color: windowtext">Chemical Board </FONT>has determined in its good faith judgment, after consultation
with its financial advisors and outside legal counsel, is reasonably likely to be consummated in accordance with its terms and
that is reasonably likely to result in the consummation of a transaction more favorable to the <FONT STYLE="color: windowtext">Chemical
Shareholders </FONT>than the <FONT STYLE="color: windowtext">Merger</FONT>, taking into account such factors as the <FONT STYLE="color: windowtext">Chemical
Board </FONT>in good faith deems relevant, <FONT STYLE="color: windowtext">including </FONT>legal, financial, regulatory and other
aspects of the proposal, and any changes to the terms of this <FONT STYLE="color: windowtext">Agreement </FONT>proposed by <FONT STYLE="color: windowtext">Talmer
</FONT>in response to such proposal or otherwise. For purposes of the definition of &ldquo;<FONT STYLE="color: windowtext">Chemical
Superior Proposal</FONT>,&rdquo; the references to &ldquo;<FONT STYLE="color: windowtext">ten percent (10%)</FONT>&rdquo; in the
definition of <FONT STYLE="color: windowtext">Chemical Takeover Proposal </FONT>shall <FONT STYLE="color: windowtext">be deemed
to be references to &ldquo;fifty percent (50%)</FONT>.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Chemical
Takeover Proposal</I></B></FONT>&rdquo; shall mean any inquiry, proposal, or offer from any <FONT STYLE="color: windowtext">Person
</FONT>(other than <FONT STYLE="color: windowtext">Talmer </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries</FONT>) or
&ldquo;<FONT STYLE="color: windowtext">group</FONT>&rdquo;, within the meaning of Section&nbsp;13(d) of the <FONT STYLE="color: windowtext">Exchange
Act</FONT>, of <FONT STYLE="color: windowtext">Persons </FONT>relating to, in a single transaction or series of related transactions
(other than any single transaction or series of related transactions to which Talmer has consented to in writing), any (i)&nbsp;acquisition
of assets of <FONT STYLE="color: windowtext">Chemical </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>equal
to more than <FONT STYLE="color: windowtext">ten percent (10%) </FONT>of <FONT STYLE="color: windowtext">Chemical</FONT>&rsquo;s
consolidated assets or to which more than <FONT STYLE="color: windowtext">ten percent (10%) </FONT>of <FONT STYLE="color: windowtext">Chemical</FONT>&rsquo;s
net income on a consolidated basis are attributable; (ii)&nbsp;acquisition of more than <FONT STYLE="color: windowtext">ten percent
(10%) </FONT>of the outstanding <FONT STYLE="color: windowtext">Chemical Common Stock </FONT>or the capital stock of any Chemical
<FONT STYLE="color: windowtext">Subsidiary</FONT>; (iii)&nbsp;tender offer or exchange offer that, if consummated, would result
in any <FONT STYLE="color: windowtext">Person </FONT>or <FONT STYLE="color: windowtext">group of Persons </FONT>beneficially owning
more than <FONT STYLE="color: windowtext">ten percent (10%) </FONT>of the outstanding <FONT STYLE="color: windowtext">Chemical
Common Stock</FONT>; (iv)&nbsp;<FONT STYLE="color: windowtext">merger</FONT>, consolidation, share exchange, business combination,
recapitalization, liquidation, dissolution, or similar transaction involving <FONT STYLE="color: windowtext">Chemical </FONT>or
any of its <FONT STYLE="color: windowtext">Subsidiaries</FONT>; or (v)&nbsp;any combination of the foregoing types of transactions
if the sum of the percentage of consolidated assets, consolidated net income, and <FONT STYLE="color: windowtext">Chemical Common
Stock </FONT>involved is more than <FONT STYLE="color: windowtext">ten percent (10%)</FONT>, in each case, other than the <FONT STYLE="color: windowtext">Merger</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Claim</I></B>&rdquo;
shall have the meaning set forth in <U>Section 6.6(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Closing&rdquo;</I></B>
shall have the meaning set forth in <U>Section 10.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Closing
Date</I></B>&rdquo; shall have the meaning set forth in <U>Section 10.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Code</I></B>&rdquo;
shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">85</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Collective
Bargaining Agreement</I></B>&rdquo; means any Contract that has been entered into with any labor organization, union, works council,
employee representative or association.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Confidentiality
Agreement</I></B></FONT>&rdquo; shall mean that certain <FONT STYLE="color: windowtext">Confidentiality Agreement</FONT>, dated
as of November 2, 2015, by and between <FONT STYLE="color: windowtext">Chemical </FONT>and <FONT STYLE="color: windowtext">Talmer</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Contract</I></B></FONT>&rdquo;
shall mean any <FONT STYLE="color: windowtext">agreement</FONT>, contract, commitment, arrangement, memorandum of understanding,
side letter, understanding, contractual obligation or other instrument of a contractual nature, whether written or oral.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Covered
Employees</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.5(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Data
Conversion</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.15</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Derivative
Transaction</I></B></FONT>&rdquo; shall mean any swap transaction, option, warrant, forward purchase or sale transaction, futures
transaction, cap transaction, floor transaction, or collar transaction relating to one or more currencies, commodities, bonds,
equity securities, loans, interest rates, prices, values, or other financial or nonfinancial assets, credit-related events, or
conditions or any indices, or any other similar transaction or combination of any of these transactions, <FONT STYLE="color: windowtext">including
</FONT>collateralized mortgage obligations or other similar instruments or any debt or equity instruments evidencing or embedding
any such types of transactions, and any related credit support, collateral, or other similar arrangements related to such transactions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Effective
Time</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.2</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>End
Date</I></B>&rdquo; shall have the meaning set forth in <U>Section 8.1(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Environmental
Claim</I></B></FONT>&rdquo; shall mean any and all administrative or judicial actions, suits, orders, claims, liens, notices, notices
of violations, investigations, complaints, requests for information, proceedings, or other communication (written or oral), whether
criminal or civil, pursuant to or relating to any applicable <FONT STYLE="color: windowtext">Environmental Law</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Environmental
Law</I></B></FONT>&rdquo; shall mean any and all <FONT STYLE="color: windowtext">Laws</FONT>, <FONT STYLE="color: windowtext">Environmental
Permits</FONT>, or binding agreements with any <FONT STYLE="color: windowtext">Governmental Entity</FONT>, relating to the protection
of health and the environment, or governing the handling, use, generation, treatment, storage, transportation, disposal, manufacture,
distribution, formulation, packaging, labeling, or <FONT STYLE="color: windowtext">Release </FONT>of or exposure to <FONT STYLE="color: windowtext">Hazardous
Materials</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Environmental
Permit</I></B></FONT>&rdquo; shall mean any <FONT STYLE="color: windowtext">Permit </FONT>required or issued by any <FONT STYLE="color: windowtext">Governmental
Entity </FONT>under or in connection with any <FONT STYLE="color: windowtext">Environmental Law</FONT>, <FONT STYLE="color: windowtext">including
</FONT>without limitation, any and all orders, consent orders or binding agreements issued by or entered into with a <FONT STYLE="color: windowtext">Governmental
Entity </FONT>under any applicable <FONT STYLE="color: windowtext">Environmental Law</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Equity
Award Exchange Ratio</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>ERISA</I></B></FONT>&rdquo;
shall mean the <FONT STYLE="color: windowtext">Employee Retirement Income Security Act of 1974</FONT>, as amended and <FONT STYLE="color: windowtext">including
</FONT>the regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">86</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>ERISA
Affiliate</I></B></FONT>&rdquo; shall mean any entity that is a member of (i) a controlled group of corporations (as defined in
Section 414(b) of the <FONT STYLE="color: windowtext">Code</FONT>), (ii) a group of trades or businesses under common <FONT STYLE="color: windowtext">control
</FONT>(as defined in Section 414(c) of the <FONT STYLE="color: windowtext">Code</FONT>), (iii) an affiliated service group (as
defined under Section 414(m) of the <FONT STYLE="color: windowtext">Code </FONT>or the regulations under Section 414(o) of the
<FONT STYLE="color: windowtext">Code</FONT>), or (iv) a &ldquo;<FONT STYLE="color: windowtext">controlled group</FONT>&rdquo; within
the meaning of <FONT STYLE="color: windowtext">Section 4001 of ERISA</FONT>, any of which <FONT STYLE="color: windowtext">includes
Talmer </FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries </FONT>or <FONT STYLE="color: windowtext">Chemical </FONT>or
any of its <FONT STYLE="color: windowtext">Subsidiaries</FONT>, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Exchange
Act</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Securities Exchange Act of 1934, as amended</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Exchange
Agent</I></B>&rdquo; shall have the meaning set forth in <U>Section 2.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Exchange
Fund</I></B>&rdquo; shall have the meaning set forth in <U>Section 2.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Exchange
Ratio</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.4(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>FDIC</I></B></FONT>&rdquo;
shall mean the Federal Deposit Insurance Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Federal
Reserve Board</I></B></FONT>&rdquo; shall mean the Board of Governors of the Federal Reserve System or its delegees.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Form
S-4</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(a)</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>GAAP</I></B></FONT>&rdquo;
shall mean United States generally accepted accounting principles.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Governmental
Entity</I></B></FONT>&rdquo; shall mean any entity or body exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to United States federal, state or local government or other non-United States international, multinational
or other government, <FONT STYLE="color: windowtext">including </FONT>any department, commission, board, agency, instrumentality,
political subdivision, bureau, official or other regulatory, administrative or judicial authority thereof and any self-regulatory
organization.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Gramm-Leach-Bliley
Act</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Gramm-Leach-Bliley Act of 1999</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Hazardous
Material</I></B>&rdquo; shall mean petroleum, petroleum hydrocarbons or petroleum products, petroleum by-products, radioactive
materials, asbestos or asbestos-containing materials, gasoline, diesel fuel, pesticides, radon, urea formaldehyde, mold, lead or
lead-containing materials, or polychlorinated biphenyls; and any other chemicals, materials, substances or wastes in any amount
or concentration that are regulated under or for which liability can be imposed under any Environmental Law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Indemnified
Party</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.6(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Injunction</I></B>&rdquo;
shall have the meaning set forth in <U>Section 7.1(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Intended
Tax Treatment</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.8</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Joint
Proxy Statement</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">87</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Knowledge</I></B></FONT>&rdquo;
shall mean the actual knowledge (without investigation) of such <FONT STYLE="color: windowtext">Person</FONT>&rsquo;s senior executive
officers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Law</I></B>&rdquo;
shall mean any statute, law, ordinance, rule, code, executive order, common law, injunction, judgment, decree, Order or regulation
of any Governmental Entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Liability</I></B>&rdquo;
shall mean all indebtedness, obligations and other liabilities and contingencies of a Person, whether absolute, accrued, contingent,
fixed or otherwise, or whether due or to become due.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Lien</I></B></FONT>&rdquo;
shall mean, with respect to any property or asset, any mortgage, lien, pledge, security interest, hypothecation or other encumbrance
affecting such property or asset.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Material
Adverse Effect</I></B></FONT>&rdquo; shall mean with respect to <FONT STYLE="color: windowtext">Talmer</FONT>, <FONT STYLE="color: windowtext">Chemical</FONT>,
or the Surviving Corporation, as the case may be, any fact, event, change, condition, development, circumstance, or effect that,
individually or in the aggregate, <FONT STYLE="color: windowtext">(i) </FONT>is or would be reasonably likely to be material and
adverse to the business, assets, liabilities, properties, results of operations, or financial condition of such <FONT STYLE="color: windowtext">Party
</FONT>and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>taken as a whole (<I>provided, however</I>, that, with respect
to this clause <FONT STYLE="color: windowtext">(i)</FONT>, a <FONT STYLE="color: windowtext">Material Adverse Effect </FONT>shall
not be deemed to <FONT STYLE="color: windowtext">include </FONT>any adverse fact, event, change, condition, development, circumstance
or effect to the extent arising from (A) changes, after the date hereof, in <FONT STYLE="color: windowtext">GAAP </FONT>or regulatory
accounting requirements applicable to banks and their holding companies, generally, in each case except to the extent such <FONT STYLE="color: windowtext">Party
</FONT>is affected in a disproportionate manner as compared to other community banks and their holding companies in the midwestern
United States, (B) changes, after the date hereof, in <FONT STYLE="color: windowtext">Laws </FONT>of general applicability to banks
and their holding companies, generally, or interpretations thereof by <FONT STYLE="color: windowtext">Governmental Entities</FONT>,
in each case except to the extent such <FONT STYLE="color: windowtext">Party </FONT>is affected in a disproportionate manner as
compared to other community banks and their holding companies in the midwestern United States, (C) changes, after the date hereof,
in global or national political conditions (<FONT STYLE="color: windowtext">including </FONT>the outbreak of war or acts of terrorism)
or in general economic or market conditions affecting banks and their holding companies, generally, in each case except to the
extent such <FONT STYLE="color: windowtext">Party </FONT>is affected in a disproportionate manner as compared to other community
banks and their holding companies in the midwestern United States, (D) the taking of any <FONT STYLE="color: windowtext">action
</FONT>required or expressly permitted by, or the failure to take any <FONT STYLE="color: windowtext">action </FONT>prohibited
by, this <FONT STYLE="color: windowtext">Agreement</FONT>, (E) the announcement or pendency of this <FONT STYLE="color: windowtext">Agreement
</FONT>or the transactions contemplated hereby, (F) the occurrence of any natural or man-made disaster, or (G) acts or omissions
of (1)&nbsp;<FONT STYLE="color: windowtext">Talmer </FONT>prior to the <FONT STYLE="color: windowtext">Effective Time </FONT>taken
at the written request of <FONT STYLE="color: windowtext">Chemical </FONT>or with the prior written consent of <FONT STYLE="color: windowtext">Chemical
</FONT>or (2)&nbsp;<FONT STYLE="color: windowtext">Chemical </FONT>prior to the <FONT STYLE="color: windowtext">Effective Time
</FONT>taken at the written request of <FONT STYLE="color: windowtext">Talmer </FONT>or with the prior written consent of <FONT STYLE="color: windowtext">Talmer);</FONT>
or (ii) prohibits or materially impairs or would be reasonably likely to materially impair the ability of such <FONT STYLE="color: windowtext">Party
</FONT>to timely consummate the <FONT STYLE="color: windowtext">Merger </FONT>and the related transactions contemplated by this
<FONT STYLE="color: windowtext">Agreement</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Materially
Burdensome Regulatory Condition</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.1(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Maximum
Amount</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.6(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">88</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>MBCA</I></B>&rdquo;
shall have the meaning set forth in <U>Section 1.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Merger</I></B>&rdquo;
shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Merger
Consideration</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.4(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Michigan
Banking Code</I></B>&rdquo; means the Michigan Banking Code of 1999, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Multiemployer
Plan</I></B>&rdquo; means a multiemployer plan within the meaning of Section 3(37) of ERISA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>NASDAQ</I></B></FONT>&rdquo;
shall mean the NASDAQ Global Select Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>NLRB</I></B>&rdquo;
shall mean the National Labor Relations Board.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Option
Cancellation Agreements</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Option
Cash-Out Consideration</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Order</I></B></FONT>&rdquo;
shall mean any award, <FONT STYLE="color: windowtext">injunction</FONT>, judgment, decree, order, ruling or verdict or other similar
decision issued, promulgated or entered by or with any <FONT STYLE="color: windowtext">Governmental Entity </FONT>of competent
jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Party</I></B></FONT><B><I>(ies<FONT STYLE="color: windowtext">)</FONT></I></B><FONT STYLE="color: windowtext">&rdquo;
shall have the meaning set forth in the <U>Preamble</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Permit</I></B>&rdquo;
shall mean any grant, exemption, declaration, registration, filing, order, authorization, approval, consent, exception, accreditation,
certificate, license, permit or franchise of, from or required by any Governmental Entity of competent jurisdiction or pursuant
to any Law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Permitted
Liens</I></B></FONT>&rdquo; shall mean with respect to any <FONT STYLE="color: windowtext">Person</FONT>, (a) <FONT STYLE="color: windowtext">Liens
</FONT>for <FONT STYLE="color: windowtext">Taxes </FONT>that are not yet due and payable or that may hereafter be paid without
material penalty or that are being contested in good faith for which adequate accruals or reserves have been established on the
books and records of such <FONT STYLE="color: windowtext">Person</FONT>, (b) statutory <FONT STYLE="color: windowtext">Liens </FONT>of
landlords and workers&rsquo;, carriers&rsquo; and mechanics&rsquo; or other like <FONT STYLE="color: windowtext">Liens incurred
in the ordinary course of business </FONT>for amounts that are not yet due and payable or that are being contested in good faith
for which adequate accruals or reserves have been established on the books and records of such <FONT STYLE="color: windowtext">Person</FONT>,
(c) <FONT STYLE="color: windowtext">Liens </FONT>and encroachments that do not materially interfere with the present use of the
properties or assets they affect, (d) <FONT STYLE="color: windowtext">Liens </FONT>that will be released prior to or as of the
<FONT STYLE="color: windowtext">Closing</FONT>, (e) <FONT STYLE="color: windowtext">Liens </FONT>that are disclosed on the most
recent consolidated balance sheet of such <FONT STYLE="color: windowtext">Person </FONT>or notes thereto included in the <FONT STYLE="color: windowtext">Talmer
SEC Reports </FONT>or <FONT STYLE="color: windowtext">Chemical SEC Reports</FONT>, as applicable, or securing liabilities reflected
on such balance sheet, (f) <FONT STYLE="color: windowtext">Liens </FONT>that were <FONT STYLE="color: windowtext">incurred in the
ordinary course of business </FONT>since the date of the most recent consolidated balance sheet of such <FONT STYLE="color: windowtext">Person</FONT>,
(g) <FONT STYLE="color: windowtext">Liens </FONT>set forth in <U>Section 9</U> of the <FONT STYLE="color: windowtext">Talmer Disclosure
Schedules </FONT>or <U>Section 9</U> of the <FONT STYLE="color: windowtext">Chemical Disclosure Schedules</FONT>, and (h) with
respect to real property, whether owned or leased, <FONT STYLE="color: windowtext">any Lien that has not had, and would not reasonably
be </FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">89</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">expected to have, individually or in the aggregate, a Material Adverse Effect on Talmer </FONT>or a <FONT STYLE="color: windowtext">Material
Adverse Effect </FONT>on <FONT STYLE="color: windowtext">Chemical</FONT>, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Person</I></B></FONT>&rdquo;
shall mean an individual, corporation, partnership, limited <FONT STYLE="color: windowtext">liability </FONT>company, joint venture,
association, trust, unincorporated organization, or other entity (<FONT STYLE="color: windowtext">including </FONT>its permitted
successors and assigns).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Regulatory
Agreement</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.12</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Regulatory
Approvals</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.1(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Release</I></B>&rdquo;
shall mean any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, migrating, leaching,
dumping or disposing of a Hazardous Material.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Representatives</I></B>&rdquo;
means, with respect to any Person, the officers, directors, managers, members, employees, consultants, accountants, brokers, financial
advisors, legal counsel, agents, advisors and other representatives of that Person or of the Subsidiaries of that Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>SEC</I></B></FONT>&rdquo;
shall mean the Securities and Exchange Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Securities
Act</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Securities Act of 1933</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Site</I></B>&rdquo;
shall mean, with respect to any Person, any real properties (in each case, including all soil, subsoil, surface waters and groundwater
thereat) currently or previously owned, leased or operated by: (a) such Person or any of its Subsidiaries; (b) any predecessors
of such Person or any of its Subsidiaries; or (c) any entities previously owned by such Person or any of its Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Stock
Consideration</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.4(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Subsidiary</I></B></FONT>&rdquo;
shall mean, when used with respect to either <FONT STYLE="color: windowtext">Party</FONT>, any bank, corporation, partnership,
limited <FONT STYLE="color: windowtext">liability </FONT>company, or other entity or organization, whether incorporated or unincorporated,
that is consolidated with such <FONT STYLE="color: windowtext">Party </FONT>for financial reporting purposes under <FONT STYLE="color: windowtext">GAAP.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Subsidiary
Plan of Merger</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.9</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Support
Agreement</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Surviving
Bank</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Surviving
Corporation</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Surviving
Corporation Stock Award</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Surviving
Corporation Stock Option</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">90</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Takeover
Statute</I></B></FONT>&rdquo; shall mean any &ldquo;moratorium,&rdquo; &ldquo;<FONT STYLE="color: windowtext">control </FONT>share
acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;shareholder protection,&rdquo; &ldquo;takeover,&rdquo; or &ldquo;interested
shareholder&rdquo; <FONT STYLE="color: windowtext">Law </FONT>applicable to either <FONT STYLE="color: windowtext">Talmer </FONT>or
<FONT STYLE="color: windowtext">Chemical</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer</I></B>&rdquo;
shall have the meaning set forth in the <U>Preamble</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Acquisition Agreement</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.9(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Adverse Recommendation Change</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.9(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Articles</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Articles of Incorporation of Talmer</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Bank</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Talmer
Benefit Plan</I></B>&rdquo; shall mean (a) any &ldquo;employee benefit plan&rdquo; within the meaning of Section 3(3) of ERISA,
(b) any Talmer Stock Plan, and (c) any deferred compensation, retirement, defined contribution, defined benefit, pension, profit
sharing, employee welfare, fringe benefit, flexible spending account, stock purchase, stock option, stock ownership, phantom stock,
stock appreciation rights, restricted stock, restricted stock units, severance, separation, employment, change in control, vacation
pay, leave of absence, layoff, salary continuation, sick leave, excess benefit, bonus or other incentive compensation, day or dependent
care, legal services, cafeteria, health, life, accident, disability, workers&rsquo; compensation or other insurance, or other employee
benefit plan, or Contract, program, or practice, whether written or oral, for the benefit of Talmer&rsquo;s current or former officers,
employees, independent contractors, or directors, in each case either (i) existing at the Closing Date and sponsored, maintained,
or contributed to by Talmer or any Talmer Subsidiary, or (ii) existing at the Closing Date or prior thereto, in respect of which
Talmer or any Talmer Subsidiary has any Liability.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Board</I></B>&rdquo; shall have the meaning set forth in the <U>Recitals</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Board Recommendation</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Bylaws</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Bylaws of Talmer</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Talmer
Call Reports</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.5(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Capital Stock</I></B></FONT>&rdquo; shall mean the <FONT STYLE="color: windowtext">Talmer Common Stock, the Talmer Class B Common
Stock, </FONT>and the <FONT STYLE="color: windowtext">Talmer Preferred Stock.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Certificates</I></B>&rdquo; shall have the meaning set forth in <U>Section 2.1</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Class B Common Stock</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.4(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Common Stock</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.4(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Talmer
Continuing Directors</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">91</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Disclosure Schedules</I></B>&rdquo; shall have the meaning set forth in <U>Article III</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Expense Reimbursement</I></B>&rdquo; shall mean </FONT>the out-of-pocket fees and expenses (<FONT STYLE="color: windowtext">including
</FONT>fees and expenses of financial advisors, outside legal counsel, accountants, experts, consultants, and other <FONT STYLE="color: windowtext">representatives</FONT>)
actually incurred by or on behalf of <FONT STYLE="color: windowtext">Talmer </FONT>in connection with the authorization, preparation,
negotiation, execution, or performance of this <FONT STYLE="color: windowtext">Agreement </FONT>and the transactions contemplated
by this <FONT STYLE="color: windowtext">Agreement </FONT>and the due diligence and evaluation by <FONT STYLE="color: windowtext">Talmer
</FONT>of the transactions contemplated by this <FONT STYLE="color: windowtext">Agreement</FONT>, in an aggregate amount not to
exceed $<FONT STYLE="color: windowtext">3,000,000</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Financial Statements</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.5(a)</U></FONT><U>.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Investment Banker</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.22</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Talmer
Material Contract</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.17(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer-Owned
Intellectual Property</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.15</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Preferred Stock</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.4(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Talmer-Related
Person</I></B>&rdquo; shall mean any shareholder owning five percent (5%) or more of the issued and outstanding Talmer Common Stock,
any director or executive officer of Talmer or any Talmer Subsidiary, his or her spouses and children, any Affiliate of or member
of the same household as such persons, and any Person of which such persons, alone or together, have control.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
SEC Reports</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.33(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Share-Based Awards</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.4(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Shareholder Approval</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Shareholder Meeting</I></B>&rdquo; shall have the meaning set forth in <U>Section 6.3(c)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Shareholders</I></B></FONT>&rdquo; shall mean the shareholders of <FONT STYLE="color: windowtext">Talmer</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Talmer
Site</I></B>&rdquo; shall mean a Site with respect to Talmer or any Talmer Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Stock Award</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(d)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Stock Options</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Stock Plans</I></B>&rdquo; shall have the meaning set forth in <U>Section 1.5(a)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Subsidiary</I></B>&rdquo; shall have the meaning set forth in <U>Section 3.1(b)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Superior Proposal</I></B></FONT>&rdquo; shall mean any bona fide written <FONT STYLE="color: windowtext">Talmer Takeover Proposal
</FONT>that the <FONT STYLE="color: windowtext">Talmer Board </FONT>has determined in its good faith judgment, after consultation
</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">92</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">with its financial advisors and outside legal counsel, is reasonably likely to be consummated in accordance with its terms and
that is reasonably likely to result in the consummation of a transaction more favorable to the <FONT STYLE="color: windowtext">Talmer
Shareholders </FONT>than the <FONT STYLE="color: windowtext">Merger</FONT>, taking into account such factors as the <FONT STYLE="color: windowtext">Talmer
Board </FONT>in good faith deems relevant, <FONT STYLE="color: windowtext">including </FONT>legal, financial, regulatory and other
aspects of the proposal, and any changes to the terms of this <FONT STYLE="color: windowtext">Agreement </FONT>proposed by <FONT STYLE="color: windowtext">Chemical
</FONT>in response to such proposal or otherwise. For purposes of the definition of &ldquo;<FONT STYLE="color: windowtext">Talmer
Superior Proposal</FONT>,&rdquo; the references to &ldquo;<FONT STYLE="color: windowtext">ten percent (10%)</FONT>&rdquo; in the
definition of <FONT STYLE="color: windowtext">Talmer Takeover Proposal </FONT>shall <FONT STYLE="color: windowtext">be deemed to
be references to &ldquo;fifty percent (50%)</FONT>.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Talmer
Takeover Proposal</I></B></FONT>&rdquo; shall mean any inquiry, proposal, or offer from any <FONT STYLE="color: windowtext">Person
</FONT>(other than <FONT STYLE="color: windowtext">Chemical </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries</FONT>)
or &ldquo;<FONT STYLE="color: windowtext">group</FONT>&rdquo;, within the meaning of Section&nbsp;13(d) of the <FONT STYLE="color: windowtext">Exchange
Act</FONT>, of <FONT STYLE="color: windowtext">Persons </FONT>relating to, in a single transaction or series of related transactions
(other than any single transaction or series of related transactions to which Chemical has consented to in writing), any (i)&nbsp;acquisition
of assets of <FONT STYLE="color: windowtext">Talmer </FONT>and its <FONT STYLE="color: windowtext">Subsidiaries </FONT>equal to
more than <FONT STYLE="color: windowtext">ten percent (10%) </FONT>of <FONT STYLE="color: windowtext">Talmer</FONT>&rsquo;s consolidated
assets or to which more than <FONT STYLE="color: windowtext">ten percent (10%) </FONT>of <FONT STYLE="color: windowtext">Talmer</FONT>&rsquo;s
net income on a consolidated basis are attributable; (ii)&nbsp;acquisition of more than <FONT STYLE="color: windowtext">ten percent
(10%) </FONT>of the outstanding <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>or the capital stock of any Talmer <FONT STYLE="color: windowtext">Subsidiary</FONT>;
(iii)&nbsp;tender offer or exchange offer that, if consummated, would result in any <FONT STYLE="color: windowtext">Person </FONT>or
<FONT STYLE="color: windowtext">group of Persons </FONT>beneficially owning more than <FONT STYLE="color: windowtext">ten percent
(10%) </FONT>of the outstanding <FONT STYLE="color: windowtext">Talmer Common Stock</FONT>; (iv)&nbsp;<FONT STYLE="color: windowtext">merger</FONT>,
consolidation, share exchange, business combination, recapitalization, liquidation, dissolution, or similar transaction involving
<FONT STYLE="color: windowtext">Talmer </FONT>or any of its <FONT STYLE="color: windowtext">Subsidiaries</FONT>; or (v)&nbsp;any
combination of the foregoing types of transactions if the sum of the percentage of consolidated assets, consolidated net income,
and <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>involved is more than <FONT STYLE="color: windowtext">ten percent
(10%)</FONT>, in each case, other than the <FONT STYLE="color: windowtext">Merger</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Tax</I></B>&rdquo;<B><I>
or </I></B>&ldquo;<B><I>Taxes</I></B>&rdquo;<B><I> </I></B>shall mean any and all federal, state, local, or foreign net or gross
income, gross receipts, net proceeds, sales, use, ad valorem, value added, franchise, withholding, payroll, employment, excise,
property, abandoned property, escheat, deed, stamp, alternative or add-on minimum, environmental, profits, windfall profits, transaction,
license, lease, service, service use, occupation, severance, energy, transfer, real property transfer, recording, documentary,
stamp, registration, unemployment, social security, workers&rsquo; compensation, capital, premium, and other governmental taxes,
assessments, customs, duties or levies, whether disputed or not, together with any interest, penalties, additions to tax, or additional
amounts with respect thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Tax
Return</I></B>&rdquo; shall mean a report, return, or other information (including any amendments) required to be supplied to a
Governmental Entity with respect to Taxes, including, where permitted or required, combined or consolidated returns for any group
of entities that includes Talmer or any of its Subsidiaries or that includes Chemical or any of its Subsidiaries, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Termination
Fee</I></B>&rdquo; shall have the meaning set forth in <U>Section 8.2(a)(i)</U></FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">93</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Transaction
Documents</I></B></FONT>&rdquo; means (a) the <FONT STYLE="color: windowtext">Joint Proxy Statement</FONT>, (b) the <FONT STYLE="color: windowtext">Form
S-4</FONT>, and (c) any other documents to be filed with the <FONT STYLE="color: windowtext">SEC</FONT>, the <FONT STYLE="color: windowtext">Federal
Reserve Board </FONT>or any other <FONT STYLE="color: windowtext">Governmental Entity </FONT>in connection with the <FONT STYLE="color: windowtext">Merger</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="color: windowtext"><B><I>Trust
Account Shares</I></B></FONT>&rdquo; shall mean any shares of <FONT STYLE="color: windowtext">Talmer Common Stock </FONT>held in
trust accounts (<FONT STYLE="color: windowtext">including </FONT>grantor or rabbi trust accounts), managed accounts, and the like,
or otherwise held in a fiduciary or agency capacity, that are beneficially owned by third parties.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
X</FONT><BR>
GENERAL PROVISIONS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U></FONT>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">On the terms and subject to conditions set forth in this Agreement, the
closing of the Merger (the &ldquo;<B><I>Closing</I></B>&rdquo;) shall take place at 10:00 a.m., or at another time designated by
the Parties, on a date and at a place to be specified by the Parties, which date shall be no later than five (5) Business Days
after the satisfaction or waiver (subject to applicable Law) of the latest to occur of the conditions set forth in <U>Article VII</U>
(other than those conditions that by their nature are to be satisfied or waived at the Closing), unless extended by mutual agreement
of the Parties (the &ldquo;<B><I>Closing Date</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Nonsurvival
of Representations, Warranties and Agreements</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">None of the representations,
warranties, covenants, and agreements set forth in this Agreement or in any instrument delivered pursuant to this Agreement shall
survive the Effective Time, except for those other covenants and agreements contained in this Agreement that by their terms apply
or are to be performed in whole or in part after the Effective Time and this <U>Article X</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">All notices and other communications in connection with this Agreement
shall be in writing and shall be deemed given effective immediately if delivered personally, sent via facsimile (with confirmation),
mailed by registered or certified mail (return receipt requested), delivered by an express courier (with confirmation), or delivered
by email (with confirmation) to the Parties at the following addresses (or at such other address for a Party as shall be specified
by like notice):</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 7%; font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="width: 78%; font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">if to Chemical, to:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chemical Financial Corporation</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">235 E. Main Street</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">P.O. Box 569</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Midland, MI 48640</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: David B. Ramaker</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail: david.ramaker@chemicalbankmi.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>with a copy (which shall not constitute notice) to:</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chemical Financial Corporation</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">235 E. Main Street</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">P.O. Box 569</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Midland, MI 48640</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: William C. Collins, General Counsel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">94</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in; width: 15%">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in; width: 7%">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warner Norcross &amp; Judd LLP</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">900 Fifth Third Center</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">111 Lyon Street, N.W.</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Grand Rapids, MI 49503</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: Jeffrey A. Ott, Esq.</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Email: jott@wnj.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">if to Talmer, to:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Talmer Bancorp, Inc.</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">2301 W. Big Beaver Rd.</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Troy, MI 48084</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: David Provost</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Email: dprovost@talmerbank.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>with a copy (which shall not constitute notice) to:</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-weight: normal; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nelson Mullins Riley &amp; Scarborough LLP</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">201 17<SUP>th</SUP> Street NW</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Suite 1700</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Atlanta, GA 30363</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: J. Brennan Ryan, Esq.</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Email: brennan.ryan@nelsonmullins.com</FONT></TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Interpretation</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">When a reference is made in this Agreement to articles, sections, exhibits,
or schedules, such reference shall be to an article or section of, or exhibit or schedule to, this Agreement, unless otherwise
indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect
in any way the meaning or interpretation of this Agreement. Whenever the words &ldquo;include,&rdquo; &ldquo;includes,&rdquo;
or &ldquo;including&rdquo; are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without limitation.&rdquo;
The schedules and all exhibits hereto, shall be deemed part of this Agreement and included in any reference to this Agreement.
This Agreement shall not be interpreted or construed to require any Person to take any action, or fail to take any action, if
to do so would violate any applicable Law. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Entire
<FONT STYLE="color: windowtext">Agreement</FONT></U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">This Agreement (including
the schedules and exhibits hereto, and the other documents and instruments referred to in this Agreement), together with the Confidentiality
Agreement, constitutes the entire agreement between the Parties and supersedes all prior agreements and understandings, both written
and oral, between the Parties with respect to the subject matter of this Agreement, other than the Confidentiality Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">95</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. <FONT STYLE="font-family: Times New Roman, Times, Serif">This
Agreement shall be governed and construed in accordance with the internal Laws of the State of Michigan applicable to contracts
made and performed within such state, without regard to any applicable conflict of laws principles.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exclusive Jurisdiction</U>.
Each of the Parties to this Agreement irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction
of the Circuit Courts of the State of Michigan or any federal courts of the United States of America sitting in the State of Michigan,
and any appellate courts from any thereof, in any Action or proceeding arising out of or relating to this Agreement or the transactions
contemplated by this Agreement, or for recognition or enforcement of any judgment, and agrees that all claims in respect of any
such Action or proceeding shall be heard and determined in such Michigan court or, to the extent permitted by Law, in such federal
court.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>.
Each of the Parties waives to the fullest extent permitted by applicable Law any right it may have to a trial by jury with respect
to any Action or proceeding directly or indirectly arising out of, under, or in connection with this Agreement or the transactions
contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Publicity</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">Neither Party shall, and neither Party shall permit any of its Subsidiaries
or agents to, issue or cause the publication of any press release or other public announcement with respect to the transactions
contemplated by this Agreement without the prior consent (which consent shall not be unreasonably withheld) of the other Party;
<I>provided, however</I>, that either Party may, without the prior consent of the other Party (but after prior consultation with
the other Party to the extent practicable under the circumstances) issue or cause the publication of any press release or other
public announcement to the extent required by Law or by the rules and regulations of NASDAQ after consultation with outside legal
counsel.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Assignment;
Third-<FONT STYLE="color: windowtext">Party </FONT>Beneficiaries</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither this
Agreement nor any of the rights, interests, or obligations under this Agreement shall be assigned by either of the Parties (whether
by operation of law or otherwise) without the prior written consent of the other Party. Subject to the preceding sentence, this
Agreement shall be binding upon, inure to the benefit of, and be enforceable by, each of the Parties and their respective successors
and assigns. Other than (i) as otherwise specifically provided in <U>Section 6.6</U> and (ii) <U>Articles I</U> and <U>II</U> (which,
after the Effective Time, shall be for the benefit of holders of Talmer Common Stock and any holder of an award granted under a
Talmer Stock Plan), this Agreement (including the documents and instruments referred to in this Agreement) is not intended to and
does not confer upon any Person other than the Parties any rights or remedies under this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
provision in this <FONT STYLE="color: windowtext">Agreement </FONT>modifies or amends or creates any employee benefit plan, program,
or document (each, a &ldquo;<FONT STYLE="color: windowtext"><B><I>Benefit Plan</I></B></FONT>&rdquo;) unless this <FONT STYLE="color: windowtext">Agreement
</FONT>explicitly states that the provision &ldquo;amends&rdquo; or &ldquo;creates&rdquo; that <FONT STYLE="color: windowtext">Benefit
Plan</FONT>, and no third <FONT STYLE="color: windowtext">party </FONT>shall be entitled to enforce any provision of this <FONT STYLE="color: windowtext">Agreement
</FONT>on the grounds that it is an amendment to, or a creation of, a <FONT STYLE="color: windowtext">Benefit Plan</FONT>, unless
that provision explicitly states that such enforcement rights are being conferred. This provision shall not prevent the <FONT STYLE="color: windowtext">Parties
</FONT>to this <FONT STYLE="color: windowtext"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">96</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="color: windowtext">Agreement </FONT>from enforcing any provision of this <FONT STYLE="color: windowtext">Agreement</FONT>.
If a <FONT STYLE="color: windowtext">Person </FONT>not entitled to enforce this <FONT STYLE="color: windowtext">Agreement </FONT>brings
a lawsuit or other <FONT STYLE="color: windowtext">action </FONT>to enforce any provision in this <FONT STYLE="color: windowtext">Agreement
</FONT>as an amendment to, or creation of a <FONT STYLE="color: windowtext">Benefit Plan</FONT>, and that provision is construed
to be such an amendment or creation despite not being explicitly designated as one in this <FONT STYLE="color: windowtext">Agreement</FONT>,
that provision shall lapse retroactively, thereby precluding it from having any effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: windowtext">10.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Enforcement</U>.
<FONT STYLE="font-family: Times New Roman, Times, Serif">The Parties agree that irreparable damage would occur in the event that
any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.
Accordingly, each of the Parties shall be entitled to seek specific performance of the terms hereof, including an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this
being in addition to any other remedy to which such Party is entitled at law or in equity. Each of the Parties hereby further waives
(a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any
Law to post security as a prerequisite to obtaining equitable relief.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. If
any term, provision, covenant, or restriction contained in this Agreement is held by a final and unappealable Order of a court
of competent jurisdiction to be invalid, void, or unenforceable, then the remainder of the terms, provisions, covenants, and restrictions
contained in this Agreement shall remain in full force and effect, and shall in no way be affected, impaired, or invalidated unless
the effect would be to cause this Agreement to not achieve its essential purposes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This
Agreement may be executed in one or more counterparts which, taken together, shall constitute one and the same instrument. Executed
counterparts of this Agreement shall be deemed to have been fully delivered and shall become legally binding if and when executed
signature pages are received by facsimile or electronic mail transmission from a Party. If so delivered by facsimile or electronic
mail transmission, the Parties agree, if requested by the other Party, to promptly send original, manually executed copies by nationwide
overnight delivery service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Construction</U>. The
Parties have participated jointly in the negotiation and drafting of this Agreement, and, in the event an ambiguity or question
of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the Parties, and no presumption or
burden of proof will arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">10.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculation of Dates
and Deadlines</U>. Unless otherwise specified, any period of time to be determined under this Agreement shall be deemed to commence
at 12:01 a.m. on the first full day after the specified starting date, event, or occurrence. Any deadline, due date, expiration
date, or period-end to be calculated under this Agreement shall be deemed to end at 11:59 p.m. on the last day of the specified
period. The time of day shall be determined with reference to the then-current local time in Michigan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">97</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
Chemical and Talmer have caused this Agreement to be executed by their respective duly authorized officers as of the date first
above written.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 12pt"><B>CHEMICAL FINANCIAL CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: left; vertical-align: top"><FONT STYLE="font-size: 12pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid">/s/ David B. Ramaker</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 12pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 12pt">David B. Ramaker</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 12pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 12pt">Chairman, Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 12pt">and President</FONT></TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 12pt"><B>TALMER BANCORP, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 12pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid">/s/ David Provost</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 12pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 12pt">David Provost</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 12pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 12pt">Chief Executive Officer and President</FONT></TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">Signature Page to
Merger Agreement</P>

<P STYLE="font: 12pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U></U></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT A-1</U></B></P>

<P STYLE="font: 12pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><BR>&nbsp;</B></P>

<P STYLE="font: 12pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF TALMER SUPPORT AGREEMENT</B></P>

<P STYLE="font: 12pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SUPPORT AGREEMENT </B></P>

<P STYLE="font: 12pt/12.5pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Support
Agreement is entered into between Chemical Financial Corporation and the undersigned director of Talmer Bancorp, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;).
The undersigned director hereby agrees in his or her individual capacity as a shareholder to vote his or her shares of Company
Common Stock that are registered in his or her personal name (and agrees to use his or her reasonable efforts to cause all additional
shares of Company Common Stock owned jointly by him or her with any other person or over which he or she has shared voting control
to be voted) in favor of the Agreement and Plan of Merger by and between Chemical Financial Corporation and Company, dated January
25, 2016 (the &ldquo;<B><I>Agreement</I></B>&rdquo;). In addition, the undersigned director hereby agrees, that until the earlier
of the record date of the Talmer Shareholder Meeting (as defined in the Agreement) or the termination of this Support Agreement,
that he or she will not make any transfers of shares of Company Common Stock with the purpose of avoiding his or her agreements
set forth in the preceding sentence and agrees to cause any permitted transferee of such shares to abide by the terms of this Support
Agreement. The undersigned is entering into this Support Agreement solely in his or her capacity as an individual shareholder and,
notwithstanding anything to the contrary in this Support Agreement, nothing in this Support Agreement is intended or shall be construed
to require the undersigned, (i) in his or her capacity as a director of Company or (ii) in his or her capacity as a trustee, personal
representative or other fiduciary capacity, to act or fail to act in accordance with his or her duties in such director or fiduciary
capacity. Furthermore, the undersigned does not make any agreement or understanding herein in his or her capacity as a director
of Company. Notwithstanding any contrary provision herein, this Support Agreement shall be effective from the date hereof and shall
terminate and be of no further force and effect upon the earliest of (a) the obtainment of the Talmer Shareholder Approval (as
defined in the Agreement); (b) the termination of the Agreement in accordance with its terms; or (c) a Talmer Adverse Recommendation
Change (as defined in the Agreement). This Support Agreement may be executed in any number of counterparts, each of which shall
be an original, but such counterparts shall together constitute one and the same instrument.</P>

<P STYLE="font: 12pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Dated this ___ day
of January, 2016.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CHEMICAL FINANCIAL CORPORATION</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 39%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">David B. Ramaker</FONT></TD>
    <TD STYLE="width: 54%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Its:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman, Chief Executive Officer and President</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid">
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">DIRECTOR</P>
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="width: 54%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">[Exhibit A-1]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U></U></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT A-2</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF CHEMICAL SUPPORT AGREEMENT</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/12.5pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SUPPORT AGREEMENT </B></P>

<P STYLE="font: 12pt/12.5pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Support
Agreement is entered into between Talmer Bancorp, Inc. and the undersigned director of Chemical Financial Corporation (the &ldquo;<B><I>Company</I></B>&rdquo;).
The undersigned director hereby agrees in his or her individual capacity as a shareholder to vote his or her shares of Company
Common Stock that are registered in his or her personal name (and agrees to use his or her reasonable efforts to cause all additional
shares of Company Common Stock owned jointly by him or her with any other person or over which he or she has shared voting control
to be voted) in favor of the Agreement and Plan of Merger by and between Talmer Bancorp, Inc. and Company, dated January 25, 2016
(the &ldquo;<B><I>Agreement</I></B>&rdquo;). In addition, the undersigned director hereby agrees, that until the earlier of the
record date of the Chemical Shareholder Meeting (as defined in the Agreement) or the termination of this Support Agreement, that
he or she will not make any transfers of shares of Company Common Stock with the purpose of avoiding his or her agreements set
forth in the preceding sentence and agrees to cause any permitted transferee of such shares to abide by the terms of this Support
Agreement. The undersigned is entering into this Support Agreement solely in his or her capacity as an individual shareholder and,
notwithstanding anything to the contrary in this Support Agreement, nothing in this Support Agreement is intended or shall be construed
to require the undersigned, (i) in his or her capacity as a director of Company or (ii) in his or her capacity as a trustee, personal
representative or other fiduciary capacity, to act or fail to act in accordance with his or her duties in such director or fiduciary
capacity. Furthermore, the undersigned does not make any agreement or understanding herein in his or her capacity as a director
of Company. Notwithstanding any contrary provision herein, this Support Agreement shall be effective from the date hereof and shall
terminate and be of no further force and effect upon the earliest of (a) the obtainment of the Chemical Shareholder Approval (as
defined in the Agreement); (b) the termination of the Agreement in accordance with its terms; or (c) a Chemical Adverse Recommendation
Change (as defined in the Agreement). This Support Agreement may be executed in any number of counterparts, each of which shall
be an original, but such counterparts shall together constitute one and the same instrument.</P>

<P STYLE="font: 12pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Dated this ___ day
of January, 2016.</P>

<P STYLE="font: 12pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">TALMER BANCORP, INC.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 39%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">David Provost</FONT></TD>
    <TD STYLE="width: 54%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Its:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer and President</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid">
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">DIRECTOR</P>
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="width: 54%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Exhibit A-2]</P>







</BODY>
</HTML>
</TEXT>
</DOCUMENT>
